Processing 00000000.tx.1: Neurotoxic Mechanisms Caused by the Alzheimer's Disease-linked Swedish Amyloid Precursor Protein Mutation OXIDATIVE STRESS, CASPASES, AND THE JNK PATHWAY* Celio A. 

Phrase: "Neurotoxic Mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "Caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "by the Alzheimer's Disease-linked Swedish Amyloid Precursor Protein Mutation OXIDATIVE STRESS,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   790   C0038435:Stress [Finding]
   790   C0311404:Oxidative [Functional Concept]
   718 E C0231297:Stressful [Functional Concept]

Phrase: "CASPASES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010656:Caspases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "AND"

Phrase: "THE JNK PATHWAY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1621396:JNK Pathway [Molecular Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "* Celio A."
Processing 00000000.tx.2: Marques, Uta Keil, Astrid Bonert, Barbara Steiner, Christian Haass, Walter E. 

Phrase: "Marques,"

Phrase: "Uta Keil,"

Phrase: "Astrid Bonert,"

Phrase: "Barbara Steiner,"

Phrase: "Christian Haass,"

Phrase: "Walter E."
Processing 00000000.tx.3: Mller and Anne Eckert From the Department of Pharmacology, Biocenter, University of Frankfurt, 60439 Frankfurt, Germany and the Department of Biochemistry, Adolf Butenandt Institute, 80336 Munich, Germany Received for publication, December 3, 2002 , and in revised form, April 23, 2003.  

Phrase: "Mller"

Phrase: "and"

Phrase: "Anne Eckert From the Department of Pharmacology,"

Phrase: "Biocenter,"

Phrase: "University of Frankfurt,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "60439 Frankfurt,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "and"

Phrase: "the Department of Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Adolf Butenandt Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021622:institute [Organization]
   827   C1272753:Institute [Idea or Concept]

Phrase: "80336 Munich,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "December 3,"

Phrase: "2002 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "April 23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "2003."
Processing 00000000.tx.4: ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Autosomal dominant forms of familial Alzheimer's disease (FAD) are caused by mutations of the amyloid precursor protein (APP) gene and by mutations of the genes encoding for presenilin 1 or presenilin 2. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Autosomal dominant forms of familial Alzheimer's disease (FAD)"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   757   C1832428:Familial form [Finding]
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "are"

Phrase: "caused by mutations of the amyloid precursor protein (APP) gene"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0596611:gene mutations [Genetic Function]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0017337:Gene [Gene or Genome]
   742   C0026882:Mutations [Genetic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]
   708   C0015127:cause [Functional Concept]
   708   C1524003:Cause [Conceptual Entity]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and by mutations of the genes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   767   C0596611:gene mutations [Genetic Function]
   753   C0017337:Genes [Gene or Genome]
   753   C0026882:Mutations [Genetic Function]
   753   C1515981:And [Idea or Concept]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "encoding for presenilin 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1418985:PRESENILIN 1 [Gene or Genome]
   770   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   770   C1547699:Encoding [Idea or Concept]
   770   C2700640:Encoding [Activity]

Phrase: "or"

Phrase: "presenilin 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.5: Simultaneously, evidence is provided that increased oxidative stress might play a crucial role in the rapid progression of the Swedish FAD. 

Phrase: "Simultaneously,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521115:simultaneously [Temporal Concept]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "is"

Phrase: "provided that"

Phrase: "increased oxidative stress"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   913   C0231298:Increased stress [Functional Concept]
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "might"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a crucial role in the rapid progression of the Swedish FAD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   735   C0035820:Role [Social Behavior]
   735   C1705810:Role [Conceptual Entity]
   713   C0680074:family role [Social Behavior]
Processing 00000000.tx.6: Here we investigated the effect of the Swedish double mutation (K670M/N671L) in the -amyloid precursor protein on oxidative stress-induced cell death mechanisms in PC12 cells. 

Phrase: "Here"

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the effect of the Swedish double mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0949293:double effect [Idea or Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "(K670M/N671L"

Phrase: ")"

Phrase: "in the -amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "on oxidative stress-induced cell death mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0441712:Mechanisms [Functional Concept]
   766 E C1706376:Mechanism [Manufactured Object]

Phrase: "in PC12 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.7: Western blot analysis and cleavage studies of caspase substrates revealed an elevated activity of the executor caspase 3 after treatment with hydrogen peroxide in cells containing the Swedish APP mutation. 

Phrase: "Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "studies of caspase substrates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C2603343:Study [Research Activity]
   737   C1710236:Substrate [Manufactured Object]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "an elevated activity of the executor caspase 3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C1150132:caspase-3 activity [Molecular Function]
   767   C1150130:caspase activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "after treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the Swedish APP mutation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0026882:Mutation [Genetic Function]
   804   C1705285:Mutation [Cell or Molecular Dysfunction]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
Processing 00000000.tx.8: This elevated activity is the result of the enhanced activation of both intrinsic and extrinsic apoptosis pathways, including activation of caspase 2 and caspase 8. 

Phrase: "This elevated activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "the result of the enhanced activation of both intrinsic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1274040:Result [Functional Concept]
   742   C1546471:Result [Idea or Concept]
   742   C2825142:Result [Finding]

Phrase: "and"

Phrase: "extrinsic apoptosis pathways,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   965   C3269136:extrinsic apoptotic pathway [Molecular Function]
   884   C0162638:Apoptosis Pathway [Cell Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]
   734   C3269138:extrinsic apoptosis [Molecular Function]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "activation of caspase 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1159825:Caspase Activation [Molecular Function]
   770   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "caspase 8."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0667830:caspase-8 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.9: Furthermore, we observed an enhanced activation of JNK pathway and an attenuation of apoptosis by SP600125, a JNK inhibitor, through protection of mitochondrial dysfunction and reduction of caspase 9 activity. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "an enhanced activation of JNK pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "an attenuation of apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0599946:Attenuation [Activity]

Phrase: "by SP600125,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0968383:SP600125 [Organic Chemical,Pharmacologic Substance]

Phrase: "a JNK inhibitor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "through protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1545588:Protection [Finding]

Phrase: "of mitochondrial dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "reduction of caspase 9 activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C2267000:Reduction Activity [Molecular Function]
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.10: Our findings provide evidence that the massive neurodegeneration in early age of FAD patients could be a result of an increased vulnerability of neurons through activation of different apoptotic pathways as a consequence of elevated levels of oxidative stress.  

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the massive neurodegeneration in early age of FAD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "could"

Phrase: "be"

Phrase: "a result of an increased vulnerability of neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]

Phrase: "through activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of different apoptotic pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   848   C0162638:Apoptosis Pathway [Cell Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "as a consequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "of elevated levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.11: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Alzheimer's disease is the most frequent neurodegenerative disorder in the aged population and is characterized by the presence of senile plaques and neurofibrillary tangles in the brain. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "the most frequent neurodegenerative disorder in the aged population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0524851:Neurodegenerative Disorder [Disease or Syndrome]
   742   C0012634:Disorder [Disease or Syndrome]

Phrase: "and"

Phrase: "is"

Phrase: "characterized by the presence of senile plaques"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   748   C0392079:Senile [Finding]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1880022:Characterized [Activity]
   714 E C0011389:Plaque [Disease or Syndrome]
   714 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "neurofibrillary tangles in the brain."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   806   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   773 E C3543859:neurofibrillary tangle [Cell Component]
Processing 00000000.tx.12: Senile plaques are deposits of amyloid--protein (A),1 which arises by proteolysis from the amyloid precursor protein (APP) through an initial -secretase cleavage by the aspartyl protease beta-site APP-cleaving enzyme (1, 2) followed by an intramembranous cut of -secretase, which resides in a high molecular weight complex composed of presenilin (3), nicastrin (46), PEN-2 (5), and probably Aph-1 (6). 

Phrase: "Senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "are"

Phrase: "deposits of amyloid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C2936349:Amyloid Deposits [Acquired Abnormality]
   790   C0333562:Deposits [Functional Concept]

Phrase: "--"

Phrase: "protein (A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "which"

Phrase: "arises by proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0597304:Proteolysis [Molecular Function]
   718 E C1947941:proteolytic [Enzyme]

Phrase: "from the amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "through an initial -secretase cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]

Phrase: "by the aspartyl protease beta-site APP-cleaving enzyme (1,"
Meta Candidates (Total=23; Excluded=1; Pruned=0; Remaining=22)
   870   C1414078:BETA PROTEIN 1 [Gene or Genome]
   844   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
           amyloid precursor protein
   836   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]
   835   C1750295:beta protein [Genetic Function]
   835   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   821   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   813   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   813   C2825879:Amyloid, Beta [Laboratory Procedure]
   804   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0014442:Enzyme [Enzyme,Organic Chemical]
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0205145:Site [Spatial Concept]
   790   C0330390:Beta [Plant]
   790   C0439096:Beta [Intellectual Product]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1515974:Site [Body Location or Region]
   790   C1709634:Precursor [Idea or Concept]
   790   C2004068:Beta [Qualitative Concept]
   790   C2825164:Site [Spatial Concept]
   706 E C0014445:enzymes [Functional Concept]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "followed by an intramembranous cut of -secretase,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0000925:Cut [Injury or Poisoning]
   748   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1883724:CUT [Phenomenon or Process]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "which"

Phrase: "resides in a high molecular weight complex"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C1979900:High molecular weight [Qualitative Concept]
   778   C0026385:Molecular Weight [Quantitative Concept]
   774   C0948775:high weight [Sign or Symptom]
   748   C0005910:weight [Organism Attribute]
   748   C0043100:Weight [Quantitative Concept]
   748   C0205250:High [Qualitative Concept]
   748   C0439855:Complex [Qualitative Concept]
   748   C1299351:High [Qualitative Concept]
   748   C1305866:weight [Diagnostic Procedure]
   748   C1521991:Molecular [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]
   748   C1705104:Weight [Idea or Concept]
   748   C2700149:HIGH [Intellectual Product]
   748   C2982691:Reside [Activity]

Phrase: "composed of presenilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "nicastrin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538050:NICASTRIN [Gene or Genome]

Phrase: "(46"

Phrase: ")"

Phrase: ","

Phrase: "PEN-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3541303:PEN-2 [Gene or Genome]
   861   C3273588:Pen [Manufactured Object]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "probably Aph-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0750492:Probably [Idea or Concept]
   827   C1332101:APH [Gene or Genome]
   827   C1705550:APH [Gene or Genome]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.13: Several mutations in the APP and presenilin genes cause some forms of familial Alzheimer's disease (FAD) (79). 

Phrase: "Several mutations in the APP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "presenilin genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "some"

Phrase: "forms of familial Alzheimer's disease"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   862   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   797   C1832428:Familial form [Finding]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "(FAD"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: ")"

Phrase: "(79"

Phrase: ")."
Processing 00000000.tx.14: These mutations alter APP processing with respect to an enhanced A production (10, 11) and have been associated with an increased vulnerability to cell death (1215). 

Phrase: "These mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "APP processing with respect to an enhanced"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0033666:protein processing [Molecular Function]
   742   C1709694:Processing [Activity]

Phrase: "A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "(10,"

Phrase: "11"

Phrase: ")"

Phrase: "and"

Phrase: "have"

Phrase: "been"

Phrase: "associated with an increased vulnerability"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "to cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(1215"

Phrase: ")."
Processing 00000000.tx.15: -Secretase cleavage of the Swedish double mutation form of APP (APPsw; K670M/N671L) occurs in Golgi-derived secretory vesicles, whereas wild-type APP (APPwt) must be reinternalized before -secretase cleavage (16). 

Phrase: "-Secretase cleavage of the Swedish double mutation form of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   751   C0597304:Protein Cleavage [Molecular Function]
   736   C0010813:cleavage [Cell Function]
   736   C0596311:Cleavage [Phenomenon or Process]
   736   C1330957:cleavage [Cell Function]

Phrase: "(APPsw"

Phrase: "; K670M/N671L"

Phrase: ")"

Phrase: "occurs in Golgi-derived secretory vesicles,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0886515:Secretory Vesicles [Cell Component]
   767   C0230767:Golgi vesicle [Cell Component]
   753   C0018042:Golgi [Cell Component]
   753   C0333262:VESICLES [Acquired Abnormality]
   753   C1327616:Secretory [Cell Function]
   753   C1441547:Derived [Qualitative Concept]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]
   753   C3245521:derived [Idea or Concept]
   719 E C1622418:vesicle [Cell Component]

Phrase: "whereas"

Phrase: "wild-type APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "(APPwt"

Phrase: ")"

Phrase: "must"

Phrase: "be"

Phrase: "reinternalized"

Phrase: "before -secretase cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.16: This altered APP production leads to a 36-fold increased A production of both A-(140) and A-(142) (17, 18), which probably possess the same structural peptide architecture (19, 20). 

Phrase: "This altered APP production"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0033268:production [Occupational Activity]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "leads to a 36-fold"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0181586:leads [Medical Device]
   760   C0332462:Fold [Spatial Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1880834:FOLD [Phenomenon or Process]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "A production of both A-(140"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: ")"

Phrase: "and"

Phrase: "A-(142"

Phrase: ")"

Phrase: "(17,"

Phrase: "18"

Phrase: ")"

Phrase: ","

Phrase: "which probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "the same structural peptide architecture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003737:Architecture [Occupation or Discipline]

Phrase: "(19,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.17: Recent reports have demonstrated an intraneuronal A accumulation in transgenic mice expressing FAD proteins (21). 

Phrase: "Recent reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "an intraneuronal"

Phrase: "A accumulation in transgenic mice"

Phrase: "expressing"

Phrase: "FAD proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   708   C0277558:Familial disease [Disease or Syndrome]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.18: Alzheimer mice transgenic for APPsw mutation, but not wild-type mice, exhibited an age-dependent increase in soluble A-(140) and A-(142) levels and progressive amyloid deposition in brain (22, 23). 

Phrase: "Alzheimer mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "transgenic for APPsw mutation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003069:Transgenic [Animal]

Phrase: "but"

Phrase: "not wild-type mice,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   890   C1520150:Wild Type Mouse [Mammal]
   861   C1883559:Wild Type [Organism Attribute]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "an age-dependent increase in soluble A-(140"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "A-(142"

Phrase: ")"

Phrase: "levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "progressive amyloid deposition in brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0011560:Amyloid deposition [Pathologic Function]
   806   C1705760:Amyloid Deposition [Finding]
   760   C0333562:Deposition [Functional Concept]

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.19: Despite all of these findings, the underlying mechanisms responsible for the massive neurodegeneration in early age of FAD patients are still not completely understood. 

Phrase: "Despite all"

Phrase: "of these findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "the underlying mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "responsible for the massive neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "in early age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "of FAD patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0030705:Patients [Patient or Disabled Group]
   756   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   708   C0277558:Familial disease [Disease or Syndrome]

Phrase: "are"

Phrase: "still"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "understood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]
Processing 00000000.tx.20: Persuasive evidence indicates that oxidative stress plays an important role in the neuropathological process in AD (2427). 

Phrase: "Persuasive evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "indicates"

Phrase: "that oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in the neuropathological process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in AD (2427"

Phrase: ")."
Processing 00000000.tx.21: AD-related mutations probably enhance oxidative stress. 

Phrase: "AD-related mutations probably"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.22: Increased oxidative stress levels have been found in the temporal inferior cortex from Swedish FAD patients (28), and brains of mice transgenic for human presenilin 1 show reduced antioxidative enzyme activity (29). 

Phrase: "Increased oxidative stress levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   844   C1319127:Stress level [Finding]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   708   C0231298:Increased stress [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "found in the temporal inferior cortex"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   783   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   753   C0007776:Cortex [Body Part, Organ, or Organ Component]
   753   C0150312:Found [Quantitative Concept]
   753   C0442043:Temporal [Spatial Concept]
   753   C0542339:Inferior [Spatial Concept]
   753   C0678975:inferior [Social Behavior]
   753   C1176472:Cortex [Body Part, Organ, or Organ Component]
   753   C2362314:Temporal [Temporal Concept]
   753   C2700441:Cortex [Plant]
   719 E C0243095:Find [Finding]

Phrase: "from Swedish FAD patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030705:Patients [Patient or Disabled Group]
   717   C0276496:Alzheimer disease, familial [Disease or Syndrome]

Phrase: "(28"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "brains of mice"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   824   C1521713:Mouse Brain [Tissue]
   790   C0006104:Brains [Body Part, Organ, or Organ Component]
   756 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "transgenic for human presenilin 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003069:Transgenic [Animal]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "reduced antioxidative enzyme activity"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   902   C0086439:Reduced Activity [Sign or Symptom]
   861   C0243102:enzyme activity [Molecular Function]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.23: Moreover, convincing evidence indicates that A is neurotoxic, probably via an apoptotic pathway (12, 3034). 

Phrase: "Moreover,"

Phrase: "convincing"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "indicates"

Phrase: "that"

Phrase: "A"

Phrase: "is"

Phrase: "neurotoxic, probably via an apoptotic pathway"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C0162638:Apoptosis Pathway [Cell Function]
   753   C0750492:Probably [Idea or Concept]
   753   C1516044:Apoptotic [Qualitative Concept]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]

Phrase: "(12,"

Phrase: "3034"

Phrase: ")."
Processing 00000000.tx.24: A is believed to play a major role in promoting neuronal degeneration and death by rendering neurons vulnerable to age-related increases in levels of oxidative stress and impairments in cellular energy metabolism (32, 35). 

Phrase: "A"

Phrase: "is"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a major role in promoting neuronal degeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "death by rendering neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C2754100:neuron death [Cell Function]
   770   C0011065:Death [Organism Function]
   770   C1306577:Death, NOS [Finding]

Phrase: "vulnerable to age-related increases"

Phrase: "in levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "of oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "impairments in cellular energy metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0684336:Impairments [Pathologic Function]
   760   C2598156:Impairments [Clinical Attribute]

Phrase: "(32,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.25: New evidence indicates that reactive oxygen species-induced cellular events implicate the activation of mitogen-activated protein kinases (36, 37). 

Phrase: "New evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "indicates"

Phrase: "that reactive oxygen species-induced cellular events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0441471:Events [Event]
   799   C3541888:Events [Classification]

Phrase: "implicate"

Phrase: "the activation of mitogen-activated protein kinases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   788   C1819041:protein kinase activation [Cell Function]
   774   C0599177:protein activation [Genetic Function]
   748   C1879547:Activation [Activity]

Phrase: "(36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.26: Oxidative stress may cause the activation of c-Jun N-terminal kinase (JNK; also known as stress-activated protein kinase) in degenerating neurons in AD (38). 

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "may"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the activation of c-Jun N-terminal kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1879547:Activation [Activity]

Phrase: "(JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "; also"

Phrase: "known as stress-activated protein kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0872280:stress activated protein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0018850:stress protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0038435:Stress [Finding]
   753   C0205309:Known [Qualitative Concept]
   753   C1879547:Activated [Activity]
   719 E C1515877:Activate [Functional Concept]

Phrase: ")"

Phrase: "in degenerating neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in AD (38"

Phrase: ")."
Processing 00000000.tx.27: An involvement of JNK pathway by the induction of Fas ligand in A-induced neuronal apoptosis was described by Morishima et al. 

Phrase: "An involvement of JNK pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "by the induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of Fas ligand"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0253023:Fas Ligand [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1515370:Fas Ligand [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0023688:Ligand [Chemical]

Phrase: "in A-induced neuronal apoptosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   825   C1660771:neuron apoptosis [Cell Function]
   812   C0162638:Apoptosis [Cell Function]
   741 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "was"

Phrase: "described by Morishima et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.28: (39). 

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.29: Activation of JNK and p38 associated with amyloid deposition was observed in mice transgenic for the human APPsw mutation (40). 

Phrase: "Activation of JNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "p38"

Phrase: "associated with amyloid deposition"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0011560:Amyloid deposition [Pathologic Function]
           Amyloid
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1705760:Amyloid Deposition [Finding]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0333562:Deposition [Functional Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "was"

Phrase: "observed in mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
   790   C1441672:Observed [Functional Concept]

Phrase: "transgenic for the human APPsw mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0003069:Transgenic [Animal]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.30: The inhibition of the JNK pathway was proposed as a potential therapeutic target in AD (41). 

Phrase: "The inhibition of the JNK pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "was"

Phrase: "proposed as a potential therapeutic target"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   753   C0302350:Therapeutic [Functional Concept]
   753   C1441414:PROPOSED [Idea or Concept]
   753   C1521840:Target [Functional Concept]
   753   C1553874:Proposed [Qualitative Concept]
   753   C1578820:Proposed [Idea or Concept]
   753   C2986546:TARGET [Diagnostic Procedure]
   753   C3245505:Potential [Qualitative Concept]

Phrase: "in AD (41"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0101467:AD 41 [Organic Chemical]

Phrase: ")."
Processing 00000000.tx.31: Caspases can be divided into initiator caspases and effector caspases based on the presence of a large prodomain at their amino-terminal region. 

Phrase: "Caspases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010656:Caspases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "can"

Phrase: "be"

Phrase: "divided into initiator caspases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1720986:Caspases, Initiator [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0010656:Caspases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0332849:Divided [Functional Concept]
   770   C1444748:Initiator [Qualitative Concept]

Phrase: "and"

Phrase: "effector caspases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720985:Caspases, Effector [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:Caspases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "based on the presence of a large prodomain"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0549177:Large [Quantitative Concept]
   744   C1527178:Based [Functional Concept]
   744   C1705938:Based [Idea or Concept]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1880279:Base [Biomedical or Dental Material]

Phrase: "at their amino-terminal region."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0017446:Region [Geographic Area]
   827   C0205088:Terminal [Temporal Concept]
   827   C0205147:Region [Spatial Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.32: Initiator caspases containing a long prodomain, like caspase 2, caspase 8, caspase 9, and caspase 10 generally act in early stages of a proteolytic cascade, whereas effector caspases, like caspase 3, caspase 6, and caspase 7 act downstream and are involved in the cleavage of specific cellular proteins (for a review, see Refs. 42 and 43). 

Phrase: "Initiator caspases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720986:Caspases, Initiator [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:Caspases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a long prodomain,"

Phrase: "like caspase 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "caspase 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0667830:caspase-8 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "caspase 9,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0910167:caspase-9 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "caspase 10 generally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0758959:caspase-10 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "act in early stages of a proteolytic cascade,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C2363430:early stages [Temporal Concept]
   754 E C1517886:Early Stage [Classification]
   744   C0079613:ACT [Therapeutic or Preventive Procedure]
   744   C0597304:Proteolytic [Molecular Function]
   744   C1279919:Early [Temporal Concept]
   744   C1306673:Stages [Qualitative Concept]
   744   C1707310:Cascade [Manufactured Object]
   744   C1947941:proteolytic [Enzyme]
   711 E C0205390:Stage [Temporal Concept]
   711 E C1300072:Stage [Clinical Attribute]

Phrase: "whereas"

Phrase: "effector caspases,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720985:Caspases, Effector [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:Caspases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "like caspase 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "caspase 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0538091:caspase-6 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "caspase 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0537969:caspase-7 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "downstream"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522506:Downstream [Spatial Concept]

Phrase: "and"

Phrase: "are"

Phrase: "involved in the cleavage of specific cellular proteins"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   750   C0597304:Protein Cleavage [Molecular Function]
   744   C0007634:Cellular [Cell]
   744   C0010813:cleavage [Cell Function]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0178539:Cellular [Functional Concept]
   744   C0205369:Specific [Qualitative Concept]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C1314939:Involved [Functional Concept]
   744   C1330957:cleavage [Cell Function]
   744   C1552740:specific [Intellectual Product]

Phrase: "("

Phrase: "for a review,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Refs. 42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: "and"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.33: Among the identified caspases, caspase 3 is of particular interest, since it appears to be very important in the progression of AD (12, 44, 45). 

Phrase: "Among the identified caspases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010656:Caspases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "caspase 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is of particular interest,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0543488:Interest [Mental Process]

Phrase: "since"

Phrase: "it"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "very important in the progression of AD (12,"

Phrase: "44,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.34: In addition to caspase 3, other caspases have been associated with AD (4649). 

Phrase: "In addition to caspase 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "other caspases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010656:Caspases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "have"

Phrase: "been"

Phrase: "associated with AD (4649"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.35: Here we report on the effects of FAD-related APP mutation, using stably transfected PC12 (rat pheochromocytoma) cells expressing the Swedish mutant APP, wild-type APP, or empty vector. 

Phrase: "Here"

Phrase: "we"

Phrase: "report on the effects"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0684224:Report [Intellectual Product]
   770   C0700287:Report [Health Care Activity]
   770   C1280500:effects [Qualitative Concept]
   770   C3273238:Report [Intellectual Product]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "of FAD-related APP mutation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0026882:Mutation [Genetic Function]
   793   C1705285:Mutation [Cell or Molecular Dysfunction]
   704   C0611285:Alzheimer's Disease Amyloid Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1955168:Alzheimer precursor protein [Amino Acid, Peptide, or Protein]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "stably transfected PC12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085262:PC-12 [Cell]
   827   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]

Phrase: "(rat pheochromocytoma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031511:Pheochromocytoma [Neoplastic Process]
   861   C2697417:PHEOCHROMOCYTOMA [Gene or Genome]

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the Swedish mutant APP,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "wild-type APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "or"

Phrase: "empty vector."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
   861   C1880497:Empty [Qualitative Concept]
   805 E C0333668:Depleted [Functional Concept]
   777 E C1550032:Unload [Idea or Concept]
   777 E C1996907:Emptying [Activity]
Processing 00000000.tx.36: We examined the effect of hydrogen peroxide on the activation of different caspases and the JNK pathway to elucidate the relationship between mutant APP expression, increased A production, and neuronal cell death. 

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effect of hydrogen peroxide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on the activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of different caspases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010656:Caspases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "the JNK pathway to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1621396:JNK Pathway [Molecular Function]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "elucidate"

Phrase: "the relationship between mutant APP expression,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0439849:Relationship [Qualitative Concept]
   744   C1705630:Relationship [Idea or Concept]
   744   C1706279:Relationship [Idea or Concept]
   744   C3540605:Relationship [Intellectual Product]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "A production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "neuronal cell death."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C2754100:neuronal cell death [Cell Function]
           neuron death
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.37: Furthermore, we investigated the protective effects of caspase inhibitors as well as JNK inhibitor in preventing oxidative stress-mediated cell death.  

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the protective effects of caspase inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "as well as"

Phrase: "JNK inhibitor in preventing oxidative stress-mediated cell death."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.38: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  MaterialsPhospho-JNK (Thr183/Tyr185) and phospho-c-Jun (Ser63) antibodies were purchased from Cell Signaling Technology, and cytochrome c antibody was from BD Biosciences. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "MaterialsPhospho-JNK (Thr183/Tyr185"

Phrase: ")"

Phrase: "and"

Phrase: "phospho-c-Jun"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Ser63"

Phrase: ")"

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "purchased from Cell Signaling Technology,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0037083:Cell Signaling [Cell Function]
           Signaling
   760   C0007634:Cell [Cell]
   760   C0039421:Technology [Occupation or Discipline]
   760   C0869011:purchased [Activity]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3537152:signaling [Biologic Function]
   726 E C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "cytochrome c antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
   734   C1153524:cytochrome c [Molecular Function]
   734   C1426584:CYTOCHROME C [Gene or Genome]

Phrase: "was from BD Biosciences."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.39: Rat-specific caspase 3 and caspase 9 antibodies were also purchased from Cell Signaling Technology. 

Phrase: "Rat-specific caspase 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1567334:caspase 3, rat [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "caspase 9 antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   896   C1320096:Caspase antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0910167:caspase-9 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "also"

Phrase: "purchased from Cell Signaling Technology."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0037083:Cell Signaling [Cell Function]
           Signaling
   760   C0007634:Cell [Cell]
   760   C0039421:Technology [Occupation or Discipline]
   760   C0869011:purchased [Activity]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3537152:signaling [Biologic Function]
   726 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.40: Caspase 2 antibody was purchased from Alexis. 

Phrase: "Caspase 2 antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1320096:Caspase antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "purchased from Alexis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0445425:alexis [Intellectual Product]
   790   C0869011:purchased [Activity]
Processing 00000000.tx.41: Caspase 8 antibody was from Biocat. 

Phrase: "Caspase 8 antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1320096:Caspase antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0667830:caspase-8 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was from Biocat."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.42: The caspase substrates were purchased from Calbiochem (Ac-DEVD-para-nitroaniline (pNA), Ac-VEID-pNA, Ac-VDVAD-pNA, and Ac-IETD-pNA for caspase 3, caspase 6, caspase 2, and caspase 8, respectively). 

Phrase: "The caspase substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "were"

Phrase: "purchased from Calbiochem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(Ac-DEVD-para-nitroaniline (pNA),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0048553:para-nitroaniline [Organic Chemical]
   812   C0030563:Para [Finding]
   812   C0068820:nitroaniline [Organic Chemical]

Phrase: "Ac-VEID-pNA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0048553:para-nitroaniline [Organic Chemical]
   812   C0030563:Para [Finding]
   812   C0068820:nitroaniline [Organic Chemical]

Phrase: "Ac-VDVAD-pNA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0048553:para-nitroaniline [Organic Chemical]
   812   C0030563:Para [Finding]
   812   C0068820:nitroaniline [Organic Chemical]

Phrase: "and"

Phrase: "Ac-IETD-pNA for caspase 3,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0048553:para-nitroaniline [Organic Chemical]
   774   C0233072:Para 3 [Finding]
   748   C0030563:Para [Finding]
   748   C0068820:nitroaniline [Organic Chemical]

Phrase: "caspase 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0538091:caspase-6 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "caspase 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "caspase 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0667830:caspase-8 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.43: JNK inhibitor II (SP600125; anthrax(1,9-cd)pyrazol-6(2H)-one) was from Calbiochem. 

Phrase: "JNK inhibitor II"

Phrase: "(SP600125"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0968383:SP600125 [Organic Chemical,Pharmacologic Substance]

Phrase: "; anthrax"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003175:Anthrax [Disease or Syndrome]
  1000   C1254288:Anthrax [Eukaryote]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "9-cd)pyrazol-6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0072662:Pyrazol [Organic Chemical]

Phrase: "(2H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: ")-"

Phrase: "one)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "was from Calbiochem."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.44: Cell Culture and TransfectionThe generation and characterization of PC12 cell lines expressing human APPwt-, mutant APP (APPsw)-, and vector-transfected control clones have been described previously (12). 

Phrase: "Cell Culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "TransfectionThe generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: "and"

Phrase: "characterization of PC12 cell lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "expressing"

Phrase: "human APPwt-,"

Phrase: "mutant APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "(APPsw"

Phrase: ")-"

Phrase: ","

Phrase: "and"

Phrase: "vector-transfected control clones"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0009013:Clones [Cell]
   779 E C1522642:Clone [Tissue]
   729 E C1704387:Clonal [Qualitative Concept]
   708   C0031249:vector control [Occupational Activity]
   706 E C0796368:clonality [Diagnostic Procedure]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.45: In brief, PC12 cells were transfected with DNA constructs harboring human mutant (APPsw; K670M/N671L) or wild-type APP (APPwt) gene, inserted downstream of a cytomegalovirus promotor, using the FUGENE technique (Roche Applied Science). 

Phrase: "In brief, PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with DNA constructs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   816   C0012931:DNA Construct [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   737   C2827421:Construct [Classification]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "human mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(APPsw"

Phrase: "; K670M/N671L"

Phrase: ")"

Phrase: "or"

Phrase: "wild-type APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "(APPwt"

Phrase: ")"

Phrase: "gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "inserted downstream of a cytomegalovirus promotor,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0010825:Cytomegalovirus [Virus]
   753   C0086860:promotor [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0441587:Inserted [Health Care Activity]
   753   C0522506:Downstream [Spatial Concept]
   719 E C1743766:Insert [Medical Device]
   719 E C1883719:Insert [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the FUGENE technique"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449851:Technique [Functional Concept]
   777 E C0025664:techniques [Intellectual Product]

Phrase: "(Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0681834:Applied Science [Research Activity]
   827   C0036397:Science [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: ")."
Processing 00000000.tx.46: The transfected cell lines APPwt PC12, APPsw PC12, and vector-transfected PC12 were cultured in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal calf serum, 5% heat-inactivated horse serum, 50 units/ml penicillin, 50 g/ml streptomycin, and 400 g/ml G418 at 37 C in a humidified incubator containing 5% CO2. 

Phrase: "The transfected cell lines APPwt PC12, APPsw"

Phrase: "PC12,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085262:PC-12 [Cell]
  1000   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "vector-transfected PC12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085262:PC-12 [Cell]
   827   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "cultured in Dulbecco's modified Eagle's medium"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   767   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagle [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1551720:Eagle [Population Group]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "supplemented with 10% heat-inactivated fetal calf serum,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0015965:Fetal [Embryonic Structure]
   744   C0018837:Heat [Natural Phenomenon or Process]
   744   C0229671:Serum [Body Substance]
   744   C0230445:Calf [Body Location or Region]
   744   C0521457:Fetal [Functional Concept]
   744   C1305418:Calf [Body Part, Organ, or Organ Component]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]
   711   C0242295:Supplement [Food]
   711   C1947943:Supplement [Intellectual Product]
   711   C2348609:Supplement [Functional Concept]

Phrase: "5% heat-inactivated horse serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C1518416:Serum, Horse [Immunologic Factor]
   804   C0019944:Horse [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C0242616:Horse [Mammal]
   804   C1265527:Horse [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "50 units/ml penicillin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030842:Penicillin [Antibiotic,Organic Chemical]
   812   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "50 g/ml streptomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "400 g/ml G418 at 37 C in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0052009:G418 [Antibiotic,Organic Chemical]

Phrase: "a humidified incubator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021178:Incubator [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5% CO2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]
Processing 00000000.tx.47: The stably transfected clones (APPwt M5, N10, and U7 and APPsw Q8 and Q9) were selected for the present study based on their similar expression of APP695 and the 5-fold increased secretion of A-(140) in the APPsw clones (Fig. 1). 

Phrase: "The stably transfected clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0009013:Clones [Cell]
   793 E C1522642:Clone [Tissue]
   743 E C1704387:Clonal [Qualitative Concept]
   721 E C0796368:clonality [Diagnostic Procedure]

Phrase: "(APPwt M5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1550079:M5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C1561481:M5 [Intellectual Product]

Phrase: "N10,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0442788:N10 [Finding]
  1000   C1367453:N10 [Gene or Genome]
  1000   C1705265:N10 [Gene or Genome]

Phrase: "and"

Phrase: "U7"

Phrase: "and"

Phrase: "APPsw Q8"

Phrase: "and"

Phrase: "Q9"

Phrase: ")"

Phrase: "were"

Phrase: "selected for the present study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
   726   C1707391:Select [Activity]

Phrase: "based on their similar expression of APP695"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C1527178:Based [Functional Concept]
   748   C1705938:Based [Idea or Concept]
   748   C2348205:Similar [Qualitative Concept]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "the 5-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "secretion of A-(140"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]

Phrase: ")"

Phrase: "in the APPsw clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.48: To rule out potential influences on the APP expression levels, APPsw and APPwt clones were routinely screened in parallel to the experiments presented in this work. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out potential influences on the APP expression levels,"

Phrase: "APPsw"

Phrase: "and"

Phrase: "APPwt clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "routinely"

Phrase: "screened"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0220908:screen [Health Care Activity]
   966   C1305399:screen [Functional Concept]
   966   C1705053:Screen [Medical Device]

Phrase: "in parallel to the experiments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0150312:In [Quantitative Concept]
   760   C0332285:In [Spatial Concept]
   760   C2348042:Parallel [Qualitative Concept]
   760   C2826345:PARALLEL [Research Activity]

Phrase: "presented in this work."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0043227:Work [Occupational Activity]
   770   C0449450:Presented [Idea or Concept]
   737 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.49: No alterations in the expression of APP were found. 

Phrase: "No alterations in the expression of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1515926:Alteration [Idea or Concept]

Phrase: "were"

Phrase: "found."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]
Processing 00000000.tx.50: View larger version (37K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(37K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.51: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.52: Expression of human APP in transfected cell lines. 

Phrase: "Expression of human APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in transfected cell lines."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.53: A, representative Western blot. neo, PC12 vector-transfected cell line; 

Phrase: "A,"

Phrase: "representative Western blot. neo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1366752:NEO [Gene or Genome]

Phrase: "PC12 vector-transfected cell line"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   875   C0085262:PC12 Cell [Cell]
   840   C0007600:Cell Line [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:Line [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.54: wtM5, wtN10, and wtU7, PC12 clones stably transfected with pCMV695wt; 

Phrase: "wtM5,"

Phrase: "wtN10,"

Phrase: "and"

Phrase: "wtU7,"

Phrase: "PC12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085262:PC-12 [Cell]
  1000   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]

Phrase: "clones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]

Phrase: "stably"

Phrase: "transfected with pCMV695wt"

Phrase: ";"
Processing 00000000.tx.55: swQ8 and swO9, PC12 clones stably transfected with pCMV695sw. 

Phrase: "swQ8"

Phrase: "and"

Phrase: "swO9,"

Phrase: "PC12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085262:PC-12 [Cell]
  1000   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]

Phrase: "clones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]

Phrase: "stably"

Phrase: "transfected with pCMV695sw."
Processing 00000000.tx.56: The higher molecular weight band differs from the posttranslational modification of APP. 

Phrase: "The higher molecular weight band"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0175723:Band [Medical Device]
   812   C0439645:Band [Spatial Concept]
   812   C1521913:band [Cell Component]
   740   C1979900:High molecular weight [Qualitative Concept]

Phrase: "differs from the posttranslational modification of APP."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   781   C0033666:Protein Modification, Post-Translational [Molecular Function]
           Post-Translational Modification
           Protein Modification
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   762   C2263112:protein modification [Molecular Function]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0392747:Modification [Functional Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1554963:modification [Qualitative Concept]
   742   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.57: Human APP expression was similar in APPsw and APPwt clones. 

Phrase: "Human APP expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1171362:protein expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "similar in APPsw"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "APPwt clones."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]
Processing 00000000.tx.58: B, analyzed conditioned media for A. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "conditioned media for A."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.59: The clones expressing the Swedish mutant APPsw showed a 45-fold increase in the A-(140) production when compared with the APPwt clones (ANOVA; ***, p < 0.001; **, p < 0.01 versus swO9 and swQ8; +++, p < 0.001 versus swQ8; ++, p < 0.01 versus swO9 (Tukey's post hoc test)). 

Phrase: "The clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0009013:Clones [Cell]
   966 E C1522642:Clone [Tissue]
   916 E C1704387:Clonal [Qualitative Concept]
   893 E C0796368:clonality [Diagnostic Procedure]

Phrase: "expressing"

Phrase: "the Swedish mutant APPsw"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a 45-fold increase in the A-(140"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: ")"

Phrase: "production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "when"

Phrase: "compared with the APPwt clones"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0009013:Clones [Cell]
   760   C1707455:Compared [Activity]
   726 E C1522642:Clone [Tissue]

Phrase: "(ANOVA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: ";"

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "swO9"

Phrase: "and"

Phrase: "swQ8"

Phrase: "; +++,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "swQ8"

Phrase: "; ++,"

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "swO9"

Phrase: "(Tukey's post hoc test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.60: The increase in the production of A-(1-40) was confirmed in three independent experiments for each clone. 

Phrase: "The increase in the production of A-(1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: ")"

Phrase: "was"

Phrase: "confirmed in three independent experiments"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0085862:Independent [Idea or Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C0521093:confirmed [Qualitative Concept]
   760   C0681814:Experiments [Research Activity]
   760   C0750484:Confirmed [Idea or Concept]
   760   C1299583:Independent [Finding]
   726 E C1456348:Confirm [Qualitative Concept]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "for each clone."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]
   928 E C1704387:Clonal [Qualitative Concept]
   900 E C0796368:clonality [Diagnostic Procedure]
Processing 00000000.tx.61: PC12 cells bearing human APPwt showed only a 23-fold increase in A production compared with vector-transfected PC12 cells (ANOVA; *, p < 0.05; *, p < 0.05 versus APPwt M5, N10, and U7 (Tukey's post hoc test)). 

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "human APPwt"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a 23-fold increase in A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "compared with vector-transfected PC12 cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   790   C0085262:PC12 Cells [Cell]
           PC-12
   753   C0007634:Cells [Cell]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   753   C1705099:Vector [Idea or Concept]
   753   C1707455:Compared [Activity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(ANOVA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: ";"

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "APPwt M5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1550079:M5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C1561481:M5 [Intellectual Product]

Phrase: "N10,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0442788:N10 [Finding]
  1000   C1367453:N10 [Gene or Genome]
  1000   C1705265:N10 [Gene or Genome]

Phrase: "and"

Phrase: "U7"

Phrase: "(Tukey's post hoc test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.62: C, increase in apoptotic cells after treatment with H2O2 in different clones from each cell line. 

Phrase: "C,"

Phrase: "increase in apoptotic cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "after treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "in different clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "from each cell line."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007600:Cell Line [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:Line [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.63: Apoptotic cell death was assessed by propidium iodide staining and flow cytometry. 

Phrase: "Apoptotic cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0162638:apoptotic cell death [Cell Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "assessed by propidium iodide staining"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0021966:Iodide [Inorganic Chemical]
   760   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1516048:Assessed [Activity]
   760   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "flow cytometry."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016263:Flow Cytometry [Laboratory Procedure]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0814048:Cytometry [Laboratory Procedure]
Processing 00000000.tx.64: APPsw PC12 cells showed enhanced sensitivity to oxidative stress-induced death compared with APPwt and vector cells (ANOVA; p < 0.001). 

Phrase: "APPsw PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "enhanced sensitivity to oxidative stress-induced death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]
   743   C0332324:Sensitive to [Functional Concept]

Phrase: "compared with APPwt and vector cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   753   C0007634:Cells [Cell]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   753   C1707455:Compared [Activity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(ANOVA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "; p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.65: Difference from pCMV695sw PC12 cells was as follows: Tukey's post hoc test: ***, p < 0.001; 

Phrase: "Difference from pCMV695sw PC12 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "was"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "Tukey's post hoc test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]

Phrase: ":"

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.66: **, p < 0.01 versus swO9 and swQ8; 

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "swO9"

Phrase: "and"

Phrase: "swQ8"

Phrase: ";"
Processing 00000000.tx.67: ++, p < 0.01; 

Phrase: "++,"

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.68: +, p < 0.05 versus swQ8; 

Phrase: "+,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "swQ8"

Phrase: ";"
Processing 00000000.tx.69: #, p < 0.05 versus swO9. 

Phrase: "#,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "swO9."
Processing 00000000.tx.70: Values are means  S.E. from 46 independent experiments.  

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "from 46 independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.71: Detection of AFor the detection of secreted A-(140), we used a specific sandwich enzyme-linked immunosorbent assay employing monoclonal antibodies as described previously (50). 

Phrase: "Detection of AFor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "the detection of secreted A-(140"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a specific sandwich enzyme-linked immunosorbent assay"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   858   C2717977:Enzyme Assay [Laboratory Procedure]
   799   C0005507:Assay [Laboratory Procedure]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   799   C0243073:assay [Qualitative Concept]
   799   C1510438:Assay [Laboratory Procedure]
   766   C1517892:Link [Intellectual Product]
   766   C1704666:Link [Intellectual Product]
   716 E C0014445:enzymes [Functional Concept]

Phrase: "employing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:employing [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "monoclonal antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0746619:monoclonal [Finding]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.72: Oxidative Stress-induced Cell DeathCell death was induced with hydrogen peroxide (freshly prepared solution; 250 M; Sigma). 

Phrase: "Oxidative Stress-induced Cell DeathCell death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   839   C0007587:Cell Death [Cell Function]
   799   C0011065:Death [Organism Function]
   799   C1306577:Death, NOS [Finding]

Phrase: "was"

Phrase: "induced with hydrogen peroxide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0020275:Hydrogen [Element, Ion, or Isotope]
   770   C0031180:Peroxide [Inorganic Chemical]
   770   C0205263:Induced [Functional Concept]
   770   C0523702:HYDROGEN [Laboratory Procedure]
   770   C0885426:hydrogen [Inorganic Chemical]

Phrase: "(freshly prepared solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "; 250 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.73: In respective experiments, caspase inhibitors were added 3 h before exposure to H2O2 (250 M, 24 h) at a final concentration of 10 M: caspase 3 inhibitor (AC-DEVD-CMK), caspase 6 inhibitor (VEID-CHO), caspase 8 inhibitor (IETD-CHO), and caspase 9 inhibitor (LEHD-CHO). 

Phrase: "In respective experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "caspase inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1516312:Caspase Inhibitors [Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "3 h before exposure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0041119:3 H [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "to H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(250 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "24 h) at a final concentration of 10 M"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0020283:H+ concentration [Quantitative Concept]
   762   C2348952:H/m [Quantitative Concept]
   742   C0033727:H+ [Element, Ion, or Isotope]
   742   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441932:H+ [Classification]
   742   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "caspase 3 inhibitor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1516312:Caspase Inhibitor [Pharmacologic Substance]
   827   C1999216:Inhibitor [Qualitative Concept]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(AC-DEVD-CMK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1311742:Ac-DEVD-CMK [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C1707170:CMK [Gene or Genome]
   827   C1824761:CMK [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "caspase 6 inhibitor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1516312:Caspase Inhibitor [Pharmacologic Substance]
   827   C1999216:Inhibitor [Qualitative Concept]
   734   C0538091:caspase-6 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(VEID-CHO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0672008:VEID-CHO [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "caspase 8 inhibitor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1516312:Caspase Inhibitor [Pharmacologic Substance]
   827   C1999216:Inhibitor [Qualitative Concept]
   734   C0667830:caspase-8 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(IETD-CHO"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "caspase 9 inhibitor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1516312:Caspase Inhibitor [Pharmacologic Substance]
   827   C1999216:Inhibitor [Qualitative Concept]
   734   C0910167:caspase-9 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(LEHD-CHO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1259600:LEHD-CHO [Amino Acid, Peptide, or Protein]

Phrase: ")."
Processing 00000000.tx.74: Only cell-permeable caspase inhibitors were used. 

Phrase: "Only cell-permeable caspase inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   840   C1516312:Caspase Inhibitors [Pharmacologic Substance]
   804   C0243077:inhibitors [Chemical Viewed Functionally]
   771 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.75: Measurement of Caspase ActivityPC12 cells were plated the day before at a density of 5 x 106 cells/culture dish (10 cm diameter). 

Phrase: "Measurement of Caspase ActivityPC12 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0242485:Measurement [Functional Concept]

Phrase: "were"

Phrase: "plated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005971:Plate [Medical Device]
   966   C1139930:plate [Medical Device]
   966   C3537155:Plate [Manufactured Object]

Phrase: "the day before at a density of 5 x 106 cells/culture dish"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   735   C0332173:/day [Temporal Concept]
   735   C0439228:day [Temporal Concept]
   735   C0439505:/day [Temporal Concept]

Phrase: "(10 cm diameter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1301886:Diameter [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.76: After treatment with H2O2, the cells were harvested, and after a centrifugation step, the culture medium was aspirated. 

Phrase: "After treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with H2O2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: ","

Phrase: "and after a centrifugation step,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0007703:Centrifugation [Laboratory Procedure]
   760   C1261552:Step [Conceptual Entity]
   760   C1515981:And [Idea or Concept]
   760   C1704379:Step [Functional Concept]
   760   C1705117:Step [Quantitative Concept]
   760   C2825408:Step [Manufactured Object]

Phrase: "the culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "aspirated."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0700198:Aspirated [Pathologic Function]
   966 E C0370199:Aspirate [Body Substance]
Processing 00000000.tx.77: The cell-containing pellet was washed with PBS and lysed in 100 l of lysis buffer (10 mM HEPES, 0.1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, 0.1 mM EDTA, 1 mM dithiothreitol, 1 g/ml pepstatin A, 1 g/ml leupeptin, 0.1% CHAPS, pH 7.4). 

Phrase: "The cell-containing pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441436:Pellet [Manufactured Object]
   827   C0993610:Pellet [Biomedical or Dental Material]
   827   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "washed with PBS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "lysed in 100 l of lysis buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0024348:Lysis [Pathologic Function]
           lysed
   748   C1536403:lysis [Cell Function]

Phrase: "(10 mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "0.1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "1 mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "1 g/ml pepstatin A,"

Phrase: "1 g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "0.1% CHAPS,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0047101:CHAPS [Pharmacologic Substance,Steroid]
   793 E C0950540:chap [Therapeutic or Preventive Procedure]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.78: Lysates were centrifuged at 20,000 x g for 10 min at 4 C, and the supernatant was used for caspase assay. 

Phrase: "Lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "centrifuged at 20,000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C,"

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "used for caspase assay."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0243073:assay [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1510438:Assay [Laboratory Procedure]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.79: The approximate protein amount of the probes was confirmed by a Lowry protein test. 

Phrase: "The approximate protein amount of the probes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "confirmed by a Lowry protein test."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   814   C0201123:Protein A test [Laboratory Procedure]
   790   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0788300:PROTEIN TEST [Medical Device]
   783   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   753   C0022885:Test [Laboratory Procedure]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]
   753   C0750484:Confirmed [Idea or Concept]
   719 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.80: Caspase activity was measured by cleavage of colorimetric substrates (Ac-DEVD-pNA, Ac-VEID-pNA, Ac-VDVAD-pNA, Ac-IETD-pNA, and Ac-LEHD-pNA for caspase 3, caspase 6, caspase 2, caspase 8, and caspase 9, respectively). 

Phrase: "Caspase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150130:caspase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured by cleavage of colorimetric substrates"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0010813:cleavage [Cell Function]
   753   C0444706:Measured [Qualitative Concept]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
   719   C1710236:Substrate [Manufactured Object]

Phrase: "(Ac-DEVD-pNA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0048553:para-nitroaniline [Organic Chemical]
   812   C0030563:Para [Finding]
   812   C0068820:nitroaniline [Organic Chemical]

Phrase: "Ac-VEID-pNA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0048553:para-nitroaniline [Organic Chemical]
   812   C0030563:Para [Finding]
   812   C0068820:nitroaniline [Organic Chemical]

Phrase: "Ac-VDVAD-pNA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0048553:para-nitroaniline [Organic Chemical]
   812   C0030563:Para [Finding]
   812   C0068820:nitroaniline [Organic Chemical]

Phrase: "Ac-IETD-pNA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0048553:para-nitroaniline [Organic Chemical]
   812   C0030563:Para [Finding]
   812   C0068820:nitroaniline [Organic Chemical]

Phrase: "and"

Phrase: "Ac-LEHD-pNA for caspase 3,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0048553:para-nitroaniline [Organic Chemical]
   774   C0233072:Para 3 [Finding]
   748   C0030563:Para [Finding]
   748   C0068820:nitroaniline [Organic Chemical]

Phrase: "caspase 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0538091:caspase-6 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "caspase 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "caspase 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0667830:caspase-8 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "caspase 9,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0910167:caspase-9 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.81: The production of pNA was monitored over 30 min in a photometer ( = 405 nm). 

Phrase: "The production of pNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "monitored over 30 min"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]

Phrase: "in a photometer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0182256:Photometer [Medical Device]

Phrase: "("

Phrase: "= 405 nm)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.82: The caspase activity is expressed as change in absorption units. 

Phrase: "The caspase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150130:caspase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "expressed as change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0392747:Change [Functional Concept]
   790   C0443172:change [Quantitative Concept]
   790   C1705241:Change [Quantitative Concept]

Phrase: "in absorption units."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0439148:Units [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.83: One unit was defined as the amount of enzyme required to cleave 1 pmol of NA per min of incubation per 5 x 106 cells. 

Phrase: "One unit"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439148:Unit [Quantitative Concept]
   861   C1519795:Unit [Quantitative Concept]
   861   C1704753:Unit [Manufactured Object]
   861   C1880519:Unit [Quantitative Concept]

Phrase: "was"

Phrase: "defined as the amount of enzyme"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C1265611:Amount [Quantitative Concept]
   753   C1704788:Defined [Conceptual Entity]
   753   C3539106:Defined [Intellectual Product]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cleave"

Phrase: "1 pmol of NA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439192:pmol [Quantitative Concept]

Phrase: "per min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0702093:/min [Temporal Concept]

Phrase: "of incubation"

Phrase: "per 5 x 106 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.84: Quantification of Apoptosis by Flow CytometryApoptosis was determined by propidium iodide (PI) staining and fluorescence-activated cell sorting analysis as described previously (12). 

Phrase: "Quantification of Apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709793:Quantification [Quantitative Concept]

Phrase: "by Flow CytometryApoptosis"

Phrase: "was"

Phrase: "determined by propidium iodide (PI) staining"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0021966:Iodide [Inorganic Chemical]
   760   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "fluorescence-activated cell sorting analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
   771   C0079366:Fluorescence-Activated Cell Sorting [Laboratory Procedure]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.85: Briefly, H2O2-treated PC12 cells were lysed in buffer (0.1% sodium citrate and 0.1% Triton X-100) containing 50 g/ml propidium iodide. 

Phrase: "Briefly,"

Phrase: "H2O2-treated PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0085262:PC12 Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed in buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C0024348:lysed [Pathologic Function]

Phrase: "(0.1% sodium citrate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0142825:sodium citrate [Organic Chemical,Pharmacologic Substance]
   812   C0008857:Citrate [Organic Chemical]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "50 g/ml propidium iodide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   804   C0021966:Iodide [Inorganic Chemical]
   804   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.86: Samples were analyzed by flow cytometry (FACSCalibur) using Cell Quest software (Becton Dickinson). 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed by flow cytometry"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0016263:Flow Cytometry [Laboratory Procedure]
   770   C0806140:Flow [Natural Phenomenon or Process]
   770   C0814048:Cytometry [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]

Phrase: "(FACSCalibur"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Cell Quest software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Becton Dickinson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331782:Becton Dickinson [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.87: Cells with a lower DNA content showing less propidium iodide staining than G1 have been defined as apoptotic cells (sub- G1 peak). 

Phrase: "Cells with a lower DNA content showing less propidium iodide staining"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   738   C0007634:Cells [Cell]
   738   C3282337:Cells [Cell]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]

Phrase: "than G1"

Phrase: "have"

Phrase: "been"

Phrase: "defined as apoptotic cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C1516044:Apoptotic [Qualitative Concept]
   770   C1704788:Defined [Conceptual Entity]
   770   C3282337:Cells [Cell]
   770   C3539106:Defined [Intellectual Product]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(sub- G1 peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0444505:Peak [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.88: Phospho-JNK Pathway Western Blot AnalysisPC12 cells were plated at a density of 5 x 106 cells/culture dish (10 cm diameter) and treated with H2O2. 

Phrase: "Phospho-JNK Pathway Western Blot AnalysisPC12 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated at a density of 5 x 106 cells/culture dish"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   756   C0007585:cells culture [Laboratory Procedure]
   754   C2347576:Cells/dish [Quantitative Concept]
   738   C0007634:Cells [Cell]
   738   C0010453:Culture [Idea or Concept]
   738   C0020498:DISH [Disease or Syndrome]
   738   C0178587:density [Quantitative Concept]
   738   C0220814:culture [Functional Concept]
   738   C0430400:Culture [Laboratory Procedure]
   738   C2242979:Culture [Laboratory Procedure]
   738   C3282337:Cells [Cell]
   737   C0162339:Cell Density [Quantitative Concept]
   737   C0180454:Culture plate [Medical Device]
   737   C1166718:cells plate [Cell Component]
   704   C0005971:Plate [Medical Device]
   704   C1139930:plate [Medical Device]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]
   704   C3537155:Plate [Manufactured Object]

Phrase: "(10 cm diameter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1301886:Diameter [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "treated with H2O2."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.89: Cells were harvested and lysed in SDS sample buffer: Tris-HCl (62.5 mM, pH 6.8), 2% SDS, 10% glycerol, 50 mM dithiothreitol, 0.01% bromphenol blue. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "lysed in SDS sample buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0024348:lysed [Pathologic Function]
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: ":"

Phrase: "Tris-HCl (62.5 mM,"

Phrase: "pH 6.8"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "2% SDS,"

Phrase: "10% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "50 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "0.01% bromphenol blue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006247:Bromphenol Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C1260957:Blue [Qualitative Concept]
Processing 00000000.tx.90: After sonicating and boiling, proteins were separated by electrophoresis on a 16% polyacrylamide gel. 

Phrase: "After sonicating"

Phrase: "and"

Phrase: "boiling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0242301:Boil [Disease or Syndrome]
   966   C1546559:Boil [Intellectual Product]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "separated by electrophoresis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "on a 16% polyacrylamide gel."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827   C1382104:Gel [Substance]
Processing 00000000.tx.91: The separated proteins were transferred to a polyvinylidene difluoride membrane (ImmobilonTM-P; Millipore). 

Phrase: "The separated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "transferred to a polyvinylidene difluoride membrane"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0071710:polyvinylidene difluoride [Organic Chemical]
   753   C0025255:Membrane [Tissue]
   753   C0348011:transferred [Functional Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
   719 E C0040671:Transfer [Mental Process]
   719 E C1705822:Transfer [Activity]

Phrase: "(ImmobilonTM-P"

Phrase: "; Millipore"

Phrase: ")."
Processing 00000000.tx.92: These membranes were stained with Ponceau S red (reversible stain) to visualize the proteins. 

Phrase: "These membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "stained with Ponceau S red (reversible stain"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   788   C0071720:Ponceau S stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Ponceau S
   757   C0491958:STAIN, PONCEAU [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0205343:Reversible [Functional Concept]
   748   C0332575:Red [Finding]
   748   C1260956:Red [Qualitative Concept]
   748   C2986582:Stained [Qualitative Concept]
   714 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "visualize"

Phrase: "the proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.93: Nonspecific sites on the membranes were blocked with 5% fat-free milk in Tris-buffered saline, 0.1% Tween 20 (TBST). 

Phrase: "Nonspecific sites on the membranes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0457192:Nonspecific site [Body Location or Region]
   760   C0205145:Sites [Spatial Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "blocked with 5% fat-free milk"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   783   C0991850:MILK FAT [Lipid,Pharmacologic Substance]
   753   C0026131:Milk [Body Substance]
   753   C0028778:Blocked [Pathologic Function]
   753   C0332206:Blocked [Functional Concept]
   753   C0332296:free [Functional Concept]
   753   C0349374:Milk [Food]
   753   C0424612:FAT [Organism Attribute]
   753   C0444318:Milk [Substance]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C2825079:Milk [Food]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "in Tris-buffered saline,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "0.1% Tween 20"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "(TBST"

Phrase: ")."
Processing 00000000.tx.94: The phosphorylated JNK was visualized with the appropriate primary phosphoantibody, phospho-stress-activated protein kinase/JNK (Thr183/Tyr185), which detects stress-activated protein kinase/JNK only dually phosphorylated at Thr183/Tyr185. 

Phrase: "The phosphorylated JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1150587:JNK [Molecular Function]
   861   C1367731:JNK [Gene or Genome]
   861   C1705632:JNK [Gene or Genome]

Phrase: "was"

Phrase: "visualized with the appropriate primary phosphoantibody,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205225:Primary [Qualitative Concept]
   753   C0234621:Visualized [Functional Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C1548787:Appropriate [Qualitative Concept]

Phrase: "phospho-stress-activated protein kinase/JNK (Thr183/Tyr185"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "stress-activated protein kinase/JNK only dually"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   877   C0872280:stress activated protein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   829   C0018850:stress protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0038435:Stress [Finding]
   795   C0205171:Only [Quantitative Concept]
   795   C1150587:JNK [Molecular Function]
   795   C1367731:JNK [Gene or Genome]
   795   C1705632:JNK [Gene or Genome]
   795   C1720467:Only [Intellectual Product]
   795   C1879547:Activated [Activity]
   762 E C1515877:Activate [Functional Concept]
   724 E C0231297:Stressful [Functional Concept]

Phrase: "phosphorylated at Thr183/Tyr185."
Processing 00000000.tx.95: The phosphorylated c-Jun was detected by a phospho-c-Jun (Ser63) antibody. 

Phrase: "The phosphorylated c-Jun"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected by a phospho-c-Jun"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Ser63"

Phrase: ")"

Phrase: "antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.96: After thorough washing with TBST, membranes were covered with ECLTM detection reagents and quickly exposed to an autoradiography film. 

Phrase: "After thorough washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441648:Washing [Activity]

Phrase: "with TBST,"

Phrase: "membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "covered with ECLTM detection reagents"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   760   C0439844:Covered [Functional Concept]
   760   C1511790:Detection [Therapeutic or Preventive Procedure]
   760   C1999244:Covered [Functional Concept]
   726 E C0180153:cover [Medical Device]
   726 E C1707529:Cover [Medical Device]

Phrase: "and"

Phrase: "quickly"

Phrase: "exposed to an autoradiography film."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0004400:Autoradiography [Laboratory Procedure]
   760   C0086296:Film [Manufactured Object]
   760   C1561571:film [Biomedical or Dental Material]
   760   C1561572:film [Substance]
Processing 00000000.tx.97: Membranes were routinely stripped for actin control. 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "routinely"

Phrase: "stripped for actin control."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C1321564:Strip [Medical Device]
Processing 00000000.tx.98: Caspase Immunoblot AnalysisPC12 cells were plated at a density of 5 x 106 cells/culture dish (10 cm diameter) and treated with H2O2. 

Phrase: "Caspase Immunoblot AnalysisPC12 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated at a density of 5 x 106 cells/culture dish"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   756   C0007585:cells culture [Laboratory Procedure]
   754   C2347576:Cells/dish [Quantitative Concept]
   738   C0007634:Cells [Cell]
   738   C0010453:Culture [Idea or Concept]
   738   C0020498:DISH [Disease or Syndrome]
   738   C0178587:density [Quantitative Concept]
   738   C0220814:culture [Functional Concept]
   738   C0430400:Culture [Laboratory Procedure]
   738   C2242979:Culture [Laboratory Procedure]
   738   C3282337:Cells [Cell]
   737   C0162339:Cell Density [Quantitative Concept]
   737   C0180454:Culture plate [Medical Device]
   737   C1166718:cells plate [Cell Component]
   704   C0005971:Plate [Medical Device]
   704   C1139930:plate [Medical Device]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]
   704   C3537155:Plate [Manufactured Object]

Phrase: "(10 cm diameter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1301886:Diameter [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "treated with H2O2."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.99: After the indicated periods of time, the medium was aspirated, and cells were processed for Western blotting with rat-specific cleaved caspase 3, caspase 8, and caspase 9 antibodies. 

Phrase: "After the indicated periods"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]

Phrase: "of time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "aspirated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0700198:Aspirated [Pathologic Function]
   966 E C0370199:Aspirate [Body Substance]

Phrase: ","

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "processed for Western blotting"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1522240:Processed [Phenomenon or Process]
   770   C1705493:Western [Spatial Concept]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "with rat-specific cleaved caspase 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   911   C1567334:caspase 3, rat [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "caspase 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0667830:caspase-8 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "caspase 9 antibodies."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   896   C1320096:Caspase antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0910167:caspase-9 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.100: Blots were scanned (Umax Astra 4000 U), and the band intensity was determined after background subtraction using densitometric analysis. 

Phrase: "Blots"

Phrase: "were"

Phrase: "scanned"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0441633:scanned [Diagnostic Procedure]
   966 E C0034606:Scan [Diagnostic Procedure]
   966 E C2826292:SCAN [Finding]

Phrase: "(Umax Astra 4000 U"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the band intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "determined after background subtraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1706907:Background [Conceptual Entity]
   770   C2348589:Subtraction [Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "densitometric analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.101: Determination of Cytochrome c ReleaseThe amount of cytochrome c released from the mitochondrial intermembrane space into the cytosol was determined by digitonin permeabilization (51). 

Phrase: "Determination of Cytochrome c ReleaseThe amount of cytochrome c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1148554:determination [Laboratory Procedure]

Phrase: "released from the mitochondrial intermembrane space"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   833   C1179889:Mitochondrial intermembrane space [Cell Component]
           Intermembrane Space
   753   C0026237:Mitochondrial [Cell Component]
   753   C0391871:Released [Functional Concept]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C1283071:Released [Functional Concept]
   753   C1883067:Space [Spatial Concept]
   719 E C0030685:Release [Health Care Activity]
   719 E C0439180:% release [Quantitative Concept]
   719 E C0680255:release [Health Care Activity]
   719 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "into the cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "was"

Phrase: "determined by digitonin permeabilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012256:Digitonin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.102: Briefly, 5 x 106 cells were exposed to oxidative stress for different periods of time. 

Phrase: "Briefly,"

Phrase: "5 x 106 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to oxidative stress"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]

Phrase: "for different periods"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]

Phrase: "of time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.103: After washing with ice-cold phosphate-buffered saline, cells were resuspended in permeabilization buffer containing 75 mM NaCl, 1 mM NaH2PO4, 8 mM Na2PO4, 250 mM sucrose, 1 mM phenylmethylsulfonyl fluoride, additional protease inhibitors, and 0.05% digitonin. 

Phrase: "After washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "with ice-cold phosphate-buffered saline,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   823   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C0036082:Saline [Substance]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "resuspended in permeabilization buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "75 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "1 mM NaH2PO4,"

Phrase: "8 mM Na2PO4,"

Phrase: "250 mM sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "1 mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "additional protease inhibitors,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   867 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1947941:Protease [Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "0.05% digitonin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012256:Digitonin [Carbohydrate,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.104: Following a centrifugation step at 800 x g at 4 C for 10 min, the supernatant was separated from the pellet consisting of mitochondria and cellular debris. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "a centrifugation step at 800 x g"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1261552:Step [Conceptual Entity]
   748   C1704379:Step [Functional Concept]
   748   C1705117:Step [Quantitative Concept]
   748   C2825408:Step [Manufactured Object]

Phrase: "at 4 C"

Phrase: "for 10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "separated from the pellet"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0086972:Separated [Finding]
   770   C0441436:Pellet [Manufactured Object]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C0993610:Pellet [Biomedical or Dental Material]
   770   C1998480:Pellet [Quantitative Concept]

Phrase: "consisting of mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   756   C0332529:CONSIST [Qualitative Concept]

Phrase: "and"

Phrase: "cellular debris."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0440266:Debris [Substance]
Processing 00000000.tx.105: The supernatant containing cytoplasmic proteins was purified by centrifugation at 13,000 x g at 4 C for 10 min. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "cytoplasmic proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1333198:Cytoplasmic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "purified by centrifugation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C1998793:Purified [Functional Concept]

Phrase: "at 13,000 x g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "at 4 C"

Phrase: "for 10 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.106: Equal amounts of protein (10 g) were loaded on an 18% acrylamide gel and separated by SDS-PAGE. 

Phrase: "Equal amounts of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "(10 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "loaded on an 18% acrylamide gel"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]
   753   C1382104:Gel [Substance]
   753   C1708715:Loaded [Activity]
   719 E C1550025:Load [Idea or Concept]
   719 E C1704782:Load [Manufactured Object]

Phrase: "and"

Phrase: "separated by SDS-PAGE."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]
Processing 00000000.tx.107: After immunoblotting with a monoclonal cytochrome c antibody, polyvinylidene difluoride membranes were stripped and reprobed either for COX4 or actin, ensuring equal protein loading and the absence of mitochondrial contamination. 

Phrase: "After immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "with a monoclonal cytochrome c antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "polyvinylidene difluoride membranes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]
   734   C0071710:polyvinylidene difluoride [Organic Chemical]

Phrase: "were"

Phrase: "stripped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1321564:Strip [Medical Device]

Phrase: "and"

Phrase: "reprobed"

Phrase: "either for COX4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1413634:COX4 [Gene or Genome]

Phrase: "or"

Phrase: "actin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "ensuring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0218063:Ensure [Food]

Phrase: "equal protein loading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708715:Loading [Activity]

Phrase: "and"

Phrase: "the absence of mitochondrial contamination."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.108: Determination of Mitochondrial Membrane PotentialPC12 cells were plated the day before at a density of 2 x 105 cells/well in a 24-well plate. 

Phrase: "Determination of Mitochondrial Membrane PotentialPC12 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1148554:determination [Laboratory Procedure]

Phrase: "were"

Phrase: "plated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005971:Plate [Medical Device]
   966   C1139930:plate [Medical Device]
   966   C3537155:Plate [Manufactured Object]

Phrase: "the day before at a density of 2 x 105 cells/well"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0332173:/day [Temporal Concept]
   736   C0439228:day [Temporal Concept]
   736   C0439505:/day [Temporal Concept]

Phrase: "in a 24-well plate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005971:Plate [Medical Device]
   827   C1139930:plate [Medical Device]
   827   C3537155:Plate [Manufactured Object]
Processing 00000000.tx.109: The cells were pretreated for 1 h with the JNK inhibitor SP600125, and H2O2 was added for 6 h. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pretreated for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "with the JNK inhibitor SP600125,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0968383:SP600125 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "added for 6 h."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   819   C0444953:H 6 [Intellectual Product]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.110: The membrane potential of the inner mitochondrial membrane was measured using the dye rhodamine 123. 

Phrase: "The membrane potential of the inner mitochondrial membrane"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   793   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   789   C0230840:Mitochondrial Inner Membrane [Cell Component]
   770   C0025251:Membrane Potential [Cell Function]
   767   C0596952:Mitochondrial membrane [Cell Component]
   744   C0025255:Membrane [Tissue]
   744   C0596901:Membrane [Cell Component]
   744   C1706182:Membrane [Manufactured Object]
   744   C3245505:Potential [Qualitative Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the dye rhodamine 123."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0073192:Rhodamine 123 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.111: The dye was added to the cell culture medium at a concentration of 0.4 M for 15 min. 

Phrase: "The dye"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "added to the cell culture medium"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   790   C0007585:Cell Culture [Laboratory Procedure]
   790   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0007634:Cell [Cell]
   753   C0009458:Medium [Intellectual Product]
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0439536:Medium [Quantitative Concept]
   753   C1269647:Cell [Cell]
   753   C1524062:Added [Functional Concept]
   753   C1704653:Cell [Medical Device]
   753   C1705217:Medium [Substance]
   753   C1948049:Cell [Spatial Concept]
   753   C2242979:Culture [Laboratory Procedure]
   753   C3244283:medium [Intellectual Product]
   719 E C1883712:Add [Functional Concept]

Phrase: "at a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 0.4 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "for 15 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.112: The cells were washed twice with Hanks' balanced salt solution, and the fluorescence was determined with a fluorescence reader (Victor Multilabel counter; PerkinElmer Life Sciences). 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with Hanks' balanced salt solution,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   882   C0120742:Hanks Balanced Salt Solution [Pharmacologic Substance]
   833   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]
   753   C0036140:Salt [Chemical Viewed Structurally]
   753   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0037633:Solution [Substance]
   753   C0205415:Balanced [Functional Concept]
   753   C0206136:Salt [Food,Inorganic Chemical]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C1720725:Twice [Intellectual Product]
   753   C1948050:Twice [Quantitative Concept]
   719   C1423529:HANK [Gene or Genome]

Phrase: "and"

Phrase: "the fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "determined with a fluorescence reader"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C1514743:Reader [Professional or Occupational Group]
   760   C1706461:Reader [Manufactured Object]

Phrase: "(Victor Multilabel counter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0677601:Counter [Manufactured Object]
   827   C1705206:Counter [Medical Device]

Phrase: "; PerkinElmer Life Sciences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0005526:Life Sciences [Occupation or Discipline]
   827   C0036397:Sciences [Occupation or Discipline]
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: ")."
Processing 00000000.tx.113: Transmembrane distribution of the dye depends on the mitochondrial membrane potential (m). 

Phrase: "Transmembrane distribution of the dye"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "depends on the mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   790   C0025251:Membrane Potential [Cell Function]
   790   C0596952:Mitochondrial membrane [Cell Component]
   753   C0025255:Membrane [Tissue]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C0596901:Membrane [Cell Component]
   753   C0725813:depend [Medical Device]
   753   C1706182:Membrane [Manufactured Object]
   753   C3245505:Potential [Qualitative Concept]

Phrase: "("

Phrase: "m)."
Processing 00000000.tx.114: Statistical AnalysisData are given as mean  S.E. 

Phrase: "Statistical AnalysisData"

Phrase: "are"

Phrase: "given as mean"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0444504:Mean [Quantitative Concept]
   790   C1442162:GIVEN [Conceptual Entity]
   790   C1550718:given [Idea or Concept]
   790   C2347634:Mean [Quantitative Concept]
   790   C2348143:Mean [Quantitative Concept]
   790   C3244317:given [Intellectual Product]
   756 E C1947971:Give [Functional Concept]

Phrase: "S."

Phrase: "E."
Processing 00000000.tx.115: For statistical comparison, paired t test, Student's t test, or one-way ANOVA followed by Tukey's post hoc test or two-way ANOVA were used. p values less than 0.05 were considered statistically significant.  

Phrase: "For statistical comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707455:Comparison [Activity]

Phrase: "paired t test,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709451:Paired t-Test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "Student's t test,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: "or"

Phrase: "one-way ANOVA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0205447:One [Quantitative Concept]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]

Phrase: "followed by Tukey's post hoc test"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]
   753   C0687676:Post [Temporal Concept]
   753   C1704687:Post [Manufactured Object]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "or"

Phrase: "two-way ANOVA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0205448:Two [Quantitative Concept]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]

Phrase: "were"

Phrase: "used. p values less than 0.05"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0042295:Values [Qualitative Concept]
   745   C1709380:P-Value [Quantitative Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "statistically significant."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.116: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Generation and Characterization of PC12 Cell Lines Overexpressing APPwt and APPswTo investigate the effects of APP overexpression in oxidative stress-induced apoptosis, we used several clones of PC12 cells stably transfected with APP cDNAs. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "and"

Phrase: "Characterization of PC12 Cell Lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "Overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "APPwt"

Phrase: "and"

Phrase: "APPswTo"

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the effects of APP overexpression"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "in oxidative stress-induced apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0162638:Apoptosis [Cell Function]
   741 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "several clones of PC12 cells stably"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0009013:Clone Cells [Cell]
           Clones
   719 E C1522642:Clone [Tissue]

Phrase: "transfected with APP cDNAs."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]
   719   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.117: Similar expression of human APP in the investigated cell lines was confirmed by Western blotting. 

Phrase: "Similar expression of human APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the investigated cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "was"

Phrase: "confirmed by Western blotting."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1705493:Western [Spatial Concept]
   737 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.118: As expected, the human-specific antibody does not recognize any APP species in vector-transfected PC12 cells (Fig. 1A), whereas equal expression levels of human APP were detected in clones of APPwt cells and in clones of cells containing the Swedish mutation. 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "the human-specific antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "recognize"

Phrase: "any APP species in vector-transfected PC12 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1705920:Species [Conceptual Entity]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "equal expression levels of human APP"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   767   C1171362:expression protein [Genetic Function]
   750   C0428479:Protein level [Laboratory or Test Result]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Levels [Qualitative Concept]
   737   C3244092:expression level [Idea or Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "detected in clones of APPwt cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   767   C0009013:Clone Cells [Cell]
           Clones
   753   C0007634:Cells [Cell]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1522642:Clone [Tissue]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "and in clones of cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   781   C0009013:Clone Cells [Cell]
           Clones
   760   C0007634:Cells [Cell]
   760   C1515981:And [Idea or Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1522642:Clone [Tissue]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the Swedish mutation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.119: Culture supernatants of the APP-transfected cells were also analyzed for A-(140) production revealing 45-fold elevated A-(140) levels in clones of APPsw cells compared with clones of APPwt cells (Fig. 1B). 

Phrase: "Culture supernatants of the APP-transfected cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0007585:cells culture [Laboratory Procedure]
   742   C0010453:Culture [Idea or Concept]
   742   C0220814:culture [Functional Concept]
   742   C0430400:Culture [Laboratory Procedure]
   742   C2242979:Culture [Laboratory Procedure]
   708   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "also"

Phrase: "analyzed for A-(140"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0936012:Analyzed [Research Activity]

Phrase: ")"

Phrase: "production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "revealing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:revealing [Qualitative Concept]

Phrase: "45-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "A-(140"

Phrase: ")"

Phrase: "levels in clones of APPsw cells"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "compared with clones of APPwt cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   767   C0009013:Clone Cells [Cell]
           Clones
   753   C0007634:Cells [Cell]
   753   C1707455:Compared [Activity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1522642:Clone [Tissue]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.120: APPsw Mutation Leads to an Enhanced Vulnerability to Oxidative Stress-induced ApoptosisWe induced apoptosis in transfected PC12 cells using the oxidative stressor hydrogen peroxide. 

Phrase: "APPsw Mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "Leads to an Enhanced Vulnerability"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0181586:leads [Medical Device]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C2349975:Enhanced [Activity]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to Oxidative Stress-induced ApoptosisWe"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "apoptosis in transfected PC12 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162638:Apoptosis [Cell Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the oxidative stressor hydrogen peroxide."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0020275:Hydrogen [Element, Ion, or Isotope]
   812   C0031180:Peroxide [Inorganic Chemical]
   812   C0523702:HYDROGEN [Laboratory Procedure]
   812   C0885426:hydrogen [Inorganic Chemical]
Processing 00000000.tx.121: Nuclear DNA fragmentation was quantitatively detected by propidium iodide staining and flow cytometry. 

Phrase: "Nuclear DNA fragmentation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0376669:DNA Fragmentation [Molecular Function]
   827   C0332472:Fragmentation [Anatomical Abnormality]
   827   C1881708:FRAGMENTATION [Phenomenon or Process]
   734   C1179920:Nuclear DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "quantitatively"

Phrase: "detected by propidium iodide staining"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0021966:Iodide [Inorganic Chemical]
   760   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0442726:Detected [Finding]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "flow cytometry."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016263:Flow Cytometry [Laboratory Procedure]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0814048:Cytometry [Laboratory Procedure]
Processing 00000000.tx.122: Very importantly, clones bearing the APPsw mutation are sensitized to an exposure to oxidative stress for 24 h in a concentration-dependent manner with a maximum increase of apoptotic cells at a concentration of 500 M H2O2 (12). 

Phrase: "Very importantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442824:Very [Qualitative Concept]

Phrase: "clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0009013:Clones [Cell]
   966 E C1522642:Clone [Tissue]
   916 E C1704387:Clonal [Qualitative Concept]
   893 E C0796368:clonality [Diagnostic Procedure]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the APPsw mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "sensitized to an exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0332157:Exposure to [Clinical Attribute]
           Exposure
   770   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "to oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in a concentration-dependent manner"

Phrase: "with a maximum increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "of apoptotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "at a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 500 M H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.123: Treatment with H2O2 led to a significantly enhanced maximum increase of apoptotic cells in APPsw-bearing PC12 cells (51.4  5.3%) compared with APPwt-bearing cells (28.4  4.7%) and vector control cells (21.3%  4.3%). 

Phrase: "Treatment with H2O2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "led to a significantly enhanced maximum increase of apoptotic cells"
Meta Candidates (Total=17; Excluded=8; Pruned=0; Remaining=9)
   739   C0007634:Cells [Cell]
   739   C0442805:Increase [Functional Concept]
   739   C0806909:Maximum [Quantitative Concept]
   739   C1516044:Apoptotic [Qualitative Concept]
   739   C1552615:maximum [Quantitative Concept]
   739   C1708698:LED [Manufactured Object]
   739   C2349975:Enhanced [Activity]
   739   C2826546:MAXIMUM [Quantitative Concept]
   739   C3282337:Cells [Cell]
   706 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   706 E C1269647:Cell [Cell]
   706 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   706 E C1522538:Lead [Functional Concept]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]
   706 E C2348269:Lead [Element, Ion, or Isotope]
   706 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in APPsw-bearing PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0085262:PC12 Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(51.4  5.3%"

Phrase: ")"

Phrase: "compared with APPwt-bearing cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C1704689:Bearing [Medical Device]
   760   C1707455:Compared [Activity]
   760   C3282337:Cells [Cell]
   726 E C0004897:Bear [Mammal]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(28.4  4.7%"

Phrase: ")"

Phrase: "and"

Phrase: "vector control cells"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   901   C0031249:vector control [Occupational Activity]
   827   C0007634:Cells [Cell]
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0243148:control [Qualitative Concept]
   827   C0442335:Vector [Spatial Concept]
   827   C1550141:Control [Substance]
   827   C1705099:Vector [Idea or Concept]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(21.3%  4.3%"

Phrase: ")."
Processing 00000000.tx.124: Different clones with the same transfectant behave similarly in their sensitivity to H2O2-induced cell death (Fig. 1C). 

Phrase: "Different clones with the same transfectant"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0009013:Clones [Cell]
   719 E C1522642:Clone [Tissue]

Phrase: "behave"

Phrase: "similarly in their sensitivity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]

Phrase: "to H2O2-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.125: Oxidative Stress Induces Activation of Caspase 2 in PC12 CellsOxidative stress in the human brain has been implicated as one major cause of neuronal cell loss in AD patients. 

Phrase: "Oxidative Stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "Induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Activation of Caspase 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1159825:Caspase Activation [Molecular Function]
   770   C1879547:Activation [Activity]

Phrase: "in PC12 CellsOxidative stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "in the human brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "has"

Phrase: "been"

Phrase: "implicated as one major cause of neuronal cell loss"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   762   C1850496:Neuronal loss [Finding]
   760   C0598940:Loss of neurons [Finding]
       E   neuron loss
   742   C0007634:Cell [Cell]
   742   C0015127:cause [Functional Concept]
   742   C0205164:Major [Qualitative Concept]
   742   C0205447:One [Quantitative Concept]
   742   C0521390:Neuronal [Immunologic Factor]
   742   C1269647:Cell [Cell]
   742   C1517945:Loss [Quantitative Concept]
   742   C1524003:Cause [Conceptual Entity]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]

Phrase: "in AD patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.126: However, the exact mechanism still remains unknown. 

Phrase: "However,"

Phrase: "the exact mechanism still"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "remains"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.127: A appears to bind redox-active metals like zinc, copper, or iron with high affinity, resulting in production of hydrogen peroxide and autoxidation of the metallopeptide complex (52, 53). 

Phrase: "A"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "redox-active metals like zinc,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0025552:Metals [Inorganic Chemical]

Phrase: "copper,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2347872:Copper+ [Element, Ion, or Isotope]
  1000   C2348263:Copper [Element, Ion, or Isotope]

Phrase: "or"

Phrase: "iron with high affinity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0860976:high iron [Finding]
   770   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0376520:Iron [Inorganic Chemical]
   770   C1166521:iron [Pharmacologic Substance]

Phrase: "resulting in production of hydrogen peroxide"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C0332294:Resulting in [Functional Concept]
   753   C0020275:Hydrogen [Element, Ion, or Isotope]
   753   C0031180:Peroxide [Inorganic Chemical]
   753   C0033268:production [Occupational Activity]
   753   C0523702:HYDROGEN [Laboratory Procedure]
   753   C0678226:resulting [Functional Concept]
   753   C0885426:hydrogen [Inorganic Chemical]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "autoxidation of the metallopeptide complex"

Phrase: "(52,"

Phrase: "53"

Phrase: ")."
Processing 00000000.tx.128: The signaling cascades activated following the oxidative stress have not been widely studied. 

Phrase: "The signaling cascades"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C2611812:signaling cascade [Cell Function]
   827   C1707310:Cascade [Manufactured Object]

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "widely"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.129: Therefore, we studied the implication of caspase 2 by measuring the activity and by Western blotting. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the implication of caspase 2"

Phrase: "by measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "and by Western blotting."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1515981:And [Idea or Concept]
   770   C1705493:Western [Spatial Concept]
Processing 00000000.tx.130: Cleavage of the photometric substrate Ac-VDVAD-p-nitroanilide by cytosolic protein extracts indicates the presence of caspase 2 protease activity in the cultures after exposure to hydrogen peroxide. 

Phrase: "Cleavage of the photometric substrate Ac-VDVAD-p-nitroanilide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0010813:cleavage [Cell Function]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]

Phrase: "by cytosolic protein extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2828366:Extract [Substance]

Phrase: "indicates"

Phrase: "the presence of caspase 2 protease activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "after exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to hydrogen peroxide."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]
Processing 00000000.tx.131: The activity was already induced early in APPsw cells within 2 h of induction (Fig. 2A). 

Phrase: "The activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "already"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "early in APPsw cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1279919:Early [Temporal Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "within 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.132: Caspase 2 activity was continuously elevated over time compared with APPwt and vector-transfected cells. 

Phrase: "Caspase 2 activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1150139:caspase-2 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "continuously"

Phrase: "elevated over time"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0040223:Time [Temporal Concept]
   790   C0205250:Elevated [Qualitative Concept]
   790   C3163633:Elevated [Qualitative Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "compared with APPwt and vector-transfected cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0007634:Cells [Cell]
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0442335:Vector [Spatial Concept]
   748   C1705099:Vector [Idea or Concept]
   748   C1707455:Compared [Activity]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.133: Maximum caspase 2 activity was measured after 2 h, with a 4-fold higher activity in APPsw cells than in APPwt and vector PC12 cells, respectively (Fig. 2B). 

Phrase: "Maximum caspase 2 activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1150139:caspase-2 activity [Molecular Function]
   875   C1150130:caspase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured after 2 h,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0444706:Measured [Qualitative Concept]
   770   C0564385:/h [Quantitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "with a 4-fold higher activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "in APPsw cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "than"

Phrase: "in APPwt and vector PC12 cells,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   827   C0085262:PC12 Cells [Cell]
           PC-12
   799   C0007634:Cells [Cell]
   799   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0150312:In [Quantitative Concept]
   799   C0332285:In [Spatial Concept]
   799   C0442335:Vector [Spatial Concept]
   799   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   799   C1705099:Vector [Idea or Concept]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "respectively"

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.134: View larger version (32K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(32K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.135: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.136: A, time course of caspase 2 activity in protein extracts from PC12 cells after treatment with H2O2. 

Phrase: "A,"

Phrase: "time course of caspase 2 activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0449247:Time course [Temporal Concept]
   783   C0808270:Time 2 [Finding]
   753   C0040223:Time [Temporal Concept]
   753   C0750729:Course [Temporal Concept]
   753   C3541383:Time [Temporal Concept]

Phrase: "in protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "extracts from PC12 cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0085262:PC12 Cells [Cell]
           PC-12
   802   C0007592:Cell Extracts [Cell Component]
   770   C0007634:Cells [Cell]
   770   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   770   C2828366:Extract [Substance]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "after treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with H2O2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.137: Over the whole time period, APPsw-bearing cells exhibit a significantly increased caspase 2 activity compared with APPwt-transfected cells and vector controls; 

Phrase: "Over the whole time period,"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   901   C0439582:Time period [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   755 E C0332182:Periodic [Temporal Concept]
   755 E C1706381:PERIODIC [Intellectual Product]
   743 E C1632851:Times [Quantitative Concept]
   727 E C0031084:Periodicities [Temporal Concept]

Phrase: "APPsw-bearing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a significantly increased caspase 2 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C1150139:caspase-2 activity [Molecular Function]
   875   C0474395:increased activity [Finding]
   853   C1150130:caspase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "compared with APPwt-transfected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C1707455:Compared [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "vector controls"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   966   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.138: two-way ANOVA revealed significant differences between cell lines (p < 0.001) and time course (p < 0.001). 

Phrase: "two-way ANOVA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0205448:Two [Quantitative Concept]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "significant differences between cell lines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "(p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "time course"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0449247:Time course [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C0750729:Course [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "(p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.139: B, the caspase 2 activity was induced early in APPsw cells within 2 h of oxidative stress induction and 4-fold higher compared with APPwt and vector controls (**, p < 0.01 versus APPwt and vector (ANOVA)). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the caspase 2 activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1150139:caspase-2 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "early in APPsw cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1279919:Early [Temporal Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "within 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of oxidative stress induction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1518761:Oxidative Stress Induction [Cell or Molecular Dysfunction]
   827   C0205263:Induction [Functional Concept]
   827   C0857127:induction [Therapeutic or Preventive Procedure]
   734   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "4-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0205250:High [Qualitative Concept]
   966   C1299351:High [Qualitative Concept]
   966   C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "compared with APPwt and vector controls"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   767   C0031249:control vector [Occupational Activity]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   753   C1707455:Compared [Activity]
   719   C0243148:control [Qualitative Concept]
   719   C1550141:Control [Substance]
   719   C1882979:Control [Conceptual Entity]
   719   C2587213:Control [Functional Concept]
   719   C3274648:Control [Qualitative Concept]

Phrase: "("

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "APPwt and vector (ANOVA)"

Phrase: ")."
Processing 00000000.tx.140: Data are means  S.E. from 46 independent experiments. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "from 46 independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.141: C, representative Western blot analysis of caspase 2 activation in cell lysates of H2O2-treated PC12 cells. 

Phrase: "C,"

Phrase: "representative Western blot analysis of caspase 2 activation in cell lysates"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   775   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   756   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   754   C0001282:Activation Analysis [Laboratory Procedure]
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0936012:Analysis [Research Activity]
   738   C1524024:analysis [Functional Concept]
   738   C1705493:Western [Spatial Concept]

Phrase: "of H2O2-treated PC12 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0085262:PC12 Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.142: Increased expression of cleaved caspase 2 in APPsw cells is already detectable after 2 h of treatment.  

Phrase: "Increased expression of cleaved caspase 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in APPsw cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "already detectable after 2 h of treatment."
Processing 00000000.tx.143: The mechanism of activation of caspases occurs by a sequential cleavage of the zymogen to release the large and the small cleavage products. 

Phrase: "The mechanism of activation of caspases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "occurs by a sequential cleavage of the zymogen to"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0010813:cleavage [Cell Function]
   742   C0014436:zymogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]
   742   C1548958:Sequential [Idea or Concept]
   742   C1705294:Sequential [Qualitative Concept]
   742   C1709305:Occur [Activity]
   742   C2745955:OCCUR [Temporal Concept]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "the large"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549177:Large [Quantitative Concept]

Phrase: "and"

Phrase: "the small cleavage products."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.144: In accordance with our findings from the determination of activity, Western blotting confirmed cleavage of caspase 2 within 2 h of hydrogen peroxide induction (Fig. 2C). 

Phrase: "In accordance with our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "from the determination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1148554:determination [Laboratory Procedure]

Phrase: "of activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "Western blotting confirmed cleavage of caspase 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "within 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of hydrogen peroxide induction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205263:Induction [Functional Concept]
   827   C0857127:induction [Therapeutic or Preventive Procedure]
   734   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.145: Again, the activation of caspase 2 was noticeably higher in APPsw cells compared with vector-transfected controls. 

Phrase: "Again,"

Phrase: "the activation of caspase 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1159825:Caspase Activation [Molecular Function]
   760   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "noticeably higher in APPsw cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "compared with vector-transfected controls."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   781   C0031249:control vector [Occupational Activity]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1707455:Compared [Activity]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.146: Involvement of Caspase 8 Apoptosis associated with the Fas/tumor necrosis factor receptor family of death receptors requires caspase 8 activity and adaptor proteins such as FADD. 

Phrase: "Involvement of Caspase 8 Apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "associated with the Fas/tumor necrosis factor receptor family of death receptors"
Meta Candidates (Total=29; Excluded=3; Pruned=0; Remaining=26)
   810   C0077503:Tumor Necrosis Factor Receptor Family [Amino Acid, Peptide, or Protein,Receptor]
           Tumor Necrosis Factor Receptor
           Receptors, Tumor Necrosis Factor
   770   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1323304:tumor necrosis factor [Molecular Function]
   770   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0333516:Tumor necrosis [Neoplastic Process]
   753   C1720947:Death Receptors [Amino Acid, Peptide, or Protein,Receptor]
   751   C0245662:fas Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
           fas Receptors
   751   C0425043:death family [Finding]
   736   C0011065:Death [Organism Function]
   736   C0015576:Family [Family Group]
   736   C0027540:Necrosis [Organ or Tissue Function]
   736   C0027651:Tumor [Neoplastic Process]
   736   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
           receptors
   736   C1306577:Death, NOS [Finding]
   736   C1334928:Necrosis [Finding]
   736   C1521761:Factor [Functional Concept]
   736   C1578706:Tumor [Intellectual Product]
   736   C1704727:Family [Conceptual Entity]
   736   C2827422:Factor [Conceptual Entity]
   736   C3273930:Tumor [Finding]
   715 E C1300818:Necrotic tumor [Neoplastic Process]
   703 E C0750490:Associate [Idea or Concept]
   703 E C1706221:Associate [Professional or Occupational Group]

Phrase: "requires"

Phrase: "caspase 8 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150142:caspase-8 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0667830:caspase-8 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "adaptor proteins such as FADD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1135629:Adaptor Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C0296346:FADD protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.147: The involvement of caspase 8 in processing of APP during apoptosis by caspase 8 has been reported recently (46). 

Phrase: "The involvement of caspase 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "in processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]

Phrase: "of APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "during apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "by caspase 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0667830:caspase-8 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.148: The blocking of neuronal death by caspase 8 inhibitor IETD-fmk in A-induced cell death was also demonstrated (54). 

Phrase: "The blocking of neuronal death"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   760   C0233660:Blocking [Mental or Behavioral Dysfunction]
   760   C0332206:Blocking [Functional Concept]
   726 E C0028778:Block [Pathologic Function]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "by caspase 8 inhibitor IETD-fmk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C0966060:IETD-fmk [Amino Acid, Peptide, or Protein]

Phrase: "in A-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "also"

Phrase: "demonstrated"

Phrase: "(54"

Phrase: ")."
Processing 00000000.tx.149: Hence, we examined the activation of caspase 8 in our transfected cell lines overexpressing intracellular high levels of A in order to ascertain the involvement of this initiator caspase in oxidative stress. 

Phrase: "Hence,"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the activation of caspase 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1159825:Caspase Activation [Molecular Function]
   760   C1879547:Activation [Activity]

Phrase: "in our transfected cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "intracellular high levels of A in order to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "ascertain"

Phrase: "the involvement of this initiator caspase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1314939:Involvement [Functional Concept]

Phrase: "in oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.150: We utilized Ac-IETD-pNA to measure caspase 8 activity in lysates of treated cells. 

Phrase: "We"

Phrase: "utilized"

Phrase: "Ac-IETD-pNA to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0048553:para-nitroaniline [Organic Chemical]
   804   C0030563:Para [Finding]
   804   C0068820:nitroaniline [Organic Chemical]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "caspase 8 activity in lysates of treated cells."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C1150142:caspase-8 activity [Molecular Function]
   767   C1150130:caspase activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.151: In parallel to the early activation of caspase 2, caspase 8 activity increased about 3-fold after 2 h of stress induction in PC12 cells expressing the Swedish double mutation and was significantly enhanced in a time-dependent manner compared with vector transfected controls (Fig. 3, A and B). 

Phrase: "In parallel to the early activation of caspase 2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0150312:In [Quantitative Concept]
   742   C0332285:In [Spatial Concept]
   742   C2348042:Parallel [Qualitative Concept]
   742   C2826345:PARALLEL [Research Activity]

Phrase: "caspase 8 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150142:caspase-8 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0667830:caspase-8 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "increased about 3-fold"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205217:Increased [Quantitative Concept]
   770   C0332462:Fold [Spatial Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1880834:FOLD [Phenomenon or Process]

Phrase: "after 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of stress induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205263:Induction [Functional Concept]
   861   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "in PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the Swedish double mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "was"

Phrase: "significantly"

Phrase: "enhanced in a time-dependent manner"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0040223:Time [Temporal Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C2349975:Enhanced [Activity]
   753   C3244310:dependent [Functional Concept]
   753   C3541383:Time [Temporal Concept]

Phrase: "compared with vector transfected controls"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   781   C0031249:control vector [Occupational Activity]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1707455:Compared [Activity]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.152: Activation of caspase 8 involves a two-step proteolysis: the cleavage of the procaspase 8 to generate a 43-kDa fragment and a 12-kDa fragment that is further processed to 10 kDa. 

Phrase: "Activation of caspase 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1159825:Caspase Activation [Molecular Function]
   770   C1879547:Activation [Activity]

Phrase: "involves"

Phrase: "a two-step proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0597304:Proteolysis [Molecular Function]
   755 E C1947941:proteolytic [Enzyme]

Phrase: ":"

Phrase: "the cleavage of the procaspase 8 to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "generate"

Phrase: "a 43-kDa fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "a 12-kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "processed to 10 kDa."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1522240:Processed [Phenomenon or Process]
   770   C1532717:kDa [Quantitative Concept]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]
Processing 00000000.tx.153: The large fragment is then cleaved to yield p26. 

Phrase: "The large fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "is"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "yield"

Phrase: "p26."
Processing 00000000.tx.154: Here, we used an antibody recognizing the 26-kDa large fragment of caspase 8. 

Phrase: "Here,"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "recognizing"

Phrase: "the 26-kDa large fragment of caspase 8."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.155: Western blot analysis showed a notable expression of active caspase 8 even in the untreated APPsw PC12 cells. 

Phrase: "Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a notable expression of active caspase 8 even"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the untreated APPsw PC12 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0085262:PC12 Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.156: Over the whole time period, the protein expression in APPsw cells was continuously higher compared with vector control (Fig. 3C). 

Phrase: "Over the whole time period,"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   901   C0439582:Time period [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   755 E C0332182:Periodic [Temporal Concept]
   755 E C1706381:PERIODIC [Intellectual Product]
   743 E C1632851:Times [Quantitative Concept]
   727 E C0031084:Periodicities [Temporal Concept]

Phrase: "the protein expression in APPsw cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1171362:protein expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "continuously higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   777 E C0489786:Height [Organism Attribute]

Phrase: "compared with vector control"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0031249:vector control [Occupational Activity]
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0243148:control [Qualitative Concept]
   770   C0442335:Vector [Spatial Concept]
   770   C1550141:Control [Substance]
   770   C1705099:Vector [Idea or Concept]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.157: View larger version (17K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.158: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.159: A, time course of caspase 8 activity in protein extracts from PC12 cells after treatment with H2O2. 

Phrase: "A,"

Phrase: "time course of caspase 8 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0449247:Time course [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0750729:Course [Temporal Concept]
   753   C3541383:Time [Temporal Concept]

Phrase: "in protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "extracts from PC12 cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0085262:PC12 Cells [Cell]
           PC-12
   802   C0007592:Cell Extracts [Cell Component]
   770   C0007634:Cells [Cell]
   770   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   770   C2828366:Extract [Substance]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "after treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with H2O2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.160: B, the maximal caspase 8 activity was measured after a 2-h induction. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the maximal caspase 8 activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1150142:caspase-8 activity [Molecular Function]
   875   C1150130:caspase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured after a 2-h induction."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   783   C0011744:h 2 [Element, Ion, or Isotope]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0205263:Induction [Functional Concept]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0444706:Measured [Qualitative Concept]
   753   C0564385:/h [Quantitative Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.161: APPsw-bearing cells exhibit a significantly enhanced activity compared with vector controls (*, p < 0.05 versus vector (ANOVA)). 

Phrase: "APPsw-bearing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a significantly enhanced activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1707919:Enhanced Activity [Quantitative Concept]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "compared with vector controls"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   802   C0031249:control vector [Occupational Activity]
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]
   770   C1707455:Compared [Activity]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "("

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "(ANOVA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.162: C, over the whole time period, the protein expression in APPsw cells was continuously higher compared with vector control as detected by an antibody recognizing the 26-kDa large cleaved fragment of caspase 8. 

Phrase: "C,"

Phrase: "over the whole time period,"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   901   C0439582:Time period [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   755 E C0332182:Periodic [Temporal Concept]
   755 E C1706381:PERIODIC [Intellectual Product]
   743 E C1632851:Times [Quantitative Concept]
   727 E C0031084:Periodicities [Temporal Concept]

Phrase: "the protein expression in APPsw cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1171362:protein expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "continuously higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   777 E C0489786:Height [Organism Attribute]

Phrase: "compared with vector control"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0031249:vector control [Occupational Activity]
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0243148:control [Qualitative Concept]
   770   C0442335:Vector [Spatial Concept]
   770   C1550141:Control [Substance]
   770   C1705099:Vector [Idea or Concept]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "as"

Phrase: "detected by an antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "recognizing"

Phrase: "the 26-kDa large cleaved fragment of caspase 8."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332255:fragment [Functional Concept]
   742   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.163: Representative Western blotting is shown from at least three independent observations.  

Phrase: "Representative Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   884 E C0949466:Western Blot [Laboratory Procedure]
   827   C1705493:Western [Spatial Concept]

Phrase: "is"

Phrase: "shown from"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1547282:Show [Intellectual Product]

Phrase: "at least three independent observations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0302523:observations [Research Activity]
   812   C0700325:observations [Health Care Activity]
   812   C3244290:observations [Functional Concept]
   779 E C1964257:Observation [Diagnostic Procedure]
   729 E C1518527:OBSERVATIONAL [Research Activity]
Processing 00000000.tx.164: In addition, we analyzed the activities of caspase 1 and caspase 6 using AC-YVAD-pNA and AC-VEID-pNA. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the activities of caspase 1"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C1150137:caspase-1 activity [Molecular Function]
   781   C1150130:caspase activity [Molecular Function]
   760   C0441655:Activities [Activity]
   726 E C0205177:Activity [Functional Concept]
   726 E C0439167:% activity [Quantitative Concept]
   726 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "caspase 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0538091:caspase-6 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "AC-YVAD-pNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0048553:para-nitroaniline [Organic Chemical]
   812   C0030563:Para [Finding]
   812   C0068820:nitroaniline [Organic Chemical]

Phrase: "and"

Phrase: "AC-VEID-pNA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0048553:para-nitroaniline [Organic Chemical]
   812   C0030563:Para [Finding]
   812   C0068820:nitroaniline [Organic Chemical]
Processing 00000000.tx.165: Interestingly, no changes in the activities of caspase 1 and caspase 6 were found in oxidative stress-induced cell death between mutant APP-bearing PC12 cells and controls (data not shown). 

Phrase: "Interestingly,"

Phrase: "no changes in the activities of caspase 1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   754   C0442739:No change [Finding]
   754   C1548568:No change [Intellectual Product]
   744   C0392747:changes [Functional Concept]
   744   C0443172:changes [Quantitative Concept]
   711 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "caspase 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0538091:caspase-6 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "found in oxidative stress-induced cell death"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   778   C0007587:Cell Death [Cell Function]
   778   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   748   C0007634:Cell [Cell]
   748   C0011065:Death [Organism Function]
   748   C0038435:Stress [Finding]
   748   C0150312:Found [Quantitative Concept]
   748   C0205263:Induced [Functional Concept]
   748   C0311404:Oxidative [Functional Concept]
   748   C1269647:Cell [Cell]
   748   C1306577:Death, NOS [Finding]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714 E C0243095:Find [Finding]

Phrase: "between mutant APP-bearing PC12 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   845   C0018956:precursor cell [Cell]
   818   C0085262:PC12 Cells [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.166: Increased Caspase 3 Activity of APPsw PC12 Cells in Response to Oxidative StressFurthermore, we prepared extracts from H2O2-treated PC12 cells and measured their ability to cleave the colorimetric substrate to Ac-DEVD-pNA, which is specifically cleaved by caspase 3. 

Phrase: "Increased Caspase 3 Activity of APPsw PC12 Cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C1150132:caspase-3 activity [Molecular Function]
   767   C0474395:increased activity [Finding]
   767   C1150130:caspase activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "in Response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to Oxidative StressFurthermore,"

Phrase: "we"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "extracts from H2O2-treated PC12 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0007592:Cell Extracts [Cell Component]
   719   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "cleave"

Phrase: "the colorimetric substrate to Ac-DEVD-pNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1710236:Substrate [Manufactured Object]

Phrase: "which"

Phrase: "is"

Phrase: "specifically"

Phrase: "cleaved by caspase 3."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0205242:Cleaved [Spatial Concept]
   770   C0333853:Cleaved [Cell]
Processing 00000000.tx.167: Cellular extracts from untreated control cultures showed very low Ac-DEVD-pNA cleavage in all cell lines (Fig. 4). 

Phrase: "Cellular extracts from untreated control cultures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C2828366:Extract [Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "very low Ac-DEVD-pNA cleavage in all cell lines"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   754   C1183162:Cleavage lines [Body Location or Region]
   738   C0010813:cleavage [Cell Function]
   738   C0596311:Cleavage [Phenomenon or Process]
   738   C1330957:cleavage [Cell Function]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.168: Under these base-line conditions, no significant differences could be detected between vector-, APPwt-, and APPsw-transfected PC12 cells. 

Phrase: "Under these base-line conditions,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   734   C0168634:baseline [Biomedical or Dental Material]
   734   C1442488:Baseline [Quantitative Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "no significant differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "detected between vector-,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0442335:Vector [Spatial Concept]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   790   C1705099:Vector [Idea or Concept]

Phrase: "APPwt-,"

Phrase: "and"

Phrase: "APPsw-transfected PC12 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0085262:PC12 Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.169: After exposure to oxidative stress, caspase 3 activity increased gradually and reached a maximum activity after 6 h of incubation, demonstrating a delayed increase as compared with the initiator caspases 2 and 8. 

Phrase: "After exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "caspase 3 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150132:caspase-3 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "gradually"

Phrase: "and"

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "a maximum activity after 6 h of incubation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "demonstrating"

Phrase: "a delayed increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "as"

Phrase: "compared with the initiator caspases 2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1720986:Caspases, Initiator [Amino Acid, Peptide, or Protein,Enzyme]
   773   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   773   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0010656:Caspases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1444748:Initiator [Qualitative Concept]
   753   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "8."
Processing 00000000.tx.170: APPsw and APPwt PC12 cells showed a significantly enhanced caspase 3 activity compared with vector-transfected clones with the strongest increase in the APPsw cells (Fig. 4A). 

Phrase: "APPsw"

Phrase: "and"

Phrase: "APPwt PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a significantly enhanced caspase 3 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C1150132:caspase-3 activity [Molecular Function]
   875   C1707919:Enhanced Activity [Quantitative Concept]
   853   C1150130:caspase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "compared with vector-transfected clones"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0009013:Clones [Cell]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1707455:Compared [Activity]
   726 E C1522642:Clone [Tissue]

Phrase: "with the strongest increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "in the APPsw cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.171: By Western blotting, we also found a significantly increased protein expression of the active caspase 3 in APPsw PC12 cells compared with control cells (Fig. 4B). 

Phrase: "By Western blotting,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "we also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "a significantly increased protein expression of the active caspase 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1171362:protein expression [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in APPsw PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "compared with control cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0007634:Cells [Cell]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.172: The highest protein expression was evidenced after 6 h of H2O2 exposure by densitometric immunoblot analysis (Fig. 4C). 

Phrase: "The highest protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1171362:protein expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "evidenced after 6 h of H2O2 exposure"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   774   C0444953:H 6 [Intellectual Product]
   757   C0332120:Evidence of [Functional Concept]
           Evidence
   748   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0274281:Exposure, NOS [Injury or Poisoning]
   748   C0332157:Exposure [Clinical Attribute]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]

Phrase: "by densitometric immunoblot analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.173: View larger version (25K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.174: 4. 

Phrase: "4."
Processing 00000000.tx.175: A, time course of caspase 3 activity in cytosolic protein extracts from H2O2-treated PC12 cells. 

Phrase: "A,"

Phrase: "time course of caspase 3 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0449247:Time course [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0750729:Course [Temporal Concept]
   753   C3541383:Time [Temporal Concept]

Phrase: "in cytosolic protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "extracts from H2O2-treated PC12 cells."
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   790   C0085262:PC12 Cells [Cell]
           PC-12
   767   C0007592:Cell Extracts [Cell Component]
   753   C0007634:Cells [Cell]
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0332293:treated [Therapeutic or Preventive Procedure]
   753   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   753   C1522326:Treated [Functional Concept]
   753   C2828366:Extract [Substance]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1292734:TREAT [Functional Concept]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.176: Maximal caspase 3 activity was reached after 6 h determined by DEVD cleavage. 

Phrase: "Maximal caspase 3 activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1150132:caspase-3 activity [Molecular Function]
   875   C1150130:caspase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "reached after 6 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0444953:H 6 [Intellectual Product]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C2584321:Reach [Organism Function]

Phrase: "determined by DEVD cleavage."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]
Processing 00000000.tx.177: APPsw cells showed enhanced caspase 3 activity after oxidative stress-induced death compared with APPwt and vector cells. 

Phrase: "APPsw cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "enhanced caspase 3 activity after oxidative stress-induced death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1150132:caspase-3 activity [Molecular Function]
   762   C1150130:caspase activity [Molecular Function]
   762   C1707919:Enhanced Activity [Quantitative Concept]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "compared with APPwt and vector cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   753   C0007634:Cells [Cell]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   753   C1707455:Compared [Activity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.178: Maximal caspase 3 activity was reached after 6 h of exposure to H2O2 (++, p < 0.01 versus APPwt; ***, p < 0.001 versus vector (ANOVA)). 

Phrase: "Maximal caspase 3 activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1150132:caspase-3 activity [Molecular Function]
   875   C1150130:caspase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "reached after 6 h of exposure"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0444953:H 6 [Intellectual Product]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0332157:Exposure [Clinical Attribute]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   719   C2584321:Reach [Organism Function]

Phrase: "to H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(++,"

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "APPwt"

Phrase: ";"

Phrase: "*"

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "(ANOVA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.179: Data are means  S.E. from five or six independent experiments. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "from five"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205451:Five [Quantitative Concept]

Phrase: "or"

Phrase: "six independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.180: B, time course of Western blot analysis of active caspase 3 (two-way ANOVA for cell line (p < 0.001) and time course (p < 0.001)). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "time course of Western blot analysis of active caspase 3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   775   C1718396:Time of analysis [Temporal Concept]
   760   C0449247:Time course [Temporal Concept]
   739   C0040223:Time [Temporal Concept]
   739   C0750729:Course [Temporal Concept]
   739   C3541383:Time [Temporal Concept]

Phrase: "(two-way ANOVA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0205448:Two [Quantitative Concept]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]

Phrase: "for cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007600:Cell Line [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:Line [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "time course"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0449247:Time course [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C0750729:Course [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "(p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.181: The highest protein concentration was detected after 6 h of H2O2 exposure by densitometric immunoblot analysis. 

Phrase: "The highest protein concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0427716:Protein concentration [Laboratory Procedure]
   901   C1304757:Protein concentration [Laboratory or Test Result]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "detected after 6 h of H2O2 exposure"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   774   C0444953:H 6 [Intellectual Product]
   748   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0274281:Exposure, NOS [Injury or Poisoning]
   748   C0332157:Exposure [Clinical Attribute]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441932:H+ [Classification]
   748   C0442726:Detected [Finding]
   748   C0564385:/h [Quantitative Concept]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "by densitometric immunoblot analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.182: *, p < 0.05; 

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.183: **, p < 0.01 versus corresponding control). 

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "corresponding control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.184: Data are means  S.E. from three independent experiments (C).  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "from three independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.185: Activation of Caspase 9 in Response to Oxidative Stress Mitochondria play a prominent role in the intrinsic apoptosis pathway. 

Phrase: "Activation of Caspase 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1159825:Caspase Activation [Molecular Function]
   770   C1879547:Activation [Activity]

Phrase: "in Response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to Oxidative Stress Mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026237:Mitochondria [Cell Component]
   734   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a prominent role in the intrinsic apoptosis pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.186: During mitochondrial dysfunction, several essential players of apoptosis, including procaspases, cytochrome c, and apoptosis-inducing factor, are released into the cytosol. 

Phrase: "During mitochondrial dysfunction,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "several essential players of apoptosis,"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "procaspases,"

Phrase: "cytochrome c,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: "and"

Phrase: "apoptosis-inducing factor,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0763396:Apoptosis Inducing Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826618:APOPTOSIS-INDUCING FACTOR [Gene or Genome]
   827   C0162638:Apoptosis [Cell Function]
   827   C0205263:Inducing [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "are"

Phrase: "released into the cytosol."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   770   C1383501:Cytosol [Cell Component]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.187: The multimeric complex formation of cytochrome c, apoptotic protease-activating factor-1, and caspase 9 activates downstream caspases, leading to apoptotic cell death (55). 

Phrase: "The multimeric complex formation of cytochrome c,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "apoptotic protease-activating factor-1,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0664613:apoptotic protease-activating factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Apoptotic Protease Activating Factor
  1000   C1332098:APOPTOTIC PROTEASE ACTIVATING FACTOR 1 [Gene or Genome]
   804   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C1516044:Apoptotic [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C1879547:activating [Activity]
   804   C1947941:Protease [Enzyme]
   804   C2827422:Factor [Conceptual Entity]
   771 E C1515877:Activate [Functional Concept]
   733 E C0162638:Apoptosis [Cell Function]

Phrase: "and"

Phrase: "caspase 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0910167:caspase-9 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "downstream caspases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010656:Caspases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "leading to apoptotic cell death"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   862   C0162638:apoptotic cell death [Cell Function]
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C0332152:Leading [Temporal Concept]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1516044:Apoptotic [Qualitative Concept]
   760   C1522538:Leading [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.188: Therefore, we examined whether oxidative stress in PC12 cells activates caspase 9 by using an polyclonal antibody specific for the inactive full-length procaspase 9 and for the cleaved fragments of the protein. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "oxidative stress in PC12 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   760   C0038435:Stress [Finding]
   760   C0311404:Oxidative [Functional Concept]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "caspase 9 by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C0910167:caspase-9 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an polyclonal antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "specific for the inactive full-length procaspase 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205369:Specific [Qualitative Concept]
   744   C1552740:specific [Intellectual Product]

Phrase: "and for the cleaved fragments of the protein."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   750   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205242:Cleaved [Spatial Concept]
   744   C0332255:fragments [Functional Concept]
   744   C0333853:Cleaved [Cell]
   744   C0486805:Fragments [Body Substance]
   744   C1515981:And [Idea or Concept]
   711 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.189: We detected a time-dependent increase in cleaved fragments of caspase 9 after treatment of the cells with hydrogen peroxide (Fig. 5A). 

Phrase: "We"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "a time-dependent increase in cleaved fragments of caspase 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "after treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "with hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.190: APPsw PC12 cells showed an elevated expression of the active cleaved fragments of caspase 9 compared with vector-transfected cells. 

Phrase: "APPsw PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an elevated expression of the active cleaved fragments of caspase 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "compared with vector-transfected cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0007634:Cells [Cell]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1707455:Compared [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.191: A time-dependent cytochrome c increase in the cytosol was also detected by Western blot using a specific antibody (Fig. 5D). 

Phrase: "A time-dependent cytochrome c increase in the cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "also"

Phrase: "detected by Western blot"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a specific antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 5D"

Phrase: ")."
Processing 00000000.tx.192: The highest cytochrome c amount in the cytosolic fraction was detected after a 4-h oxidative stress induction. 

Phrase: "The highest cytochrome c amount in the cytosolic fraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "detected after a 4-h oxidative stress induction."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C1518761:Oxidative Stress Induction [Cell or Molecular Dysfunction]
   770   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   744   C0033727:H+ [Element, Ion, or Isotope]
   744   C0038435:Stress [Finding]
   744   C0205263:Induction [Functional Concept]
   744   C0311404:Oxidative [Functional Concept]
   744   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441932:H+ [Classification]
   744   C0442726:Detected [Finding]
   744   C0564385:/h [Quantitative Concept]
   744   C0857127:induction [Therapeutic or Preventive Procedure]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.193: In addition, caspase 9 activities were measured colorimetrically using Ac-LEHD-pNA as substrate in lysates of hydrogen peroxide-treated cells (Fig. 5B). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "caspase 9 activities"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   988   C1150135:caspase-9 activity [Molecular Function]
   896   C1150130:caspase activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
   734   C0910167:caspase-9 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "colorimetrically"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Ac-LEHD-pNA as substrate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0048553:para-nitroaniline [Organic Chemical]
   753   C0030563:Para [Finding]
   753   C0068820:nitroaniline [Organic Chemical]

Phrase: "in lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "of hydrogen peroxide-treated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.194: We ascertained an early induced activation of caspase 9 after 2 h, whereas the activity was increased in the APP-transfected cells compared with vector-transfected controls but was not different between APPsw and APPwt cells (Fig. 5C). 

Phrase: "We"

Phrase: "ascertained"

Phrase: "an early induced activation of caspase 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1159825:Caspase Activation [Molecular Function]
   748   C1879547:Activation [Activity]

Phrase: "after 2 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "whereas"

Phrase: "the activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "increased in the APP-transfected cells"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0018956:cells precursor [Cell]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0007634:Cells [Cell]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "compared with vector-transfected controls"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   781   C0031249:control vector [Occupational Activity]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1707455:Compared [Activity]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "but"

Phrase: "was"

Phrase: "not different between APPsw"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "APPwt cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.195: View larger version (44K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(44K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.196: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.197: A, Western blot analysis of caspase 9 activation in cell lysates of H2O2-treated PC12 cells. 

Phrase: "A,"

Phrase: "Western blot analysis of caspase 9 activation in cell lysates"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   782   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   760   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   757   C0001282:Activation Analysis [Laboratory Procedure]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]
   739   C1705493:Western [Spatial Concept]

Phrase: "of H2O2-treated PC12 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0085262:PC12 Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.198: Data are from a representative experiment repeated at least three times with similar findings. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are from a representative experiment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0681814:Experiment [Research Activity]
   760   C1551058:Are [Quantitative Concept]
   760   C1706386:Experiment [Conceptual Entity]
   760   C1882932:Representative [Activity]

Phrase: "repeated at least three times"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0205341:Repeated [Functional Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C1547730:Repeat [Temporal Concept]
   726 E C1705914:Repeat [Conceptual Entity]
   726 E C3541383:Time [Temporal Concept]

Phrase: "with similar findings."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]
Processing 00000000.tx.199: Increased expression of cleaved caspase 9 in APPsw cells is already detectable after 2 h of treatment. 

Phrase: "Increased expression of cleaved caspase 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in APPsw cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "already detectable after 2 h of treatment."
Processing 00000000.tx.200: B and C, enhanced caspase 9 activity in cell lysates from APP-transfected cells compared with vector-transfected controls (*, p < 0.05 versus vector after 2 h of induction; +, p < 0.05 versus vector and wild type under basal conditions). 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C,"

Phrase: "enhanced caspase 9 activity in cell lysates from APP-transfected cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   733   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "compared with vector-transfected controls"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   781   C0031249:control vector [Occupational Activity]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1707455:Compared [Activity]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "("

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "vector after 2 h of induction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]

Phrase: "; +,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "and"

Phrase: "wild type under basal conditions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.201: C, cytochrome c release from the mitochondria. 

Phrase: "C,"

Phrase: "cytochrome c release from the mitochondria."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.202: Cytosolic fractions were separated from mitochondria-enriched fractions and subjected to Western blotting. 

Phrase: "Cytosolic fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "separated from mitochondria-enriched fractions"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0026237:Mitochondria [Cell Component]
   760   C0086972:Separated [Finding]
   760   C0359583:enriched [Food]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "subjected to Western blotting."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.203: A time-dependent cytochrome c increase in the cytosol was detected. 

Phrase: "A time-dependent cytochrome c increase in the cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.204: As a control, the blot was reprobed with an actin antibody to evaluate the loading of the cytosolic extracts.  

Phrase: "As a control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the blot"

Phrase: "was"

Phrase: "reprobed with an actin antibody to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1718641:Actin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the loading of the cytosolic extracts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1708715:Loading [Activity]
Processing 00000000.tx.205: Enhanced Activation of JNK Pathway in APPsw PC12 CellsThe mobilization of the stress-activated protein kinase (JNK) plays an important role in apoptosis induced by several types of environmental stress, like UV, -radiation, inflammatory cytokines, and DNA damage (5658). 

Phrase: "Enhanced Activation of JNK Pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "in APPsw PC12 CellsThe mobilization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
   812   C0300926:mobilization [Functional Concept]

Phrase: "of the stress-activated protein kinase"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0872280:stress activated protein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0018850:stress protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0038435:Stress [Finding]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]
   741 E C0231297:Stressful [Functional Concept]

Phrase: "(JNK)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "induced by several types of environmental stress,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0871732:environmental stress [Phenomenon or Process]
   748   C0014406:Environmental [Spatial Concept]
   748   C0038435:Stress [Finding]
   748   C0205263:Induced [Functional Concept]
   748   C0332307:Types [Qualitative Concept]
   714 E C1547052:*Type [Quantitative Concept]

Phrase: "like UV, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041625:UV [Natural Phenomenon or Process]
  1000   C1961129:uV [Quantitative Concept]

Phrase: "radiation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0034519:Radiation [Natural Phenomenon or Process]
  1000   C0560559:Radiation [Quantitative Concept]
  1000   C0851346:Radiation [Natural Phenomenon or Process]
  1000   C1522449:Radiation [Therapeutic or Preventive Procedure]
  1000   C1524020:Radiation [Therapeutic or Preventive Procedure]
  1000   C1524021:Radiation [Research Activity]

Phrase: "inflammatory cytokines,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "DNA damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "(5658"

Phrase: ")."
Processing 00000000.tx.206: In oxidative stress-induced cell death, the activation of mitochondrial apoptosis machinery by JNK in adult cardiac myocytes has been observed (37). 

Phrase: "In oxidative stress-induced cell death,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0007587:Cell Death [Cell Function]
   804   C0007634:Cell [Cell]
   804   C0011065:Death [Organism Function]
   804   C1269647:Cell [Cell]
   804   C1306577:Death, NOS [Finding]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "the activation of mitochondrial apoptosis machinery"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   820   C3266896:activation of apoptosis [Cell Function]
   753   C1879547:Activation [Activity]

Phrase: "by JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "in adult cardiac myocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0225828:Myocytes, Cardiac [Cell]
   827   C0596981:Myocytes [Cell]

Phrase: "has"

Phrase: "been"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.207: Hence, we addressed the question whether oxidative stress-mediated activation of the JNK pathway is affected by overexpression of APP. 

Phrase: "Hence,"

Phrase: "we"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "the question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "whether"

Phrase: "oxidative stress-mediated activation of the JNK pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "affected by overexpression of APP."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   774   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0392760:Affected [Functional Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1314939:Affected [Functional Concept]
   748   C1709634:Precursor [Idea or Concept]
   714 E C0001721:Affect [Mental Process]
Processing 00000000.tx.208: We performed a Western blotting of immunocomplexes to detect activation of JNK and c-Jun. 

Phrase: "We"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a Western blotting of immunocomplexes to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   773 E C0949466:Western Blot [Laboratory Procedure]
   753   C1705493:Western [Spatial Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "activation of JNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "c-Jun."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162508:c-Jun [Gene or Genome]
   861   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.209: H2O2 treatment of APPsw PC12 cells induced JNK phosphorylation within 2 h (Fig. 6A). 

Phrase: "H2O2 treatment of APPsw PC12 cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "JNK phosphorylation within 2 h (Fig. 6A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: ")."
Processing 00000000.tx.210: The highest expression was detected after 4 h with an elevated expression in APPsw cells compared with APPwt cells and vector control. 

Phrase: "The highest expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "detected after 4 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0442726:Detected [Finding]
   770   C0564385:/h [Quantitative Concept]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "with an elevated expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in APPsw cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "compared with APPwt cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "vector control."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0031249:vector control [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243148:control [Qualitative Concept]
   861   C0442335:Vector [Spatial Concept]
   861   C1550141:Control [Substance]
   861   C1705099:Vector [Idea or Concept]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.211: When activated, JNK translocates to the nucleus to regulate transcription through its effects on c-Jun and other transcription factors. 

Phrase: "When"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: ","

Phrase: "JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "translocates to the nucleus to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0007610:Nucleus [Cell Component]

Phrase: "regulate"

Phrase: "transcription through its effects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040649:Transcription [Genetic Function]

Phrase: "on c-Jun"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162508:c-Jun [Gene or Genome]
   861   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "other transcription factors."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.212: As for JNK, we observed a strong impact of the Swedish APP transfection on the activation of c-Jun (Fig. 6B). 

Phrase: "As for JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a strong impact of the Swedish APP transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1825598:IMPACT [Gene or Genome]

Phrase: "on the activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of c-Jun (Fig. 6B"

Phrase: ")."
Processing 00000000.tx.213: In our experiments, the kinetics of activation of c-Jun correlated with the phosphorylation of JNK with the highest detection of phosphorylated c-Jun after 6 h of H2O2 treatment. 

Phrase: "In our experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "the kinetics of activation of c-Jun"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0022702:Kinetics [Natural Phenomenon or Process]
   748   C0220865:kinetics [Functional Concept]
   748   C2825046:Kinetics [Occupation or Discipline]

Phrase: "correlated with the phosphorylation of JNK"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1150587:JNK [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1367731:JNK [Gene or Genome]
   753   C1705632:JNK [Gene or Genome]
   753   C1707520:Correlated [Qualitative Concept]

Phrase: "with the highest detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "of phosphorylated c-Jun"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "after 6 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of H2O2 treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.214: The expression of phosphorylated c-Jun was markedly elevated in APPsw compared with treated APPwt or vector-transfected controls after 4 and 6 h of hydrogen peroxide treatment. 

Phrase: "The expression of phosphorylated c-Jun"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "elevated in APPsw"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205250:Elevated [Qualitative Concept]
   790   C3163633:Elevated [Qualitative Concept]

Phrase: "compared with treated APPwt"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   819   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C1522326:Treated [Functional Concept]
   770   C1707455:Compared [Activity]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "vector-transfected controls after 4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   781   C0031249:control vector [Occupational Activity]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "6 h of hydrogen peroxide treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0020275:H - Hydrogen [Element, Ion, or Isotope]
   783   C0444953:H 6 [Intellectual Product]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.215: View larger version (31K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.216: 6. 

Phrase: "6."
Processing 00000000.tx.217: Activation of JNK and c-Jun in oxidative stress-induced cell death in APPsw-, APPwt-, and vector-transfected cells analyzed by Western blotting using anti-active p-JNK and p-c-Jun antibodies for the analysis of stress-activated protein kinase/JNK and c-Jun phosphorylation/activity. 

Phrase: "Activation of JNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "c-Jun in oxidative stress-induced cell death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0162508:c-Jun [Gene or Genome]
   744   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in APPsw-,"

Phrase: "APPwt-,"

Phrase: "and"

Phrase: "vector-transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-active p-JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "and"

Phrase: "p-c-Jun antibodies for the analysis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   774   C0368815:antibodies c [Amino Acid, Peptide, or Protein,Immunologic Factor]
   757   C0369773:P Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "of stress-activated protein kinase/JNK"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1150587:JNK [Molecular Function]
   804   C1367731:JNK [Gene or Genome]
   804   C1705632:JNK [Gene or Genome]
   771   C0872280:stress activated protein kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "c-Jun phosphorylation/activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.218: A, APPsw cells exhibit significantly enhanced protein expression levels of JNK activation in PC12 cells compared with APPwt and vector-transfected cells. 

Phrase: "A,"

Phrase: "APPsw cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "significantly enhanced protein expression levels of JNK activation"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C1171362:protein expression [Genetic Function]
   750   C0428479:Protein level [Laboratory or Test Result]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Levels [Qualitative Concept]
   737   C3244092:expression level [Idea or Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "in PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "compared with APPwt and vector-transfected cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0007634:Cells [Cell]
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0442335:Vector [Spatial Concept]
   748   C1705099:Vector [Idea or Concept]
   748   C1707455:Compared [Activity]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.219: Maximal activated phosphorylated JNK was detected after a 4-h exposure to oxidative stress. 

Phrase: "Maximal activated phosphorylated JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "was"

Phrase: "detected after a 4-h exposure"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0332157:Exposure [Clinical Attribute]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0442726:Detected [Finding]
   753   C0564385:/h [Quantitative Concept]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "to oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.220: C, the expression of phosphorylated c-Jun was markedly elevated in APPsw cells compared with H2O2-treated APPwt and vector controls after hydrogen peroxide treatment. 

Phrase: "C,"

Phrase: "the expression of phosphorylated c-Jun"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "elevated in APPsw cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0205250:Elevated [Qualitative Concept]
   770   C3163633:Elevated [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "compared with H2O2-treated APPwt and vector controls"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   767   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   750   C0031249:control vector [Occupational Activity]
   744   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0442335:Vector [Spatial Concept]
   744   C1522326:Treated [Functional Concept]
   744   C1705099:Vector [Idea or Concept]
   744   C1707455:Compared [Activity]
   711   C0243148:control [Qualitative Concept]
   711 E C1292734:TREAT [Functional Concept]
   711   C1550141:Control [Substance]
   711   C1882979:Control [Conceptual Entity]
   711   C2587213:Control [Functional Concept]
   711   C3274648:Control [Qualitative Concept]

Phrase: "after hydrogen peroxide treatment."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.221: Maximal amount of phosphorylated c-Jun was detected after a 6-h H2O2 treatment of the cells. 

Phrase: "Maximal amount of phosphorylated c-Jun"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "detected after a 6-h H2O2 treatment of the cells."
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   757   C0444953:H 6 [Intellectual Product]
   739   C0007634:Cells [Cell]
   739   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   739   C0033727:H+ [Element, Ion, or Isotope]
   739   C0039798:treatment [Functional Concept]
   739   C0087111:Treatment [Therapeutic or Preventive Procedure]
   739   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0441932:H+ [Classification]
   739   C0442726:Detected [Finding]
   739   C0564385:/h [Quantitative Concept]
   739   C1511790:Detected [Therapeutic or Preventive Procedure]
   739   C1522326:Treatment [Functional Concept]
   739   C1533734:Treatment [Therapeutic or Preventive Procedure]
   739   C1705169:Treatment [Conceptual Entity]
   739   C3282337:Cells [Cell]
   739   C3538994:TREATMENT [Research Activity]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.222: C, the blots were reprobed with an anti-actin antibody to confirm the equal loadings of the protein amounts. 

Phrase: "C,"

Phrase: "the blots"

Phrase: "were"

Phrase: "reprobed with an anti-actin antibody to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0369998:Anti-actin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   778   C1718641:Actin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the equal loadings of the protein amounts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1708715:Loading [Activity]
Processing 00000000.tx.223: Representative Western blotting are shown from at least three independent observations.  

Phrase: "Representative Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   884 E C0949466:Western Blot [Laboratory Procedure]
   827   C1705493:Western [Spatial Concept]

Phrase: "are"

Phrase: "shown from"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1547282:Show [Intellectual Product]

Phrase: "at least three independent observations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0302523:observations [Research Activity]
   812   C0700325:observations [Health Care Activity]
   812   C3244290:observations [Functional Concept]
   779 E C1964257:Observation [Diagnostic Procedure]
   729 E C1518527:OBSERVATIONAL [Research Activity]
Processing 00000000.tx.224: Prevention of Apoptosis by Caspase InhibitorsDue to the enhanced activation of several caspases in response to oxidative stress, we examined the potential against several caspase inhibitors in protecting PC12 cells of oxidative stress-induced apoptosis. 

Phrase: "Prevention of Apoptosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0199176:Prevention [Therapeutic or Preventive Procedure]
   790   C1706420:PREVENTION [Research Activity]
   790   C2700409:prevention [Qualitative Concept]

Phrase: "by Caspase InhibitorsDue"

Phrase: "to the enhanced activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "of several caspases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010656:Caspases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the potential against several caspase inhibitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3245505:Potential [Qualitative Concept]

Phrase: "in protecting PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "of oxidative stress-induced apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0162638:Apoptosis [Cell Function]
   741 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.225: Caspase inhibitors were added to cultures of PC12 cells in a time- and concentration-dependent manner (data not shown). 

Phrase: "Caspase inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1516312:Caspase Inhibitors [Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "added to cultures of PC12 cells"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   790   C0085262:PC12 Cells [Cell]
           PC-12
   783   C0007585:cells cultures [Laboratory Procedure]
   753   C0007634:Cells [Cell]
   753   C0010453:Cultures [Idea or Concept]
   753   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   753   C1524062:Added [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1883712:Add [Functional Concept]
   719 E C1948049:Cell [Spatial Concept]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "in a time-"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "concentration-dependent manner"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.226: Best protection was provided by adding caspase inhibitors at a concentration of 10 M 3 h prior to H2O2 exposure. 

Phrase: "Best protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1545588:Protection [Finding]

Phrase: "was"

Phrase: "provided by adding caspase inhibitors"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C1516312:Caspase Inhibitors [Pharmacologic Substance]
   760   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   760   C1999230:Provided [Activity]
   726   C1883712:Add [Functional Concept]
   726 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "at a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 10 M 3 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]
   708   C1883310:10^3 [Quantitative Concept]

Phrase: "prior to H2O2 exposure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]
Processing 00000000.tx.227: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.228: 7, only the inhibitor of the effector caspase 3, AC-DEVD-CMK, was able to rescue APPsw cells from apoptosis below the level of that from vector-transfected control cells. 

Phrase: "7,"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the inhibitor of the effector caspase 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1516312:Caspase Inhibitor [Pharmacologic Substance]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "AC-DEVD-CMK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1311742:Ac-DEVD-CMK [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C1707170:CMK [Gene or Genome]
   827   C1824761:CMK [Gene or Genome]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "rescue"

Phrase: "APPsw cells from apoptosis"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "below the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of that"

Phrase: "from vector-transfected control cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   875   C0031249:vector control [Occupational Activity]
   812   C0007634:Cells [Cell]
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.229: The pretreatment of the APPsw cells with inhibitors of initiator caspase 8 and caspase 9 revealed similar levels than did vector cells. 

Phrase: "The pretreatment of the APPsw cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1550147:Pretreatment [Substance]
   753   C2709094:pre treatment [Temporal Concept]
   753   C3539075:Pretreatment [Temporal Concept]
   753   C3539076:Pretreatment [Activity]

Phrase: "with inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243077:inhibitors [Chemical Viewed Functionally]
   966 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "of initiator caspase 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0667830:caspase-8 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1444748:Initiator [Qualitative Concept]

Phrase: "and"

Phrase: "caspase 9 revealed similar levels than"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "did"

Phrase: "vector cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.230: View larger version (36K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.231: 7. 

Phrase: "7."
Processing 00000000.tx.232: Apoptotic cell death after treatment with H2O2 in PC12 cells. 

Phrase: "Apoptotic cell death after treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0162638:apoptotic cell death [Cell Function]
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "with H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "in PC12 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.233: Apoptotic cell death was assessed by propidium iodide staining and flow cytometry. 

Phrase: "Apoptotic cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0162638:apoptotic cell death [Cell Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "assessed by propidium iodide staining"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0021966:Iodide [Inorganic Chemical]
   760   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1516048:Assessed [Activity]
   760   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "flow cytometry."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016263:Flow Cytometry [Laboratory Procedure]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0814048:Cytometry [Laboratory Procedure]
Processing 00000000.tx.234: APPsw PC12 cells showed enhanced sensitivity to oxidative stress-induced death compared with vector cells (+, p < 0.05; Student's t test). 

Phrase: "APPsw PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "enhanced sensitivity to oxidative stress-induced death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]
   743   C0332324:Sensitive to [Functional Concept]

Phrase: "compared with vector cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0007634:Cells [Cell]
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(+,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Student's t test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.235: In parallel experiments, APPsw cells were pretreated for 3 h with different caspase inhibitors (10 M) or the JNK inhibitor SP600125 (200 nM) and then exposed to H2O2 for 24 h. 

Phrase: "In parallel experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "APPsw cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pretreated for 3 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0041119:h 3 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "with different caspase inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1516312:Caspase Inhibitors [Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(10"

Phrase: "M)"

Phrase: "or"

Phrase: "the JNK inhibitor SP600125"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0968383:SP600125 [Organic Chemical,Pharmacologic Substance]

Phrase: "(200 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "exposed to H2O2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.236: The caspase 3 inhibitor strongly reduced apoptotic cell death in APPsw cells (**, p < 0.01; paired t test). 

Phrase: "The caspase 3 inhibitor strongly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C1516312:Caspase Inhibitor [Pharmacologic Substance]
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "apoptotic cell death in APPsw cells"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0162638:apoptotic cell death [Cell Function]
   790   C0007587:Cell Death [Cell Function]
           cells death
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; paired t test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709451:Paired t-Test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.237: Pretreatment of APPsw cells with JNK, caspase 8, and caspase 9 inhibitors reduced apoptotic cell death to levels corresponding to that of vector cells. 

Phrase: "Pretreatment of APPsw cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "with JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "caspase 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0667830:caspase-8 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "caspase 9 inhibitors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C1516312:Caspase Inhibitors [Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   793 E C1999216:Inhibitor [Qualitative Concept]
   734   C0910167:caspase-9 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "apoptotic cell death to levels"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0162638:apoptotic cell death [Cell Function]
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "corresponding to that of vector cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0007634:Cells [Cell]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.238: Values are means  S.E. from 68 independent experiments.  

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "from 68 independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.239: Inhibiton of JNK by SP600125As detected by Western blotting, we could show that the transfection of the Swedish FAD mutation in PC 12 cells leads to an enhanced activation of the JNK pathway under oxidative stress. 

Phrase: "Inhibiton of JNK"

Phrase: "by SP600125As"

Phrase: "detected by Western blotting,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "we"

Phrase: "could"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the transfection of the Swedish FAD mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "in PC 12 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0085262:PC-12 [Cell]
   734   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]

Phrase: "leads to an enhanced activation of the JNK pathway"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   764   C1621396:JNK Pathway [Molecular Function]
   742   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   742   C0181586:leads [Medical Device]
   742   C1150587:JNK [Molecular Function]
   742   C1367731:JNK [Gene or Genome]
   742   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   742   C1522538:Lead [Functional Concept]
   742   C1704259:Pathway [Molecular Function]
   742   C1705632:JNK [Gene or Genome]
   742   C1705987:Pathway [Conceptual Entity]
   742   C1879547:Activation [Activity]
   742   C2348269:Lead [Element, Ion, or Isotope]
   742   C2349975:Enhanced [Activity]
   742   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "under oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.240: Therefore, we investigated the effect of SP600125, a selective anthrapyrazolone inhibitor of JNK (59), in our cell model. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the effect of SP600125,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "a selective anthrapyrazolone inhibitor of JNK (59"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "in our cell model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]
Processing 00000000.tx.241: We measured the caspase activities of different caspases and the mitochondrial membrane potential after pretreatment with JNK inhibitor to attribute the JNK involvement in oxidative stress-induced apoptosis. 

Phrase: "We"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the caspase activities of different caspases"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   773   C1150130:caspase activity [Molecular Function]
   753   C0441655:Activities [Activity]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "the mitochondrial membrane potential after pretreatment"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   790   C0025251:Membrane Potential [Cell Function]
   790   C0596952:Mitochondrial membrane [Cell Component]
   753   C0025255:Membrane [Tissue]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
   753   C3245505:Potential [Qualitative Concept]

Phrase: "with JNK inhibitor to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "attribute"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449234:Attribute [Idea or Concept]
  1000   C1704772:Attribute [Conceptual Entity]
  1000   C1882133:Attribute [Qualitative Concept]

Phrase: "the JNK involvement in oxidative stress-induced apoptosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1314939:Involvement [Functional Concept]
Processing 00000000.tx.242: We found a highly significant reduction of caspase 9 activity (two-way ANOVA, p < 0.001) and caspase 3 activity (two-way ANOVA, p = 0.0384) in cell lysates of APPsw cells pretreated with 200 nM JNK inhibitor, whereas the activities of caspase 2 and caspase 8 were not significantly altered (Fig. 8). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "a highly significant reduction of caspase 9 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C2267000:Reduction Activity [Molecular Function]
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(two-way ANOVA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0205448:Two [Quantitative Concept]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "caspase 3 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150132:caspase-3 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(two-way ANOVA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0205448:Two [Quantitative Concept]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]

Phrase: "p = 0.0384"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in cell lysates of APPsw cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "pretreated with 200 nM JNK inhibitor,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0312860:NM [Cell Function]
   753   C1150587:JNK [Molecular Function]
   753   C1367731:JNK [Gene or Genome]
   753   C1705632:JNK [Gene or Genome]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "whereas"

Phrase: "the activities of caspase 2"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C1150139:caspase-2 activity [Molecular Function]
   781   C1150130:caspase activity [Molecular Function]
   760   C0441655:Activities [Activity]
   726 E C0205177:Activity [Functional Concept]
   726 E C0439167:% activity [Quantitative Concept]
   726 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "caspase 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0667830:caspase-8 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.243: Corresponding to the reduction of caspase 9 activity, we were able to detect a protection against a decrease in the mitochondrial membrane potential by SP600125 (Fig. 9), indicating an involvement of JNK upstream of mitochondria in oxidative stress signaling. 

Phrase: "Corresponding to the reduction of caspase 9 activity,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C1150135:caspase-9 activity [Molecular Function]
   770   C0910167:caspase-9 [Amino Acid, Peptide, or Protein,Enzyme]
   767   C1150130:caspase activity [Molecular Function]
   767   C2267000:Reduction Activity [Molecular Function]
   744   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205177:Activity [Functional Concept]
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "we"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "a protection against a decrease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1545588:Protection [Finding]

Phrase: "in the mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "by SP600125"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0968383:SP600125 [Organic Chemical,Pharmacologic Substance]

Phrase: "(Fig. 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "an involvement of JNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1314939:Involvement [Functional Concept]

Phrase: "upstream of mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "in oxidative stress signaling."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]
   734   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
Processing 00000000.tx.244: Whereas the treatment with H2O2 (250 M) led to a significant increase of apoptotic cells in APPsw-bearing PC12 cells (42.21  3.71%) compared with vector cell line (30.87  5.97%), APPsw cells pretreated with the JNK inhibitor (33.77  4.06%) exhibited similar apoptotic cell levels as the corresponding vector cells (Fig. 7). 

Phrase: "Whereas"

Phrase: "the treatment with H2O2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "(250"

Phrase: "M)"

Phrase: "led to a significant increase of apoptotic cells"
Meta Candidates (Total=16; Excluded=8; Pruned=0; Remaining=8)
   744   C0007634:Cells [Cell]
   744   C0237881:significant [Quantitative Concept]
   744   C0442805:Increase [Functional Concept]
   744   C0750502:Significant [Idea or Concept]
   744   C1516044:Apoptotic [Qualitative Concept]
   744   C1546944:Significant [Qualitative Concept]
   744   C1708698:LED [Manufactured Object]
   744   C3282337:Cells [Cell]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1269647:Cell [Cell]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C1522538:Lead [Functional Concept]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in APPsw-bearing PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0085262:PC12 Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(42.21  3.71%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450389:71 [Intellectual Product]

Phrase: ")"

Phrase: "compared with vector cell line"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0007600:Cell Line [Cell]
   760   C0007634:Cell [Cell]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205132:Line [Spatial Concept]
   760   C0442335:Vector [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]
   760   C1704653:Cell [Medical Device]
   760   C1705099:Vector [Idea or Concept]
   760   C1707455:Compared [Activity]
   760   C1948049:Cell [Spatial Concept]

Phrase: "(30.87  5.97%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439073:97 [Intellectual Product]
   812   C0439082:>97 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "APPsw cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "pretreated with the JNK inhibitor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1150587:JNK [Molecular Function]
   760   C1367731:JNK [Gene or Genome]
   760   C1705632:JNK [Gene or Genome]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(33.77  4.06%"

Phrase: ")"

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "similar apoptotic cell levels as the corresponding vector cells"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.245: View larger version (34K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.246: 8. 

Phrase: "8."
Processing 00000000.tx.247: Reduction of caspase activities by JNK-inhibitor SP60125. 

Phrase: "Reduction of caspase activities"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C2267000:Reduction Activity [Molecular Function]
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "by JNK-inhibitor SP60125."
Processing 00000000.tx.248: Cells were pretreated with 200 nM SP600125 and incubated with H2O2 in a time-dependent manner. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pretreated with 200 nM SP600125"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0312860:NM [Cell Function]
   760   C0968383:SP600125 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "incubated with H2O2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "in a time-dependent manner."
Processing 00000000.tx.249: Caspase activities were measured in cytosolic protein extracts. 

Phrase: "Caspase activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C1150130:caspase activity [Molecular Function]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "measured in cytosolic protein extracts."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0444706:Measured [Qualitative Concept]
   760   C1383501:Cytosolic [Cell Component]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726   C2828366:Extract [Substance]
Processing 00000000.tx.250: Caspase 9 activity in cell lysates of APPsw cells pretreated with JNK inhibitor was significantly reduced compared with APPsw cells without pretreatment with the inhibitor (two-way ANOVA; p < 0.001 for pretreatment). 

Phrase: "Caspase 9 activity in cell lysates of APPsw cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "pretreated with JNK inhibitor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1150587:JNK [Molecular Function]
   770   C1367731:JNK [Gene or Genome]
   770   C1705632:JNK [Gene or Genome]
   770   C1999216:Inhibitor [Qualitative Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "compared with APPsw cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "without pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1550147:Pretreatment [Substance]
  1000   C2709094:pre treatment [Temporal Concept]
  1000   C3539075:Pretreatment [Temporal Concept]
  1000   C3539076:Pretreatment [Activity]

Phrase: "with the inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(two-way ANOVA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0205448:Two [Quantitative Concept]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]

Phrase: "; p < 0.001 for pretreatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1550147:Pretreatment [Substance]
   760   C2603361:P' [Clinical Attribute]
   760   C2709094:pre treatment [Temporal Concept]
   760   C3539075:Pretreatment [Temporal Concept]
   760   C3539076:Pretreatment [Activity]

Phrase: ")."
Processing 00000000.tx.251: The maximal reduction of caspase 9 activity by pretreatment of the cells with JNK inhibitor was measured after a 2-h exposure to oxidative stress (**, p < 0.01 versus corresponding pretreated cells; *, p < 0.05 versus corresponding pretreated cells after 4-h H2O2 induction). 

Phrase: "The maximal reduction of caspase 9 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C2267000:Reduction Activity [Molecular Function]
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "by pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1550147:Pretreatment [Substance]
  1000   C2709094:pre treatment [Temporal Concept]
  1000   C3539075:Pretreatment [Temporal Concept]
  1000   C3539076:Pretreatment [Activity]

Phrase: "of the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "with JNK inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "was"

Phrase: "measured after a 2-h exposure"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   783   C0011744:h 2 [Element, Ion, or Isotope]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0332157:Exposure [Clinical Attribute]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0444706:Measured [Qualitative Concept]
   753   C0564385:/h [Quantitative Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "to oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "("

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "corresponding pretreated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ";"

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "corresponding pretreated cells after 4-h H2O2 induction"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.252: Caspase 3 was also reduced by the JNK inhibitor (two-way ANOVA; p < 0.01 for time course and pretreatment) with maximal reduction of caspase 3 activity after 2-h exposure to oxidative stress (*, p < 0.05 versus corresponding pretreated cells). 

Phrase: "Caspase 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "also"

Phrase: "reduced by the JNK inhibitor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0392756:Reduced [Qualitative Concept]
   760   C1150587:JNK [Molecular Function]
   760   C1367731:JNK [Gene or Genome]
   760   C1705632:JNK [Gene or Genome]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(two-way ANOVA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0205448:Two [Quantitative Concept]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]

Phrase: "; p < 0.01 for time course"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0449247:Time course [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0750729:Course [Temporal Concept]
   753   C2603361:P' [Clinical Attribute]
   753   C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1550147:Pretreatment [Substance]
  1000   C2709094:pre treatment [Temporal Concept]
  1000   C3539075:Pretreatment [Temporal Concept]
  1000   C3539076:Pretreatment [Activity]

Phrase: ")"

Phrase: "with maximal reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "of caspase 3 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150132:caspase-3 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "after 2-h exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]
   734   C0011744:2 H [Element, Ion, or Isotope]

Phrase: "to oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "("

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "corresponding pretreated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.253: The activities of caspase 2 and caspase 8 were not significantly altered. 

Phrase: "The activities of caspase 2"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C1150139:caspase-2 activity [Molecular Function]
   781   C1150130:caspase activity [Molecular Function]
   760   C0441655:Activities [Activity]
   726 E C0205177:Activity [Functional Concept]
   726 E C0439167:% activity [Quantitative Concept]
   726 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "caspase 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0667830:caspase-8 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "altered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]
Processing 00000000.tx.254: Values are means + S.E. from 46 independent experiments.  

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means +"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "from 46 independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.255: View larger version (22K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.256: 9. 

Phrase: "9."
Processing 00000000.tx.257: Mitochondrial membrane potential analysis: Oxidative stress leads to a decrease in the mitochondrial membrane potential (m) in PC12 cells. 

Phrase: "Mitochondrial membrane potential analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
   756   C1720920:Membrane Potential, Mitochondrial [Cell Function]

Phrase: ":"

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "leads to a decrease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the mitochondrial membrane potential"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   901   C0025251:Membrane Potential [Cell Function]
   901   C0596952:Mitochondrial membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0026237:Mitochondrial [Cell Component]
   827   C0521451:Mitochondrial [Functional Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "("

Phrase: "m) in PC12 cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   833   C0085262:PC12 Cells [Cell]
           PC-12
   819   C0599757:cells m [Cell]
   770   C0007634:Cells [Cell]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.258: The strongest reduction of the mitochondrial membrane potential occurs in APPsw cells (, p < 0.01 versus corresponding H2O2-treated vector cells; t test). 

Phrase: "The strongest reduction of the mitochondrial membrane potential"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   848   C2612224:reduction of mitochondrial membrane potential [Cell Function]
   819   C1156295:reduction of membrane potential [Cell Function]
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "occurs in APPsw cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(,"

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "corresponding H2O2-treated vector cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "; t test"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0871472:t-Test [Intellectual Product]
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.259: The pretreatment of cells with SP600125 before exposure to H2O2 significantly protects the mitochondria against oxidative damage and decrease in m in all three cell lines (**, p < 0.01 versus corresponding H2O2-treated cells, paired t test).   

Phrase: "The pretreatment of cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "with SP600125"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0968383:SP600125 [Organic Chemical,Pharmacologic Substance]

Phrase: "before exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to H2O2 significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "protects"

Phrase: "the mitochondria against oxidative damage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0026237:Mitochondria [Cell Component]

Phrase: "and"

Phrase: "decrease in m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0392756:Decrease [Qualitative Concept]
   790   C0547047:Decrease [Quantitative Concept]

Phrase: "in all three cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "("

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "corresponding H2O2-treated cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "paired t test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709451:Paired t-Test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.260: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  In this study, we provide evidence for the enhanced cell death vulnerability caused by the Swedish APP mutation and elucidate cell death mechanism probably initiated by intracellularly produced A. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES  In this study,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C2985663:Study Reference [Intellectual Product]
   770   C0557651:Study [Manufactured Object]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   770   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence for the enhanced cell death vulnerability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332120:Evidence [Functional Concept]

Phrase: "caused by the Swedish APP mutation"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0026882:Mutation [Genetic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1705285:Mutation [Cell or Molecular Dysfunction]
   744   C1709634:Precursor [Idea or Concept]
   744   C1710263:Swedish [Population Group]
   711   C0015127:cause [Functional Concept]
   711   C1524003:Cause [Conceptual Entity]

Phrase: "and"

Phrase: "elucidate"

Phrase: "cell death mechanism probably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0441712:Mechanism [Functional Concept]
   812   C1706376:Mechanism [Manufactured Object]

Phrase: "initiated by intracellularly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1548602:Initiate [Idea or Concept]
   756   C1704686:Initiate [Functional Concept]

Phrase: "produced"

Phrase: "A."
Processing 00000000.tx.261: Although A-induced cell death has been a topic of research in many studies, the relevance of these in vitro findings with regard to in vivo processes is not clear. 

Phrase: "Although"

Phrase: "A-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "a topic of research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1522168:TOPIC [Functional Concept]
   770   C1555712:topic [Idea or Concept]

Phrase: "in many studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "the relevance of these in vitro findings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2347946:Relevance [Qualitative Concept]

Phrase: "with regard to in vivo processes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1184743:Process [Body Part, Organ, or Organ Component]
   793   C1522240:Process [Phenomenon or Process]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.262: In most studies, synthetic A peptides have been applied at micromolar levels that are in contrast to the low nanomolar levels of natural A found in the brain and cerebrospinal fluid of AD patients. 

Phrase: "In most studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "synthetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:synthetic [Activity]

Phrase: "A peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "have"

Phrase: "been"

Phrase: "applied at micromolar levels"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0185125:Applied [Health Care Activity]
   770   C0439300:micromolar [Quantitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "are in contrast to the low nanomolar levels of natural A"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   738   C0205251:low [Qualitative Concept]
   738   C0205296:Natural [Functional Concept]
   738   C0439282:nanomolar [Quantitative Concept]
   738   C0441889:Levels [Qualitative Concept]
   738   C1299352:Low [Qualitative Concept]
   738   C1550472:low [Idea or Concept]
   738   C1551058:Are [Quantitative Concept]
   738   C1979874:Contrast [Qualitative Concept]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: "found in the brain"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0150312:Found [Quantitative Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "cerebrospinal fluid of AD patients."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0007806:Cerebrospinal Fluid [Body Substance]
   806   C0007807:cerebrospinal fluid [Functional Concept]
   760   C0005889:FLUID [Body Substance]
   760   C0302908:fluid [Substance]
   760   C0444611:Fluid [Qualitative Concept]
   760   C1704353:Fluid [Substance]
Processing 00000000.tx.263: Therefore, studies of A-induced neurotoxic effects under more likely physiological conditions mimicking the situation in AD brains are needed (60). 

Phrase: "Therefore,"

Phrase: "studies of A-induced neurotoxic effects"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   773   C0235032:Neurotoxic effect [Injury or Poisoning]
   753   C0205263:Induced [Functional Concept]
   753   C0557651:Study [Manufactured Object]
   753   C0947630:studies [Laboratory Procedure]
   753   C1280500:effects [Qualitative Concept]
   753   C2603343:Study [Research Activity]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "under more likely physiological conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   779   C0012634:condition [Disease or Syndrome]
   779   C0348080:Condition [Qualitative Concept]
   779   C1705253:Condition [Conceptual Entity]
   729 E C0009647:Conditioned [Mental Process]
   729 E C1701901:Conditional [Qualitative Concept]
   729 E C1963686:Conditional [Functional Concept]
   706 E C1519605:Conditionality [Conceptual Entity]

Phrase: "mimicking"

Phrase: "the situation in AD brains"

Phrase: "are"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "(60"

Phrase: ")."
Processing 00000000.tx.264: Moreover, A is produced intracellularly and can accumulate within cells (21, 61, 62) before its deposition in senile plaques. 

Phrase: "Moreover,"

Phrase: "A"

Phrase: "is"

Phrase: "produced"

Phrase: "intracellularly"

Phrase: "and"

Phrase: "can"

Phrase: "accumulate within cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "(21,"

Phrase: "61,"

Phrase: "62"

Phrase: ")"

Phrase: "before its deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposition [Functional Concept]

Phrase: "in senile plaques."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]
Processing 00000000.tx.265: Intracellular accumulation of A might impair cellular functions and may represent the primary event within the neurotoxic A cascade. 

Phrase: "Intracellular accumulation of A"

Phrase: "might"

Phrase: "impair"

Phrase: "cellular functions"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   983   C0007613:Cellular Function [Cell Function]
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the primary event within the neurotoxic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441471:Event [Event]

Phrase: "A cascade."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707310:Cascade [Manufactured Object]
Processing 00000000.tx.266: In order to mimic the situation in vivo, we decided to transfect PC12 cells with human APP and the FAD-related Swedish APP mutation. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "mimic"

Phrase: "the situation"

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "we"

Phrase: "decided"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "transfect"

Phrase: "PC12 cells with human APP"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   778   C0085262:PC12 Cells [Cell]
   774   C0018956:cells precursor [Cell]
   774   C0427861:Human cells [Laboratory or Test Result]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the FAD-related Swedish APP mutation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   791   C0026882:Mutation [Genetic Function]
   791   C1705285:Mutation [Cell or Molecular Dysfunction]
   705   C0611285:Alzheimer's Disease Amyloid Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   704   C1955168:Alzheimer precursor protein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.267: APPsw and APPwt PC12 cells showed a moderate expression of human APP, leading to low levels of A-(140) production (APPsw, 90 pg/ml; APPwt, 20 pg/ml) close to the situation in vivo. 

Phrase: "APPsw"

Phrase: "and"

Phrase: "APPwt PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085262:PC12 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a moderate expression of human APP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "leading to low levels of A-(140"
Meta Candidates (Total=15; Excluded=8; Pruned=0; Remaining=7)
   757   C0428255:lead levels [Laboratory or Test Result]
   748   C0205251:low [Qualitative Concept]
   748   C0332152:Leading [Temporal Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C1299352:Low [Qualitative Concept]
   748   C1522538:Leading [Functional Concept]
   748   C1550472:low [Idea or Concept]
   741 E C0524167:Lead level [Laboratory Procedure]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C0456079:Level [Classification]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1547707:Level [Geographic Area]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C2946261:Level [Pharmacologic Substance]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "(APPsw,"

Phrase: "90 pg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439297:pg/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "; APPwt,"

Phrase: "20 pg/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439297:pg/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "close to the situation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0587267:Close [Functional Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.268: These two cell lines with different production levels of A may additionally allow us to study dose-dependent effects of A. 

Phrase: "These two cell lines with different production levels of A"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0007600:Cell lines [Cell]
   739   C0205132:lines [Spatial Concept]
   706 E C1550648:Line [Substance]
   706 E C1552960:Line [Quantitative Concept]

Phrase: "may"

Phrase: "additionally"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "dose-dependent effects of A."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.269: Expression of APPsw rendered PC12 cells more vulnerable to the induction of cell death after exposure to oxidative stress. 

Phrase: "Expression of APPsw"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "rendered"

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "more vulnerable to the induction of cell death"

Phrase: "after exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.270: It seems likely that increased production of A at physiological levels primes APPsw cells to undergo cell death only after additional stress, a scenario that has been suggested to occur in AD brain. 

Phrase: "It"

Phrase: "seems"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that increased production of A at physiological levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0033268:production [Occupational Activity]

Phrase: "primes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "APPsw cells to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "undergo"

Phrase: "cell death only after additional stress,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0007587:Cell Death [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "a scenario"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683579:scenario [Functional Concept]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur in AD brain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.271: Moreover, we were able to show that caspase 3 activity was significantly enhanced in APPsw compared with APPwt and vector-transfected cells. 

Phrase: "Moreover,"

Phrase: "we"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that caspase 3 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150132:caspase-3 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "significantly"

Phrase: "enhanced in APPsw"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2349975:Enhanced [Activity]

Phrase: "compared with APPwt and vector-transfected cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0007634:Cells [Cell]
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0442335:Vector [Spatial Concept]
   748   C1705099:Vector [Idea or Concept]
   748   C1707455:Compared [Activity]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.272: Interestingly, APPwt also showed an increased activity of caspase 3 compared with empty vector control cells, although to a lesser extent than APPsw cells. 

Phrase: "Interestingly,"

Phrase: "APPwt also"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an increased activity of caspase 3"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   820   C1150132:caspase-3 activity [Molecular Function]
   790   C0474395:increased activity [Finding]
   783   C1150130:caspase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "compared with empty vector control cells,"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   790   C0031249:vector control [Occupational Activity]
   753   C0007634:Cells [Cell]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243148:control [Qualitative Concept]
   753   C0442335:Vector [Spatial Concept]
   753   C1550141:Control [Substance]
   753   C1705099:Vector [Idea or Concept]
   753   C1707455:Compared [Activity]
   753   C1880497:Empty [Qualitative Concept]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "although to a lesser extent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439792:Extent [Spatial Concept]
   760   C0547044:Lesser [Qualitative Concept]

Phrase: "than APPsw cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.273: Our data suggest that already very low A levels in APPwt cells are probably sufficient to prime cells to undergo apoptosis. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that already very low"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0442811:Very low [Finding]
   827   C0205251:low [Qualitative Concept]
   827   C1299352:Low [Qualitative Concept]
   827   C1550472:low [Idea or Concept]

Phrase: "A levels in APPwt cells"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "probably sufficient to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C0750492:Probably [Idea or Concept]

Phrase: "prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "cells to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "undergo"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.274: This is confirmed by our findings that caspase 9 activity is increased and at the same time mitochondrial membrane potential is lowered in APPwt as well as in APPsw cells compared with vector-transfected control cells after the induction of oxidative stress. 

Phrase: "This"

Phrase: "is"

Phrase: "confirmed by our findings"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0750484:Confirmed [Idea or Concept]
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3539655:Findings [Intellectual Product]
   737 E C0037088:Finding [Sign or Symptom]
   737 E C0243095:Finding [Finding]
   737 E C1456348:Confirm [Qualitative Concept]
   737 E C2825141:Finding [Finding]

Phrase: "that caspase 9 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150135:caspase-9 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0910167:caspase-9 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "and at the same time mitochondrial membrane potential"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   770   C0025251:Membrane Potential [Cell Function]
   770   C0596952:Mitochondrial membrane [Cell Component]
   744   C0025255:Membrane [Tissue]
   744   C0026237:Mitochondrial [Cell Component]
   744   C0040223:Time [Temporal Concept]
   744   C0445247:Same [Qualitative Concept]
   744   C0521451:Mitochondrial [Functional Concept]
   744   C0596901:Membrane [Cell Component]
   744   C1515981:And [Idea or Concept]
   744   C1706182:Membrane [Manufactured Object]
   744   C3245505:Potential [Qualitative Concept]
   744   C3541383:Time [Temporal Concept]

Phrase: "is"

Phrase: "lowered in APPwt"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0441994:lowered [Spatial Concept]
   790   C1272755:Lowered [Quantitative Concept]
   790   C2003888:Lowered [Activity]
   756 E C1548802:Lower [Body Location or Region]

Phrase: "as well as in APPsw cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   783   C2347578:Cells/well [Quantitative Concept]
   753   C0007634:Cells [Cell]
   753   C0205170:Well [Qualitative Concept]
   753   C3146287:Well [Manufactured Object]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "compared with vector-transfected control cells"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   783   C0031249:control vector [Occupational Activity]
   753   C0007634:Cells [Cell]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243148:control [Qualitative Concept]
   753   C0442335:Vector [Spatial Concept]
   753   C1550141:Control [Substance]
   753   C1705099:Vector [Idea or Concept]
   753   C1707455:Compared [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "after the induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.275: In addition, we examined the implication of two other initiator caspases, which has been described primarily in the extrinsic apoptotic pathway. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the implication of two"

Phrase: "other initiator caspases,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720986:Caspases, Initiator [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:Caspases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "which"

Phrase: "has"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "primarily in the extrinsic apoptotic pathway."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C3269136:extrinsic apoptotic pathway [Molecular Function]
   791 E C1720827:Apoptosis, Extrinsic Pathway [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C0162638:Apoptosis Pathway [Cell Function]
   754   C3269138:extrinsic apoptosis [Molecular Function]
   753   C0205101:Extrinsic [Spatial Concept]
   753   C0595947:Extrinsic [Functional Concept]
   753   C1516044:Apoptotic [Qualitative Concept]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.276: We demonstrated that caspase 8, involved in death receptor signaling, is activated in oxidative stress signaling in PC12 cells. 

Phrase: "We"

Phrase: "demonstrated"

Phrase: "that caspase 8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0667830:caspase-8 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "involved in death receptor signaling,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1514762:Receptor Signaling [Molecular Function]
   760   C0011065:Death [Organism Function]
   760   C0037083:Signaling [Cell Function]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1306577:Death, NOS [Finding]
   760   C1314939:Involved [Functional Concept]
   760   C3537152:signaling [Biologic Function]

Phrase: "is"

Phrase: "activated in oxidative stress signaling"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   760   C0037083:Signaling [Cell Function]
   760   C0038435:Stress [Finding]
   760   C0311404:Oxidative [Functional Concept]
   760   C1879547:Activated [Activity]
   760   C3537152:signaling [Biologic Function]
   726 E C1515877:Activate [Functional Concept]

Phrase: "in PC12 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.277: Importantly, this activation is markedly elevated in APPsw cells compared with APPwt cells. 

Phrase: "Importantly,"

Phrase: "this activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "elevated in APPsw cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0205250:Elevated [Qualitative Concept]
   770   C3163633:Elevated [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "compared with APPwt cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.278: Whether this increase is due to effects of extracellularly secreted A on cell death receptors or is mediated by intracellularly accumulated A is not clear and still under investigation. 

Phrase: "Whether"

Phrase: "this increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "is due to effects of extracellularly"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0678226:Due to [Functional Concept]
           due
   753   C1280500:effects [Qualitative Concept]
   753   C3146286:Due [Idea or Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "A on cell death receptors"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0007587:Cell Death [Cell Function]
   806   C1720947:Death Receptors [Amino Acid, Peptide, or Protein,Receptor]
   781   C1514760:Receptor Cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "is"

Phrase: "mediated by intracellularly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "accumulated"

Phrase: "A"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "and"

Phrase: "still under investigation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1261322:Investigation [Health Care Activity]
   790   C1552578:investigation [Idea or Concept]
   718 E C1517586:Investigational [Qualitative Concept]
   718 E C3245491:investigational [Intellectual Product]
Processing 00000000.tx.279: In parallel, we observed in PC12 cells an activation of caspase 2 in oxidative stress signaling. 

Phrase: "In parallel,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C2348042:Parallel [Qualitative Concept]
   861   C2826345:PARALLEL [Research Activity]

Phrase: "we"

Phrase: "observed in PC12 cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0085262:PC12 Cells [Cell]
           PC-12
   770   C0007634:Cells [Cell]
   770   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   770   C1441672:Observed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "an activation of caspase 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1159825:Caspase Activation [Molecular Function]
   760   C1879547:Activation [Activity]

Phrase: "in oxidative stress signaling."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]
   734   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
Processing 00000000.tx.280: In APPsw cells, the maximal activity was 4-fold higher compared with APPwt and vector PC12 cells, respectively. 

Phrase: "In APPsw cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the maximal activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "4-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0205250:High [Qualitative Concept]
   966   C1299351:High [Qualitative Concept]
   966   C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "compared with APPwt and vector PC12 cells,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C0085262:PC12 Cells [Cell]
           PC-12
   748   C0007634:Cells [Cell]
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0442335:Vector [Spatial Concept]
   748   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   748   C1705099:Vector [Idea or Concept]
   748   C1707455:Compared [Activity]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "respectively."
Processing 00000000.tx.281: This finding is of particular interest, since recent data describe caspase 2 to be localized in several intracellular compartments, including the mitochondria, Golgi, cytosol, and nucleus (6365). 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "is of particular interest,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0543488:Interest [Mental Process]

Phrase: "since"

Phrase: "recent data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "describe"

Phrase: "caspase 2 to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "be"

Phrase: "localized in several intracellular compartments,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0392752:Localized [Spatial Concept]
   760   C1185625:Compartments [Body Space or Junction]
   760   C1382196:Compartments [Natural Phenomenon or Process]
   726 E C2986730:Compartment [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the mitochondria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "Golgi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018042:Golgi [Cell Component]

Phrase: "cytosol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "and"

Phrase: "nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "(6365"

Phrase: ")."
Processing 00000000.tx.282: Cytotoxic stress causes activation of caspase 2, which is required for the permeabilization of mitochondria (66) and induces the release of cytochrome C (64, 67, 68). 

Phrase: "Cytotoxic stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "activation of caspase 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1159825:Caspase Activation [Molecular Function]
   770   C1879547:Activation [Activity]

Phrase: "which"

Phrase: "is"

Phrase: "required for the permeabilization of mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026237:Mitochondria [Cell Component]
   753   C1514873:Required [Functional Concept]

Phrase: "(66"

Phrase: ")"

Phrase: "and"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the release of cytochrome C"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(64,"

Phrase: "67,"

Phrase: "68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.283: It is assumable that the enhanced A production in the APPsw-transfected cells occurs through an increased expression and activity of beta-site APP-cleaving enzyme (26). 

Phrase: "It"

Phrase: "is"

Phrase: "assumable"

Phrase: "that"

Phrase: "the enhanced"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]
   928 E C1627358:Enhancement [Therapeutic or Preventive Procedure]

Phrase: "A production in the APPsw-transfected cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033268:production [Occupational Activity]

Phrase: "occurs through an increased expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "activity of beta-site APP-cleaving enzyme"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   781   C1325278:amyloid protein activity [Molecular Function]
   762   C0243102:enzyme activity [Molecular Function]
   762   C1537044:protein activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]
   726   C0205681:Active Site [Functional Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.284: The elevated intracellular levels of A in the mutant cells may therefore lead to an enhanced activation of caspase 2, which in turn implements the activation of the intrinsic apoptotic pathway by permeabilizing mitochondria (69). 

Phrase: "The elevated intracellular levels of A in the mutant cells"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "therefore"

Phrase: "lead to an enhanced activation of caspase 2,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   767   C1159825:Caspase Activation [Molecular Function]
   767   C2346661:Lead 2+ [Element, Ion, or Isotope]
   744   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C1879547:Activation [Activity]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C2349975:Enhanced [Activity]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "which in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "implements"

Phrase: "the activation of the intrinsic apoptotic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C3266896:activation of apoptosis [Cell Function]
   748   C1879547:Activation [Activity]

Phrase: "by permeabilizing mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026237:Mitochondria [Cell Component]

Phrase: "(69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.285: As a consequence, cytochrome c is released to the cytosol, resulting in an activation of the apoptotic protease-activating factor-1/caspase 9 apoptosome complex. 

Phrase: "As a consequence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "cytochrome c"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: "is"

Phrase: "released to the cytosol,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   770   C1383501:Cytosol [Cell Component]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "resulting in an activation"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0332294:Resulting in [Functional Concept]
   770   C0678226:resulting [Functional Concept]
   770   C1879547:Activation [Activity]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "of the apoptotic protease-activating factor-1/caspase 9 apoptosome complex."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   791   C0439855:Complex [Qualitative Concept]
   791   C1704241:Complex [Chemical Viewed Structurally]
   707   C0664613:apoptotic protease-activating factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   707   C1332098:APOPTOTIC PROTEASE ACTIVATING FACTOR 1 [Gene or Genome]
Processing 00000000.tx.286: Simultaneously, other effects of caspase 2 need to be considered, since we determined no differences in cytochrome C release and caspase 9 activation between APPsw and APPwt cells. 

Phrase: "Simultaneously,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521115:simultaneously [Temporal Concept]

Phrase: "other effects of caspase 2 need to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "be"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: ","

Phrase: "since"

Phrase: "we"

Phrase: "determined"

Phrase: "no differences in cytochrome C release"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "caspase 9 activation between APPsw"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1159825:Caspase Activation [Molecular Function]
   760   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "APPwt cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.287: Recent data indicate that A induces the release of other proapoptotic factors from the mitochondria (e.g. Diablo/Smac (second mitochondria-derived activator of caspase)) (70). 

Phrase: "Recent data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that"

Phrase: "A"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the release of other proapoptotic factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C0599947:release factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from the mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "("

Phrase: "e.g. Diablo/Smac"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1427590:SMAC [Gene or Genome]
   861   C3540545:SMAC [Gene or Genome]
   861   C3540629:Smac [Amino Acid, Peptide, or Protein]

Phrase: "(second mitochondria-derived activator of caspase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1427590:SECOND MITOCHONDRIA-DERIVED ACTIVATOR OF CASPASE [Gene or Genome]
  1000   C3540629:Second Mitochondria-Derived Activator of Caspase [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: ")"

Phrase: "(70"

Phrase: ")."
Processing 00000000.tx.288: Thus, Smac or other unknown factors may be involved in our cell model. 

Phrase: "Thus,"

Phrase: "Smac"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1427590:SMAC [Gene or Genome]
  1000   C3540545:SMAC [Gene or Genome]
  1000   C3540629:Smac [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "other unknown factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439673:Unknown [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "may"

Phrase: "be"

Phrase: "involved in our cell model."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1314939:Involved [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3161035:Model [Intellectual Product]
Processing 00000000.tx.289: Since caspase 2 activation occurs early in our cell model and neurons from caspase 2 null mice are resistant to -amyloid-induced death (47), this caspase seems to play a critical role. 

Phrase: "Since"

Phrase: "caspase 2 activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1159825:Caspase Activation [Molecular Function]
   827   C1879547:Activation [Activity]
   734   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "early in our cell model"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1279919:Early [Temporal Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "neurons from caspase 2 null mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0027882:Neurons [Cell]

Phrase: "are"

Phrase: "resistant to -amyloid-induced death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0011065:Death [Organism Function]
   804   C1306577:Death, NOS [Finding]

Phrase: "(47"

Phrase: ")"

Phrase: ","

Phrase: "this caspase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a critical role."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.290: Given the important role that mitogen-activated protein kinase pathways play in cellular stress signaling, we investigated the relationship between activated JNK, apoptosis, and the Swedish APP mutation. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the important role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "that mitogen-activated protein kinase pathways"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1704259:Pathways [Molecular Function]
   804   C1705987:Pathways [Conceptual Entity]
   771   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]

Phrase: "play in cellular stress signaling,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1516373:Cellular Stress [Cell or Molecular Dysfunction]
   760   C0007634:Cellular [Cell]
   760   C0032214:Play [Daily or Recreational Activity]
   760   C0037083:Signaling [Cell Function]
   760   C0038435:Stress [Finding]
   760   C0178539:Cellular [Functional Concept]
   760   C0600138:play [Finding]
   760   C3537152:signaling [Biologic Function]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the relationship between activated JNK,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "the Swedish APP mutation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0026882:Mutation [Genetic Function]
   804   C1705285:Mutation [Cell or Molecular Dysfunction]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
Processing 00000000.tx.291: We demonstrated that oxidative stress leads to an activation of JNK. 

Phrase: "We"

Phrase: "demonstrated"

Phrase: "that oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "leads to an activation of JNK."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0181586:leads [Medical Device]
   753   C1150587:JNK [Molecular Function]
   753   C1367731:JNK [Gene or Genome]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C1705632:JNK [Gene or Genome]
   753   C1879547:Activation [Activity]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.292: JNK phosphorylates specific sites in the N-terminal region of c-Jun, thereby enhancing its transcriptional activity. 

Phrase: "JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "phosphorylates"

Phrase: "specific sites in the N-terminal region of c-Jun,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   743   C0449604:Specific site [Spatial Concept]
   741   C2945843:Site of [Qualitative Concept]
   739   C0205145:Sites [Spatial Concept]
   706 E C1515974:Site [Body Location or Region]
   706 E C2825164:Site [Spatial Concept]

Phrase: "thereby"

Phrase: "enhancing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2349975:Enhance [Activity]

Phrase: "its transcriptional activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.293: Very importantly, we were able to demonstrate that in PC12 cells bearing mutant APPsw, the activation of JNK and c-Jun was significantly enhanced compared with APPwt cells. 

Phrase: "Very importantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442824:Very [Qualitative Concept]

Phrase: "we"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "demonstrate"

Phrase: "that in PC12 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0085262:PC12 Cells [Cell]
           PC-12
   770   C0007634:Cells [Cell]
   770   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "mutant APPsw,"

Phrase: "the activation of JNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "c-Jun"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162508:c-Jun [Gene or Genome]
   861   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "significantly"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "compared with APPwt cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.294: At the same time, activation of JNK and c-Jun is increased in APPwt compared with vector cells. 

Phrase: "At the same time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "activation of JNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "c-Jun"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162508:c-Jun [Gene or Genome]
   861   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "increased in APPwt"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "compared with vector cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0007634:Cells [Cell]
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vector [Spatial Concept]
   770   C1705099:Vector [Idea or Concept]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.295: This suggests that the different A levels induce a dose-dependent activation of JNK pathway. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]

Phrase: "A levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a dose-dependent activation of JNK pathway."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1879547:Activation [Activity]
Processing 00000000.tx.296: Interestingly, we could observe a reduction of caspase 9 activity using the selective JNK inhibitor SP600125, whereas activities of caspase 2 and caspase 8 were unaltered. 

Phrase: "Interestingly,"

Phrase: "we"

Phrase: "could"

Phrase: "observe"

Phrase: "a reduction of caspase 9 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C2267000:Reduction Activity [Molecular Function]
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the selective JNK inhibitor SP600125,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0968383:SP600125 [Organic Chemical,Pharmacologic Substance]

Phrase: "whereas"

Phrase: "activities of caspase 2"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   870   C1150139:caspase-2 activity [Molecular Function]
   802   C1150130:caspase activity [Molecular Function]
   770   C0441655:Activities [Activity]
   737 E C0205177:Activity [Functional Concept]
   737 E C0439167:% activity [Quantitative Concept]
   737 E C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "caspase 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0667830:caspase-8 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "unaltered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709843:Unaltered [Qualitative Concept]
Processing 00000000.tx.297: Furthermore, the inhibitor compensated the mitochondrial abnormality when oxidative stress was induced. 

Phrase: "Furthermore,"

Phrase: "the inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999216:Inhibitor [Qualitative Concept]

Phrase: "compensated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205432:Compensated [Qualitative Concept]

Phrase: "the mitochondrial abnormality"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1704258:Abnormality [Finding]
   789 E C0205161:Abnormal [Qualitative Concept]
   789 E C2347472:% Abnormal [Quantitative Concept]
   789 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "when"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "was"

Phrase: "induced."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]
Processing 00000000.tx.298: Due to the fact that members of the antiapoptotic Bcl-2 family proteins are inactivated through phosphorylation by JNK (71, 72), our results support evidence that JNK alters mitochondrial function. 

Phrase: "Due to the fact"

Phrase: "that members of the antiapoptotic Bcl-2 family proteins"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   762   C0086282:Family Members [Family Group]
   745 E C1611821:Family Member [Intellectual Product]
   742   C0680022:members [Population Group]
   708 E C2698041:Member [Professional or Occupational Group]

Phrase: "are"

Phrase: "inactivated through phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "by JNK (71,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0450389:71 [Intellectual Product]
   861   C1150587:JNK [Molecular Function]
   861   C1367731:JNK [Gene or Genome]
   861   C1705632:JNK [Gene or Genome]

Phrase: "72"

Phrase: ")"

Phrase: ","

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "mitochondrial function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.299: Recently, it was reported by different groups that JNK-interacting proteins JIP1b and JIP2 bind the cytoplasmic domain of APP (7376). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "was"

Phrase: "reported by different"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   882   C1709908:Reported By [Group]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C1705242:Different [Qualitative Concept]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]
   718 E C1705241:*Difference [Quantitative Concept]

Phrase: "groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "that JNK-interacting proteins JIP1b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   745   C1422725:JNK interacting protein [Gene or Genome]

Phrase: "and"

Phrase: "JIP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417025:JIP2 [Gene or Genome]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "the cytoplasmic domain of APP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1511625:Cytoplasmic Domain [Cell Component]
   774   C0162808:Protein Domain [Spatial Concept]
   774   C1514562:Protein Domain [Amino Acid Sequence]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "(7376"

Phrase: ")."
Processing 00000000.tx.300: JIP family proteins are scaffold proteins that organize specific members of the JNK/mitogen-activated protein kinase cascade to facilitate signaling. 

Phrase: "JIP family proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "scaffold proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1179132:Scaffold protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "organize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1300196:organize [Functional Concept]

Phrase: "specific members of the JNK/mitogen-activated protein kinase"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0680022:members [Population Group]
   708 E C2698041:Member [Professional or Occupational Group]

Phrase: "cascade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707310:Cascade [Manufactured Object]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "facilitate"

Phrase: "signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
Processing 00000000.tx.301: It was proposed that these scaffold proteins could serve as cargo for the microtubule motor kinesin to mediate the transportation of several transmembrane proteins (77), in which APP is supposed to be a cargo receptor (78). 

Phrase: "It"

Phrase: "was"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that"

Phrase: "these scaffold proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1179132:Scaffold protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "serve as cargo"

Phrase: "for the microtubule motor kinesin to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0085139:Kinesin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1622129:kinesin [Molecular Function]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the transportation of several transmembrane proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040756:Transportation [Organization]
   753   C2239248:Transportation [Health Care Activity]

Phrase: "(77"

Phrase: ")"

Phrase: ","

Phrase: "in which APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "supposed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a cargo receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(78"

Phrase: ")."
Processing 00000000.tx.302: Our data indicate that the altered processing of APPsw might play a crucial role in activation of the stress kinase pathway. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that"

Phrase: "the altered processing of APPsw"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709694:Processing [Activity]

Phrase: "might"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a crucial role in activation of the stress kinase pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.303: Whether this occurs by a redistribution of these scaffold proteins has to be clarified in the future. 

Phrase: "Whether"

Phrase: "this"

Phrase: "occurs by a redistribution of these scaffold proteins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   754   C1179132:Scaffold protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0332620:Redistribution [Functional Concept]
   744   C0337143:Scaffold [Manufactured Object]
   744   C1709305:Occur [Activity]
   744   C2745955:OCCUR [Temporal Concept]

Phrase: "has"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "clarified in the future."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0016884:Future [Temporal Concept]
   770   C2986669:Clarified [Activity]
Processing 00000000.tx.304: In addition, we investigated the protective effects of caspase inhibitors as well as JNK inhibitor in preventing oxidative stress-mediated cell death. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the protective effects of caspase inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "as well as"

Phrase: "JNK inhibitor in preventing oxidative stress-mediated cell death."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.305: Only the caspase 3 inhibitor was able to reduce oxidative stress-induced apoptosis significantly in APPsw cells below the level of control cells. 

Phrase: "Only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the caspase 3 inhibitor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1516312:Caspase Inhibitor [Pharmacologic Substance]
   827   C1999216:Inhibitor [Qualitative Concept]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "reduce"

Phrase: "oxidative stress-induced apoptosis significantly in APPsw cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0162638:Apoptosis [Cell Function]

Phrase: "below the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of control cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.306: The inhibition of caspase 8 or caspase 9 was less effective in preventing apoptosis. 

Phrase: "The inhibition of caspase 8"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "or"

Phrase: "caspase 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0910167:caspase-9 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "less effective in preventing apoptosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280519:effective [Qualitative Concept]
   760   C1704419:Effective [Qualitative Concept]
Processing 00000000.tx.307: The lack of efficacy of the initial caspase inhibitors to abolish completely apoptotic cell death could be attributed to the compensatory pathway. 

Phrase: "The lack of efficacy of the initial caspase inhibitors to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   782   C0235828:Lack of Efficacy [Finding]
           Efficacy Lack
   739   C0332268:lack [Qualitative Concept]

Phrase: "abolish"

Phrase: "completely apoptotic cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0162638:apoptotic cell death [Cell Function]
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "could"

Phrase: "be"

Phrase: "attributed to the compensatory pathway."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0231186:Compensatory [Functional Concept]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]
   726   C0449234:Attribute [Idea or Concept]
   726   C1704772:Attribute [Conceptual Entity]
   726   C1882133:Attribute [Qualitative Concept]
Processing 00000000.tx.308: Although the treatment of PC12 cells with hydrogen peroxide leads to activation of these initiator caspases, their inhibition is not enough to avoid apoptosis, because different caspase pathways co-exist (Fig. 10). 

Phrase: "Although"

Phrase: "the treatment of PC12 cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "leads to activation of these initiator caspases,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C1720986:Caspases, Initiator [Amino Acid, Peptide, or Protein,Enzyme]
   757   C1159825:Caspase Activation [Molecular Function]
   748   C0010656:Caspases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0181586:leads [Medical Device]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1444748:Initiator [Qualitative Concept]
   748   C1522538:Lead [Functional Concept]
   748   C1879547:Activation [Activity]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "their inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "is"

Phrase: "not enough to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1518422:Not [Functional Concept]

Phrase: "avoid"

Phrase: "apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "because"

Phrase: "different caspase pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "co-exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2987476:Exist [Conceptual Entity]

Phrase: "(Fig. 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.309: Such a compensation of caspase pathway was ascertained in sympathetic neurons from caspase 2 null animals. 

Phrase: "Such"

Phrase: "a compensation of caspase pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0152057:Compensation [Mental Process]
   760   C0152058:Compensation [Physiologic Function]
   760   C0220808:Compensation [Quantitative Concept]

Phrase: "was"

Phrase: "ascertained in sympathetic neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027882:Neurons [Cell]

Phrase: "from caspase 2 null animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]
Processing 00000000.tx.310: A lack in caspase 2 expression was compensated by an increased expression of both mRNA and protein for caspase 9 and DIABLO/Smac in trophic factor deprivation-mediated death (79). 

Phrase: "A lack in caspase 2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332268:lack [Qualitative Concept]

Phrase: "was"

Phrase: "compensated by an increased expression of both mRNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C1515670:mRNA Expression [Genetic Function]
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205217:Increased [Quantitative Concept]
   744   C0205432:Compensated [Qualitative Concept]
   744   C0442805:Increased [Functional Concept]

Phrase: "and"

Phrase: "protein for caspase 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "DIABLO/Smac in trophic factor deprivation-mediated death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1427590:SMAC [Gene or Genome]
   744   C3540545:SMAC [Gene or Genome]
   744   C3540629:Smac [Amino Acid, Peptide, or Protein]

Phrase: "(79"

Phrase: ")."
Processing 00000000.tx.311: View larger version (34K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.312: 10. 

Phrase: "10."
Processing 00000000.tx.313: Hypothetical sequence of events leading to cell death occurring in FAD. 

Phrase: "Hypothetical sequence of events"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]

Phrase: "leading to cell death"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   833   C0007587:Cell Death [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0011065:Death [Organism Function]
   770   C0332152:Leading [Temporal Concept]
   770   C1269647:Cell [Cell]
   770   C1306577:Death, NOS [Finding]
   770   C1522538:Leading [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "occurring in FAD."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   862   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   726   C1709305:Occur [Activity]
   726   C2745955:OCCUR [Temporal Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.314: Different pathways may occur in APP-transfected PC12 cells under oxidative stress conditions. 

Phrase: "Different pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "may"

Phrase: "occur in APP-transfected PC12 cells"
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0085262:PC12 Cells [Cell]
           PC-12
   767   C0018956:cells precursor [Cell]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0007634:Cells [Cell]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   744   C1709305:Occur [Activity]
   744   C1709634:Precursor [Idea or Concept]
   744   C2745955:OCCUR [Temporal Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "under oxidative stress conditions."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   734   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   721 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.315: The intrinsic pathway is activated in APPwt and APPsw bearing cells leading to mitochondrial dysfunction in an A-dose-dependent manner compared with vector-transfected controls. 

Phrase: "The intrinsic pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205102:Intrinsic [Spatial Concept]
   861   C0439674:Intrinsic [Functional Concept]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "is"

Phrase: "activated in APPwt"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "APPsw bearing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "leading to mitochondrial dysfunction"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   770   C0026237:Mitochondrial [Cell Component]
   770   C0031847:dysfunction [Functional Concept]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   770   C0332152:Leading [Temporal Concept]
   770   C0521451:Mitochondrial [Functional Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "in an A-dose-dependent manner"

Phrase: "compared with vector-transfected controls."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   781   C0031249:control vector [Occupational Activity]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   760   C1707455:Compared [Activity]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.316: Mitochondria may act as amplifiers, because cytochrome c is released and activates caspase 9. 

Phrase: "Mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "may"

Phrase: "act as amplifiers,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0002684:Amplifiers [Manufactured Object]
   790   C0079613:ACT [Therapeutic or Preventive Procedure]
   756 E C1706099:Amplifier [Manufactured Object]

Phrase: "because"

Phrase: "cytochrome c"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: "is"

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "caspase 9."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0910167:caspase-9 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.317: Since no differences in cytochrome c release and caspase 9 activity between APPsw and APPwt cells were observed, other proapoptotic factors from the mitochondria like Diablo/Smac followed by inhibition of members of the inhibitor-of-apoptosis (IAPs) family could be involved. 

Phrase: "Since"

Phrase: "no differences in cytochrome c release"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "caspase 9 activity between APPsw"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C1150135:caspase-9 activity [Molecular Function]
   797   C1150130:caspase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "APPwt cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "other proapoptotic factors from the mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "like Diablo/Smac"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1427590:SMAC [Gene or Genome]
   861   C3540545:SMAC [Gene or Genome]
   861   C3540629:Smac [Amino Acid, Peptide, or Protein]

Phrase: "followed by inhibition of members of the inhibitor-of-apoptosis (IAPs) family"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   772   C1512772:Inhibition of Apoptosis [Cell Function]
           Apoptosis Inhibition
   756   C0332283:Followed by [Temporal Concept]
           followed
   754   C0086282:Family Members [Family Group]
   754   C1332320:Apoptosis Inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0015576:Family [Family Group]
   738   C0021467:Inhibition [Mental Process]
   738   C0021469:Inhibition [Molecular Function]
   738   C0162638:Apoptosis [Cell Function]
   738   C0680022:members [Population Group]
   738   C1628982:% inhibition [Quantitative Concept]
   738   C1704727:Family [Conceptual Entity]
   738   C1999216:Inhibitor [Qualitative Concept]
   738   C3463820:Inhibition [Activity]
   737 E C1611821:Family Member [Intellectual Product]
   704 E C1719822:Follow [Intellectual Product]
   704 E C2698041:Member [Professional or Occupational Group]

Phrase: "could"

Phrase: "be"

Phrase: "involved."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]
Processing 00000000.tx.318: The 45-fold elevated A levels in APPsw compared with APPwt cells resulted in enhanced JNK, caspase 2, and caspase 8 activation. 

Phrase: "The 45-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "A levels in APPsw"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "compared with APPwt cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "resulted in enhanced JNK,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1150587:JNK [Molecular Function]
   770   C1367731:JNK [Gene or Genome]
   770   C1705632:JNK [Gene or Genome]
   770   C2349975:Enhanced [Activity]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "caspase 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0259419:caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1453171:Caspase-2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "caspase 8 activation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1159825:Caspase Activation [Molecular Function]
   827   C1879547:Activation [Activity]
   734   C0667830:caspase-8 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.319: The convergence of all pathways results in activation of the caspase 3 and the execution of cell death. 

Phrase: "The convergence of all pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0443193:Convergence [Spatial Concept]
   760   C1446614:Convergence [Finding]
   760   C2700387:Convergence [Activity]

Phrase: "results in activation of the caspase 3"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   774   C1159825:Caspase Activation [Molecular Function]
   748   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1879547:Activation [Activity]
   748   C2825142:Result [Finding]

Phrase: "and"

Phrase: "the execution of cell death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1278561:Execution [Governmental or Regulatory Activity]
   760   C1705848:Execution [Activity]
Processing 00000000.tx.320: Thus, the blocking of initiator caspases only inhibits the amplification loop and does not prevent cell death.  

Phrase: "Thus,"

Phrase: "the blocking of initiator caspases only"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   753   C0233660:Blocking [Mental or Behavioral Dysfunction]
   753   C0332206:Blocking [Functional Concept]
   719 E C0028778:Block [Pathologic Function]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the amplification loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "and"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.321: In summary, we propose a hypothetical sequence of events linking FAD, A production, JNK activation, and mitochondrial dysfunction with caspase pathway and neuronal loss for our cell model (Fig. 10). 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "we"

Phrase: "propose"

Phrase: "a hypothetical sequence of events"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "FAD,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "A production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "JNK activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "mitochondrial dysfunction with caspase pathway"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0031847:dysfunction [Functional Concept]
   760   C0277785:Dysfunction, NOS [Qualitative Concept]
   704 E C0231174:Malfunction [Functional Concept]
   704 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "neuronal loss for our cell model"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1850496:Neuronal loss [Finding]
   754 E C0598940:neuron loss [Finding]
   753   C1517945:Loss [Quantitative Concept]

Phrase: "(Fig. 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.322: The brain has a high metabolic rate and is exposed to gradually rising levels of oxidative stress during life. 

Phrase: "The brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "has"

Phrase: "a high metabolic rate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0870882:Metabolic rate [Physiologic Function]
   827   C0311400:Metabolic [Functional Concept]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   827   C1524026:Metabolic [Cell Function]
   827   C2707259:Metabolic [Clinical Attribute]

Phrase: "and"

Phrase: "is"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "to gradually rising levels of oxidative stress"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   793   C1319127:Level of stress [Finding]
           levels stress
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "during life."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0376558:Life [Idea or Concept]
   916 E C0595998:lives [Finding]
Processing 00000000.tx.323: In Swedish FAD patients, the levels of oxidative stress are increased in the temporal inferior cortex (28). 

Phrase: "In Swedish FAD patients,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0030705:Patients [Patient or Disabled Group]
   717   C0276496:Alzheimer disease, familial [Disease or Syndrome]

Phrase: "the levels of oxidative stress"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C1319127:Level of stress [Finding]
           levels stress
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "increased in the temporal inferior cortex"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   753   C0007776:Cortex [Body Part, Organ, or Organ Component]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442043:Temporal [Spatial Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0542339:Inferior [Spatial Concept]
   753   C0678975:inferior [Social Behavior]
   753   C1176472:Cortex [Body Part, Organ, or Organ Component]
   753   C2362314:Temporal [Temporal Concept]
   753   C2700441:Cortex [Plant]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.324: Our study using a cell model mimicking the in vivo situation in AD brains indicates that probably both increased A production and the gradual rise of oxidative stress throughout life lead to an increased vulnerability to apoptotic cell death in neurons from FAD patients.  

Phrase: "Our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a cell model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]

Phrase: "mimicking"

Phrase: "the in vivo situation in AD brains"

Phrase: "indicates"

Phrase: "that probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "both"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "the gradual rise of oxidative stress"

Phrase: "throughout life"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0376558:Life [Idea or Concept]
   916 E C0595998:lives [Finding]

Phrase: "lead to an increased vulnerability"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0861064:increased lead [Finding]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to apoptotic cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0162638:apoptotic cell death [Cell Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "from FAD patients."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0030705:Patients [Patient or Disabled Group]
   756   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   708   C0277558:Familial disease [Disease or Syndrome]
Processing 00000000.tx.325: FOOTNOTES  * This work was supported by grants from the Deutsche Forschungs-gemeinschaft, the Alzheimer Forschung Initiative (to A. E.) and Dr. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the Deutsche Forschungs-gemeinschaft,"

Phrase: "the Alzheimer Forschung Initiative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0424093:Initiative [Mental Process]

Phrase: "("

Phrase: "to A. E.)"

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.326: Robert Pfleger-Stiftung. 

Phrase: "Robert Pfleger-Stiftung."
Processing 00000000.tx.327: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.328: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.329: Section 1734 solely to indicate this fact.  

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.330: To whom correspondence should be addressed: Biocenter of the Johann Wolfgang Goethe-University, Bldg. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Biocenter of the Johann Wolfgang Goethe-University,"

Phrase: "Bldg."
Processing 00000000.tx.331: N260, Marie-Curie-Strasse 9, D-60439 Frankfurt am Main, Germany. 

Phrase: "N260,"

Phrase: "Marie-Curie-Strasse 9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0700085:Curie [Quantitative Concept]

Phrase: "D-"

Phrase: "60439 Frankfurt am Main,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205225:Main [Qualitative Concept]
   812   C1542147:Main [Qualitative Concept]

Phrase: "Germany."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]
Processing 00000000.tx.332: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.333: 49-69-79829380; 

Phrase: "49-69-79829380"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450388:69 [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.334: Fax: 49-69-79829374; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "49-69-79829374"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450388:69 [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.335: E-mail: A.Eckert{at}em.uni-frankfurt.de . 1 The abbreviations used are: A, amyloid--protein; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "A.Eckert{at}em.uni-frankfurt.de . 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0011198:DE [Geographic Area]
   793   C0017480:DE [Geographic Area]
   793   C3541240:DE [Idea or Concept]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "A,"

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "--"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.336: APP, amyloid precursor protein; 

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.337: AD, Alzheimer's disease; 

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.338: FAD, familial Alzheimer's disease; 

Phrase: "FAD,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "familial Alzheimer's disease"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.339: APPsw, Swedish double mutation form of APP; 

Phrase: "APPsw,"

Phrase: "Swedish double mutation form of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]

Phrase: ";"
Processing 00000000.tx.340: APPwt, wild-type APP; 

Phrase: "APPwt,"

Phrase: "wild-type APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.341: JNK, c-Jun N-terminal kinase; 

Phrase: "JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "c-Jun N-terminal kinase"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0248813:c-jun N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0380051:c-JUN N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   937   C1367731:JUN N-terminal kinase [Gene or Genome]
   911   C0872123:c JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1334482:Jun kinase [Gene or Genome]
   875   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1707271:C-Terminal [Amino Acid Sequence]
   840   C0162508:c-Jun [Gene or Genome]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0205088:Terminal [Temporal Concept]
   804   C1553033:[c] [Quantitative Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   804   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.342: pNA, para-nitroaniline; 

Phrase: "pNA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0048553:para-nitroaniline [Organic Chemical]
   861   C0030563:Para [Finding]
   861   C0068820:nitroaniline [Organic Chemical]

Phrase: "para-nitroaniline"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0048553:para-nitroaniline [Organic Chemical]
   861   C0030563:Para [Finding]
   861   C0068820:nitroaniline [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.343: CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; 

Phrase: "CHAPS,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0047101:CHAPS [Pharmacologic Substance,Steroid]
   966 E C0950540:chap [Therapeutic or Preventive Procedure]

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "["

Phrase: "(3-cholamidopropyl"

Phrase: ")"

Phrase: "dimethylammonio"

Phrase: "]-1-propanesulfonic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.344: PI, propidium iodide; 

Phrase: "PI,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0021966:Iodide [Inorganic Chemical]
   861   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "propidium iodide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0021966:Iodide [Inorganic Chemical]
   861   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.345: ANOVA, analysis of variance; 

Phrase: "ANOVA,"

Phrase: "analysis of variance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: ";"
Processing 00000000.tx.346: CHO, aldehyde.  

Phrase: "CHO,"

Phrase: "aldehyde."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001992:Aldehyde [Organic Chemical]
Processing 00000000.tx.347: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Yan, R., Bienkowski, M. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Yan,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bienkowski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.348: J., Shuck, M. 

Phrase: "J.,"

Phrase: "Shuck,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.349: E., Miao, H., Tory, M. 

Phrase: "E.,"

Phrase: "Miao,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tory,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.350: C., Pauley, A. 

Phrase: "C., Pauley,"

Phrase: "A."
Processing 00000000.tx.351: M., Brashier, J. 

Phrase: "M."

Phrase: ","

Phrase: "Brashier,"

Phrase: "J."
Processing 00000000.tx.352: R., Stratman, N. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stratman,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.353: C., Mathews, W. 

Phrase: "C., Mathews,"

Phrase: "W."
Processing 00000000.tx.354: R., Buhl, A. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Buhl,"

Phrase: "A."
Processing 00000000.tx.355: E., Carter, D. 

Phrase: "E.,"

Phrase: "Carter,"

Phrase: "D."
Processing 00000000.tx.356: B., Tomasselli, A. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Tomasselli,"

Phrase: "A."
Processing 00000000.tx.357: G., Parodi, L. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Parodi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681440:parodi [Intellectual Product]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.358: A., Heinrikson, R. 

Phrase: "A.,"

Phrase: "Heinrikson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.359: L., and Gurney, M. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Gurney,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150789:gurney [Medical Device]
  1000   C0183644:Gurney [Medical Device]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.360: E. 

Phrase: "E."
Processing 00000000.tx.361: (1999) Nature 402, 533537[CrossRef][Medline] [OrderarticleviaInfotrieve] Vassar, R., Bennett, B. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 402,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "533537"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Vassar,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bennett,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.362: D., Babu-Khan, S., Kahn, S., Mendiaz, E. 

Phrase: "D."

Phrase: ","

Phrase: "Babu-Khan,"

Phrase: "S."

Phrase: ","

Phrase: "Kahn,"

Phrase: "S."

Phrase: ","

Phrase: "Mendiaz,"

Phrase: "E."
Processing 00000000.tx.363: A., Denis, P., Teplow, D. 

Phrase: "A.,"

Phrase: "Denis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332319:denis [Qualitative Concept]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.364: B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "S."

Phrase: ","

Phrase: "Amarante,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Loeloff,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "Y.,"

Phrase: "Fisher,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325045:Fisher [Mammal]

Phrase: "S."

Phrase: ","

Phrase: "Fuller,"

Phrase: "J.,"

Phrase: "Edenson,"

Phrase: "S."

Phrase: ","

Phrase: "Lile,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1688274:Lile [Fish]

Phrase: "J.,"

Phrase: "Jarosinski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.365: A., Biere, A. 

Phrase: "A.,"

Phrase: "Biere,"

Phrase: "A."
Processing 00000000.tx.366: L., Curran, E., Burgess, T., Louis, J. 

Phrase: "L., Curran,"

Phrase: "E.,"

Phrase: "Burgess,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Louis,"

Phrase: "J."
Processing 00000000.tx.367: C., Collins, F., Treanor, J., Rogers, G., and Citron, M. 

Phrase: "C., Collins,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Treanor,"

Phrase: "J.,"

Phrase: "Rogers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3463939:Roger [Eukaryote]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.368: (1999) Science 286, 735741[Abstract/Free FullText] Capell, A., Grunberg, J., Pesold, B., Diehlmann, A., Citron, M., Nixon, R., Beyreuther, K., Selkoe, D. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Science 286,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "735741"

Phrase: "[Abstract/Free FullText"

Phrase: "] Capell,"

Phrase: "A.,"

Phrase: "Grunberg,"

Phrase: "J.,"

Phrase: "Pesold,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Diehlmann,"

Phrase: "A.,"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Nixon,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.369: J., and Haass, C. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.370: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.371: Biol. 

Phrase: "Biol."
Processing 00000000.tx.372: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.373: 273, 32053211[Abstract/Free FullText] Yang, D. 

Phrase: "273,"

Phrase: "32053211"

Phrase: "[Abstract/Free FullText"

Phrase: "] Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "D."
Processing 00000000.tx.374: S., Tandon, A., Chen, F., Yu, G., Yu, H., Arawaka, S., Hasegawa, H., Duthie, M., Schmidt, S. 

Phrase: "S."

Phrase: ","

Phrase: "Tandon,"

Phrase: "A.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Arawaka,"

Phrase: "S."

Phrase: ","

Phrase: "Hasegawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Duthie,"

Phrase: "M."

Phrase: ","

Phrase: "Schmidt,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.375: D., Ramabhadran, T. 

Phrase: "D."

Phrase: ","

Phrase: "Ramabhadran,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.376: V., Nixon, R. 

Phrase: "V., Nixon,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.377: A., Mathews, P. 

Phrase: "A.,"

Phrase: "Mathews,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.378: M., Gandy, S. 

Phrase: "M."

Phrase: ","

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.379: E., Mount, H. 

Phrase: "E.,"

Phrase: "Mount,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181909:Mount [Medical Device]
  1000   C0449878:mount [Finding]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.380: T., George-Hyslop, P., and Fraser, P. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "George-Hyslop,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.381: E. 

Phrase: "E."
Processing 00000000.tx.382: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.383: Biol. 

Phrase: "Biol."
Processing 00000000.tx.384: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.385: 277, 2813528142[Abstract/Free FullText] Steiner, H., Winkler, E., Edbauer, D., Prokop, S., Basset, G., Yamasaki, A., Kostka, M., and Haass, C. 

Phrase: "277,"

Phrase: "2813528142"

Phrase: "[Abstract/Free FullText"

Phrase: "] Steiner,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Winkler,"

Phrase: "E.,"

Phrase: "Edbauer,"

Phrase: "D."

Phrase: ","

Phrase: "Prokop,"

Phrase: "S."

Phrase: ","

Phrase: "Basset,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Yamasaki,"

Phrase: "A.,"

Phrase: "Kostka,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.386: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.387: Biol. 

Phrase: "Biol."
Processing 00000000.tx.388: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.389: 277, 3906239065[Abstract/Free FullText] Lee, S. 

Phrase: "277,"

Phrase: "3906239065"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lee,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.390: F., Shah, S., Li, H., Yu, C., Han, W., and Yu, G. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Shah,"

Phrase: "S."

Phrase: ","

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "W.,"

Phrase: "and"

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.391: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.392: Biol. 

Phrase: "Biol."
Processing 00000000.tx.393: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.394: 277, 4501345019[Abstract/Free FullText] Tanzi, R. 

Phrase: "277,"

Phrase: "4501345019"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.395: E., Kovacs, D. 

Phrase: "E.,"

Phrase: "Kovacs,"

Phrase: "D."
Processing 00000000.tx.396: M., Kim, T. 

Phrase: "M."

Phrase: ","

Phrase: "Kim,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.397: W., Moir, R. 

Phrase: "W., Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.398: D., Guenette, S. 

Phrase: "D."

Phrase: ","

Phrase: "Guenette,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.399: Y., and Wasco, W. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Wasco,"

Phrase: "W."
Processing 00000000.tx.400: (1996) Neurobiol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.401: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.402: 3, 159168[CrossRef][Medline] [OrderarticleviaInfotrieve] Goate, A., Chartier-Harlin, M. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "159168"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Goate,"

Phrase: "A.,"

Phrase: "Chartier-Harlin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.403: C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., and James, L. 

Phrase: "C., Mullan,"

Phrase: "M."

Phrase: ","

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "J.,"

Phrase: "Crawford,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Fidani,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Giuffra,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Haynes,"

Phrase: "A.,"

Phrase: "Irving,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "James,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.404: (1991) Nature 349, 704706[CrossRef][Medline] [OrderarticleviaInfotrieve] Selkoe, D. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Nature 349,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "704706"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Selkoe,"

Phrase: "D."
Processing 00000000.tx.405: J. 

Phrase: "J."
Processing 00000000.tx.406: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.407: Biol. 

Phrase: "Biol."
Processing 00000000.tx.408: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.409: 271, 1829518298[Free FullText] Haass, C., Hung, A. 

Phrase: "271,"

Phrase: "1829518298"

Phrase: "[Free FullText"

Phrase: "] Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.410: Y., Selkoe, D. 

Phrase: "Y.,"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.411: J., and Teplow, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.412: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.413: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.414: Biol. 

Phrase: "Biol."
Processing 00000000.tx.415: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.416: 269, 1774117748[Abstract/Free FullText] Suzuki, N., Cheung, T. 

Phrase: "269,"

Phrase: "1774117748"

Phrase: "[Abstract/Free FullText"

Phrase: "] Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Cheung,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.417: T., Cai, X. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X."
Processing 00000000.tx.418: D., Odaka, A., Otvos, L., Jr., Eckman, C., Golde, T. 

Phrase: "D."

Phrase: ","

Phrase: "Odaka,"

Phrase: "A.,"

Phrase: "Otvos,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.419: E., and Younkin, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.420: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.421: (1994) Science 264, 13361340[Medline] [OrderarticleviaInfotrieve] Eckert, A., Steiner, B., Marques, C., Leutz, S., Romig, H., Haass, C., and Muller, W. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Science 264,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "13361340"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Eckert,"

Phrase: "A.,"

Phrase: "Steiner,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Marques,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leutz,"

Phrase: "S."

Phrase: ","

Phrase: "Romig,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Muller,"

Phrase: "W."
Processing 00000000.tx.422: E. 

Phrase: "E."
Processing 00000000.tx.423: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.424: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.425: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.426: 64, 183192[CrossRef][Medline] [OrderarticleviaInfotrieve] Eckert, A., Schindowski, K., Leutner, S., Luckhaus, C., Touchet, N., Czech, C., and Muller, W. 

Phrase: "64,"

Phrase: "183192"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Eckert,"

Phrase: "A.,"

Phrase: "Schindowski,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Leutner,"

Phrase: "S."

Phrase: ","

Phrase: "Luckhaus,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Touchet,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Czech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337799:czech [Population Group]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Muller,"

Phrase: "W."
Processing 00000000.tx.427: E. 

Phrase: "E."
Processing 00000000.tx.428: (2001) Neurobiol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.429: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.430: 8, 331342[CrossRef][Medline] [OrderarticleviaInfotrieve] Zhao, B., Chrest, F. 

Phrase: "8,"

Phrase: "331342"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Zhao,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Chrest,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.431: J., Horton, W. 

Phrase: "J.,"

Phrase: "Horton,"

Phrase: "W."
Processing 00000000.tx.432: E., Jr., Sisodia, S. 

Phrase: "E.,"

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.433: S., and Kusiak, J. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Kusiak,"

Phrase: "J."
Processing 00000000.tx.434: W. 

Phrase: "W."
Processing 00000000.tx.435: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.436: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.437: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.438: 47, 253263[CrossRef][Medline] [OrderarticleviaInfotrieve] Guo, Q., Sopher, B. 

Phrase: "47,"

Phrase: "253263"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Guo,"

Phrase: "Q.,"

Phrase: "Sopher,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.439: L., Furukawa, K., Pham, D. 

Phrase: "L., Furukawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Pham,"

Phrase: "D."
Processing 00000000.tx.440: G., Robinson, N., Martin, G. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Robinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443050:Robinson [Intellectual Product]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Martin,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.441: M., and Mattson, M. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.442: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.443: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.444: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.445: 17, 42124222[Abstract/Free FullText] Haass, C., Lemere, C. 

Phrase: "17,"

Phrase: "42124222"

Phrase: "[Abstract/Free FullText"

Phrase: "] Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lemere,"

Phrase: "C."
Processing 00000000.tx.446: A., Capell, A., Citron, M., Seubert, P., Schenk, D., Lannfelt, L., and Selkoe, D. 

Phrase: "A.,"

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.447: J. 

Phrase: "J."
Processing 00000000.tx.448: (1995) Nat. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.449: Med. 

Phrase: "Med."
Processing 00000000.tx.450: 1, 12911296[Medline] [OrderarticleviaInfotrieve] Cai, X. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "12911296"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X."
Processing 00000000.tx.451: D., Golde, T. 

Phrase: "D."

Phrase: ","

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.452: E., and Younkin, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.453: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.454: (1993) Science 259, 514516[Medline] [OrderarticleviaInfotrieve] Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Science 259,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "514516"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Oltersdorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "McConlogue,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.455: Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., and Selkoe, D. 

Phrase: "Y.,"

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.456: J. 

Phrase: "J."
Processing 00000000.tx.457: (1992) Nature 360, 672674[CrossRef][Medline] [OrderarticleviaInfotrieve] Torok, M., Milton, S., Kayed, R., Wu, P., McIntire, T., Glabe, C. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nature 360,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "672674"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Torok,"

Phrase: "M."

Phrase: ","

Phrase: "Milton,"

Phrase: "S."

Phrase: ","

Phrase: "Kayed,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "McIntire,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Glabe,"

Phrase: "C."
Processing 00000000.tx.458: G., and Langen, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Langen,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.459: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.460: Biol. 

Phrase: "Biol."
Processing 00000000.tx.461: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.462: 277, 4081040815[Abstract/Free FullText] Soreghan, B., Pike, C., Kayed, R., Tian, W., Milton, S., Cotman, C., and Glabe, C. 

Phrase: "277,"

Phrase: "4081040815"

Phrase: "[Abstract/Free FullText"

Phrase: "] Soreghan,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kayed,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tian,"

Phrase: "W.,"

Phrase: "Milton,"

Phrase: "S."

Phrase: ","

Phrase: "Cotman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Glabe,"

Phrase: "C."
Processing 00000000.tx.463: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.464: (2002) Neuromol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neuromol."
Processing 00000000.tx.465: Med. 

Phrase: "Med."
Processing 00000000.tx.466: 1, 8194 Wirths, O., Multhaup, G., Czech, C., Blanchard, V., Moussaoui, S., Tremp, G., Pradier, L., Beyreuther, K., and Bayer, T. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "8194 Wirths,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Czech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337799:czech [Population Group]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Blanchard,"

Phrase: "V.,"

Phrase: "Moussaoui,"

Phrase: "S."

Phrase: ","

Phrase: "Tremp,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Pradier,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Bayer,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.467: A. 

Phrase: "A."
Processing 00000000.tx.468: (2001) Neurosci. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.469: Lett. 

Phrase: "Lett."
Processing 00000000.tx.470: 306, 116120[CrossRef][Medline] [OrderarticleviaInfotrieve] Gau, J. 

Phrase: "306,"

Phrase: "116120"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gau,"

Phrase: "J."
Processing 00000000.tx.471: T., Steinhilb, M. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Steinhilb,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.472: L., Kao, T. 

Phrase: "L., Kao,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.473: C., D'Amato, C. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "D'"

Phrase: "Amato,"

Phrase: "C."
Processing 00000000.tx.474: J., Gaut, J. 

Phrase: "J.,"

Phrase: "Gaut,"

Phrase: "J."
Processing 00000000.tx.475: R., Frey, K. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Frey,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.476: A., and Turner, R. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Turner,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.477: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.478: (2002) Am. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.479: J. 

Phrase: "J."
Processing 00000000.tx.480: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.481: 160, 731738[Abstract/Free FullText] Chishti, M. 

Phrase: "160,"

Phrase: "731738"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chishti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.482: A., Yang, D. 

Phrase: "A.,"

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "D."
Processing 00000000.tx.483: S., Janus, C., Phinney, A. 

Phrase: "S."

Phrase: ","

Phrase: "Janus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0266700:Janus [Congenital Abnormality]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Phinney,"

Phrase: "A."
Processing 00000000.tx.484: L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., Turner, S., Lozza, G., Grilli, M., Kunicki, S., Morissette, C., Paquette, J., Gervais, F., Bergeron, C., Fraser, P. 

Phrase: "L., Horne,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Pearson,"

Phrase: "J.,"

Phrase: "Strome,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Zuker,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Loukides,"

Phrase: "J.,"

Phrase: "French,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556084:French [Population Group]

Phrase: "J.,"

Phrase: "Turner,"

Phrase: "S."

Phrase: ","

Phrase: "Lozza,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Grilli,"

Phrase: "M."

Phrase: ","

Phrase: "Kunicki,"

Phrase: "S."

Phrase: ","

Phrase: "Morissette,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Paquette,"

Phrase: "J.,"

Phrase: "Gervais,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Bergeron,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.485: E., Carlson, G. 

Phrase: "E.,"

Phrase: "Carlson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.486: A., George-Hyslop, P. 

Phrase: "A.,"

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.487: S., and Westaway, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Westaway,"

Phrase: "D."
Processing 00000000.tx.488: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.489: Biol. 

Phrase: "Biol."
Processing 00000000.tx.490: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.491: 276, 2156221570[Abstract/Free FullText] Luth, H., Munch, G., and Arendt, T. 

Phrase: "276,"

Phrase: "2156221570"

Phrase: "[Abstract/Free FullText"

Phrase: "] Luth,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Munch"

Phrase: ","

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Arendt,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.492: (2002) Brain Res. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.493: 953, 135[CrossRef][Medline] [OrderarticleviaInfotrieve] Sajithlal, G., Huttunen, H., Rauvala, H., and Munch, G. 

Phrase: "953,"

Phrase: "135"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sajithlal,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Huttunen,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rauvala,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Munch"

Phrase: ","

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.494: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.495: Biol. 

Phrase: "Biol."
Processing 00000000.tx.496: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.497: 277, 68886897[Abstract/Free FullText] Tamagno, E., Bardini, P., Obbili, A., Vitali, A., Borghi, R., Zaccheo, D., Pronzato, M., Danni, O., Smith, M., Perry, G., and Tabaton, M. 

Phrase: "277,"

Phrase: "68886897"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tamagno,"

Phrase: "E.,"

Phrase: "Bardini,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Obbili,"

Phrase: "A.,"

Phrase: "Vitali,"

Phrase: "A.,"

Phrase: "Borghi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Zaccheo,"

Phrase: "D."

Phrase: ","

Phrase: "Pronzato,"

Phrase: "M."

Phrase: ","

Phrase: "Danni,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Perry,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Tabaton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.498: (2002) Neurobiol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.499: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.500: 10, 279[CrossRef][Medline] [OrderarticleviaInfotrieve] Hensley, K., Carney, J. 

Phrase: "10,"

Phrase: "279"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hensley,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Carney,"

Phrase: "J."
Processing 00000000.tx.501: M., Mattson, M. 

Phrase: "M."

Phrase: ","

Phrase: "Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.502: P., Aksenova, M., Harris, M., Wu, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Aksenova,"

Phrase: "M."

Phrase: ","

Phrase: "Harris,"

Phrase: "M."

Phrase: ","

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "J."
Processing 00000000.tx.503: F., Floyd, R. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Floyd,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.504: A., and Butterfield, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Butterfield,"

Phrase: "D."
Processing 00000000.tx.505: A. 

Phrase: "A."
Processing 00000000.tx.506: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.507: Natl. 

Phrase: "Natl."
Processing 00000000.tx.508: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.509: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.510: U. 

Phrase: "U."
Processing 00000000.tx.511: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.512: A. 

Phrase: "A."
Processing 00000000.tx.513: 91, 32703274[Abstract] Bogdanovic, N., Zilmer, M., Zilmer, K., Rehema, A., and Karelson, E. 

Phrase: "91,"

Phrase: "32703274"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bogdanovic,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Zilmer,"

Phrase: "M."

Phrase: ","

Phrase: "Zilmer,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Rehema,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Karelson,"

Phrase: "E."
Processing 00000000.tx.514: (2001) Dement. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Dement."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0860630:dement [Mental or Behavioral Dysfunction]
   900 E C0011265:dementia [Mental or Behavioral Dysfunction]
   900 E C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.515: Geriatr. 

Phrase: "Geriatr."
Processing 00000000.tx.516: Cogn. 

Phrase: "Cogn."
Processing 00000000.tx.517: Disord. 

Phrase: "Disord."
Processing 00000000.tx.518: 12, 364370[Medline] [OrderarticleviaInfotrieve] Leutner, S., Czech, C., Schindowski, K., Touchet, N., Eckert, A., and Muller, W. 

Phrase: "12,"

Phrase: "364370"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Leutner,"

Phrase: "S."

Phrase: ","

Phrase: "Czech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337799:czech [Population Group]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Schindowski,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Touchet,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Eckert,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Muller,"

Phrase: "W."
Processing 00000000.tx.519: E. 

Phrase: "E."
Processing 00000000.tx.520: (2000) Neurosci. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.521: Lett. 

Phrase: "Lett."
Processing 00000000.tx.522: 292, 8790[CrossRef][Medline] [OrderarticleviaInfotrieve] LaFerla, F. 

Phrase: "292,"

Phrase: "8790"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] LaFerla,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.523: M., Tinkle, B. 

Phrase: "M."

Phrase: ","

Phrase: "Tinkle,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.524: T., Bieberich, C. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bieberich,"

Phrase: "C."
Processing 00000000.tx.525: J., Haudenschild, C. 

Phrase: "J.,"

Phrase: "Haudenschild,"

Phrase: "C."
Processing 00000000.tx.526: C., and Jay, G. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Jay,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326402:Jay [Bird]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.527: (1995) Nat. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.528: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.529: 9, 2130[Medline] [OrderarticleviaInfotrieve] Loo, D. 

Phrase: "9,"

Phrase: "2130"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Loo,"

Phrase: "D."
Processing 00000000.tx.530: T., Copani, A., Pike, C. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Copani,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "C."
Processing 00000000.tx.531: J., Whittemore, E. 

Phrase: "J.,"

Phrase: "Whittemore,"

Phrase: "E."
Processing 00000000.tx.532: R., Walencewicz, A. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Walencewicz,"

Phrase: "A."
Processing 00000000.tx.533: J., and Cotman, C. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Cotman,"

Phrase: "C."
Processing 00000000.tx.534: W. 

Phrase: "W."
Processing 00000000.tx.535: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.536: Natl. 

Phrase: "Natl."
Processing 00000000.tx.537: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.538: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.539: U. 

Phrase: "U."
Processing 00000000.tx.540: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.541: A. 

Phrase: "A."
Processing 00000000.tx.542: 90, 79517955[Abstract/Free FullText] Mattson, M. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "79517955"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.543: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.544: (1997) Physiol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Physiol."
Processing 00000000.tx.545: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.546: 77, 10811132[Abstract/Free FullText] Cotman, C. 

Phrase: "77,"

Phrase: "10811132"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cotman,"

Phrase: "C."
Processing 00000000.tx.547: W. 

Phrase: "W."
Processing 00000000.tx.548: (1998) Neurobiol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.549: Aging 19, Suppl. 

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "19,"

Phrase: "Suppl."
Processing 00000000.tx.550: 1, S29S32[CrossRef][Medline] [OrderarticleviaInfotrieve] Leutz, S., Steiner, B., Marques, C. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "S29S32"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Leutz,"

Phrase: "S."

Phrase: ","

Phrase: "Steiner,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Marques,"

Phrase: "C."
Processing 00000000.tx.551: A., Haass, C., Muller, W. 

Phrase: "A.,"

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Muller,"

Phrase: "W."
Processing 00000000.tx.552: E., and Eckert, A. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Eckert,"

Phrase: "A."
Processing 00000000.tx.553: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.554: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.555: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.556: 18, 189201[CrossRef][Medline] [OrderarticleviaInfotrieve] Gibson, G. 

Phrase: "18,"

Phrase: "189201"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gibson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.557: E. 

Phrase: "E."
Processing 00000000.tx.558: (2002) Free Radic. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.559: Biol. 

Phrase: "Biol."
Processing 00000000.tx.560: Med. 

Phrase: "Med."
Processing 00000000.tx.561: 32, 10611070[CrossRef][Medline] [OrderarticleviaInfotrieve] Suzaki, Y., Yoshizumi, M., Kagami, S., Koyama, A. 

Phrase: "32,"

Phrase: "10611070"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Suzaki,"

Phrase: "Y.,"

Phrase: "Yoshizumi,"

Phrase: "M."

Phrase: ","

Phrase: "Kagami,"

Phrase: "S."

Phrase: ","

Phrase: "Koyama,"

Phrase: "A."
Processing 00000000.tx.562: H., Taketani, Y., Houchi, H., Tsuchiya, K., Takeda, E., and Tamaki, T. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Taketani,"

Phrase: "Y.,"

Phrase: "Houchi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tsuchiya,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takeda,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Tamaki,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.563: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.564: Biol. 

Phrase: "Biol."
Processing 00000000.tx.565: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.566: 277, 96149621[Abstract/Free FullText] Aoki, H., Yoshimura, K., Kang, P. 

Phrase: "277,"

Phrase: "96149621"

Phrase: "[Abstract/Free FullText"

Phrase: "] Aoki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yoshimura,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kang,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.567: M., Hampe, J., Noma, T., Matsuzaki, M., and Izumo, S. 

Phrase: "M."

Phrase: ","

Phrase: "Hampe,"

Phrase: "J.,"

Phrase: "Noma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028271:Noma [Disease or Syndrome]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Matsuzaki,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Izumo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1825632:IZUMO [Gene or Genome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.568: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.569: Biol. 

Phrase: "Biol."
Processing 00000000.tx.570: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.571: 277, 1024410250[Abstract/Free FullText] Zhu, X., Raina, A. 

Phrase: "277,"

Phrase: "1024410250"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhu,"

Phrase: "X.,"

Phrase: "Raina,"

Phrase: "A."
Processing 00000000.tx.572: K., Rottkamp, C. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Rottkamp,"

Phrase: "C."
Processing 00000000.tx.573: A., Aliev, G., Perry, G., Boux, H., and Smith, M. 

Phrase: "A.,"

Phrase: "Aliev,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Perry,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Boux,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.574: A. 

Phrase: "A."
Processing 00000000.tx.575: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.576: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.577: 76, 435441[CrossRef][Medline] [OrderarticleviaInfotrieve] Morishima, Y., Gotoh, Y., Zieg, J., Barrett, T., Takano, H., Flavell, R., Davis, R. 

Phrase: "76,"

Phrase: "435441"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Morishima,"

Phrase: "Y.,"

Phrase: "Gotoh,"

Phrase: "Y.,"

Phrase: "Zieg,"

Phrase: "J.,"

Phrase: "Barrett,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Takano,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Flavell,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.578: J., Shirasaki, Y., and Greenberg, M. 

Phrase: "J.,"

Phrase: "Shirasaki,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Greenberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.579: E. 

Phrase: "E."
Processing 00000000.tx.580: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.581: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.582: 21, 75517560[Abstract/Free FullText] Savage, M. 

Phrase: "21,"

Phrase: "75517560"

Phrase: "[Abstract/Free FullText"

Phrase: "] Savage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331893:Savage [Health Care Related Organization]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.583: J., Lin, Y. 

Phrase: "J.,"

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "Y."
Processing 00000000.tx.584: G., Ciallella, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ciallella,"

Phrase: "J."
Processing 00000000.tx.585: R., Flood, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Flood,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016248:Flood [Natural Phenomenon or Process]
  1000   C0375741:Flood [Injury or Poisoning]

Phrase: "D."
Processing 00000000.tx.586: G., and Scott, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Scott,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.587: W. 

Phrase: "W."
Processing 00000000.tx.588: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.589: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.590: 22, 33763385[Abstract/Free FullText] Troy, C. 

Phrase: "22,"

Phrase: "33763385"

Phrase: "[Abstract/Free FullText"

Phrase: "] Troy,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1420811:TROY [Gene or Genome]
  1000   C1883402:Troy [Quantitative Concept]

Phrase: "C."
Processing 00000000.tx.591: M., Rabacchi, S. 

Phrase: "M."

Phrase: ","

Phrase: "Rabacchi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.592: A., Xu, Z., Maroney, A. 

Phrase: "A.,"

Phrase: "Xu,"

Phrase: "Z.,"

Phrase: "Maroney,"

Phrase: "A."
Processing 00000000.tx.593: C., Connors, T. 

Phrase: "C., Connors,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.594: J., Shelanski, M. 

Phrase: "J.,"

Phrase: "Shelanski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.595: L., and Greene, L. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Greene,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.596: A. 

Phrase: "A."
Processing 00000000.tx.597: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.598: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.599: 77, 157164[CrossRef][Medline] [OrderarticleviaInfotrieve] Earnshaw, W. 

Phrase: "77,"

Phrase: "157164"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Earnshaw,"

Phrase: "W."
Processing 00000000.tx.600: C., Martins, L. 

Phrase: "C., Martins,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.601: M., and Kaufmann, S. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Kaufmann,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.602: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.603: (1999) Annu. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.604: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.605: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.606: 68, 383424[CrossRef][Medline] [OrderarticleviaInfotrieve] Yuan, J., and Yankner, B. 

Phrase: "68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "383424"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Yuan,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Yankner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.607: A. 

Phrase: "A."
Processing 00000000.tx.608: (2000) Nature 407, 802809[CrossRef][Medline] [OrderarticleviaInfotrieve] Weidemann, A., Paliga, K., rrwang, D., Reinhard, F. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nature 407,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "802809"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Weidemann,"

Phrase: "A.,"

Phrase: "Paliga,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3284170:Paliga [Eukaryote]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "rrwang,"

Phrase: "D."

Phrase: ","

Phrase: "Reinhard,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.609: B., Schuckert, O., Evin, G., and Masters, C. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Schuckert,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Evin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.610: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.611: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.612: Biol. 

Phrase: "Biol."
Processing 00000000.tx.613: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.614: 274, 58235829[Abstract/Free FullText] Gervais, F. 

Phrase: "274,"

Phrase: "58235829"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gervais,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.615: G., Xu, D., Robertson, G. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Xu,"

Phrase: "D."

Phrase: ","

Phrase: "Robertson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.616: S., Vaillancourt, J. 

Phrase: "S."

Phrase: ","

Phrase: "Vaillancourt,"

Phrase: "J."
Processing 00000000.tx.617: P., Zhu, Y., Huang, J., LeBlanc, A., Smith, D., Rigby, M., Shearman, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Zhu,"

Phrase: "Y.,"

Phrase: "Huang,"

Phrase: "J.,"

Phrase: "LeBlanc,"

Phrase: "A.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "D."

Phrase: ","

Phrase: "Rigby,"

Phrase: "M."

Phrase: ","

Phrase: "Shearman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.618: S., Clarke, E. 

Phrase: "S."

Phrase: ","

Phrase: "Clarke,"

Phrase: "E."
Processing 00000000.tx.619: E., Zheng, H., Van Der Ploeg, L. 

Phrase: "E.,"

Phrase: "Zheng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986502:Zheng [Therapeutic or Preventive Procedure]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Van Der Ploeg,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.620: H., Ruffolo, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ruffolo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.621: C., Thornberry, N. 

Phrase: "C., Thornberry,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.622: A., Xanthoudakis, S., Zamboni, R. 

Phrase: "A.,"

Phrase: "Xanthoudakis,"

Phrase: "S."

Phrase: ","

Phrase: "Zamboni,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.623: J., Roy, S., and Nicholson, D. 

Phrase: "J.,"

Phrase: "Roy,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Nicholson,"

Phrase: "D."
Processing 00000000.tx.624: W. 

Phrase: "W."
Processing 00000000.tx.625: (1999) Cell 97, 395406[Medline] [OrderarticleviaInfotrieve] Pellegrini, L., Passer, B. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Cell 97,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0007634:Cell [Cell]
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "395406"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pellegrini,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Passer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0491928:PASSER [Medical Device]
  1000   C0999347:Passer [Bird]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.626: J., Tabaton, M., Ganjei, J. 

Phrase: "J.,"

Phrase: "Tabaton,"

Phrase: "M."

Phrase: ","

Phrase: "Ganjei,"

Phrase: "J."
Processing 00000000.tx.627: K., and D'Adamio, L. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "D'"

Phrase: "Adamio,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.628: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.629: Biol. 

Phrase: "Biol."
Processing 00000000.tx.630: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.631: 274, 2101121016[Abstract/Free FullText] Troy, C. 

Phrase: "274,"

Phrase: "2101121016"

Phrase: "[Abstract/Free FullText"

Phrase: "] Troy,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1420811:TROY [Gene or Genome]
  1000   C1883402:Troy [Quantitative Concept]

Phrase: "C."
Processing 00000000.tx.632: M., Rabacchi, S. 

Phrase: "M."

Phrase: ","

Phrase: "Rabacchi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.633: A., Friedman, W. 

Phrase: "A.,"

Phrase: "Friedman,"

Phrase: "W."
Processing 00000000.tx.634: J., Frappier, T. 

Phrase: "J.,"

Phrase: "Frappier,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.635: F., Brown, K., and Shelanski, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Shelanski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.636: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.637: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.638: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.639: 20, 13861392[Abstract/Free FullText] Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. 

Phrase: "20,"

Phrase: "13861392"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nakagawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Zhu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Morishima,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "E.,"

Phrase: "Xu,"

Phrase: "J.,"

Phrase: "Yankner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.640: A., and Yuan, J. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Yuan,"

Phrase: "J."
Processing 00000000.tx.641: (2000) Nature 403, 98103[CrossRef][Medline] [OrderarticleviaInfotrieve] LeBlanc, A., Liu, H., Goodyer, C., Bergeron, C., and Hammond, J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nature 403,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "98103"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] LeBlanc,"

Phrase: "A.,"

Phrase: "Liu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Goodyer,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Bergeron,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Hammond,"

Phrase: "J."
Processing 00000000.tx.642: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.643: Biol. 

Phrase: "Biol."
Processing 00000000.tx.644: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.645: 274, 2342623436[Abstract/Free FullText] Steiner, H., Capell, A., Pesold, B., Citron, M., Kloetzel, P. 

Phrase: "274,"

Phrase: "2342623436"

Phrase: "[Abstract/Free FullText"

Phrase: "] Steiner,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Pesold,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Kloetzel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.646: M., Selkoe, D. 

Phrase: "M."

Phrase: ","

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.647: J., Romig, H., Mendla, K., and Haass, C. 

Phrase: "J.,"

Phrase: "Romig,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mendla,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.648: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.649: Biol. 

Phrase: "Biol."
Processing 00000000.tx.650: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.651: 273, 3232232331[Abstract/Free FullText] Gottlieb, R. 

Phrase: "273,"

Phrase: "3232232331"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gottlieb,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.652: A., and Granville, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Granville,"

Phrase: "D."
Processing 00000000.tx.653: J. 

Phrase: "J."
Processing 00000000.tx.654: (2002) Methods 26, 341347[CrossRef][Medline] [OrderarticleviaInfotrieve] Rottkamp, C. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Methods 26,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "341347"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rottkamp,"

Phrase: "C."
Processing 00000000.tx.655: A., Raina, A. 

Phrase: "A.,"

Phrase: "Raina,"

Phrase: "A."
Processing 00000000.tx.656: K., Zhu, X., Gaier, E., Bush, A. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Zhu,"

Phrase: "X.,"

Phrase: "Gaier,"

Phrase: "E.,"

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.657: I., Atwood, C. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Atwood,"

Phrase: "C."
Processing 00000000.tx.658: S., Chevion, M., Perry, G., and Smith, M. 

Phrase: "S."

Phrase: ","

Phrase: "Chevion,"

Phrase: "M."

Phrase: ","

Phrase: "Perry,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.659: A. 

Phrase: "A."
Processing 00000000.tx.660: (2001) Free Radic. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.661: Biol. 

Phrase: "Biol."
Processing 00000000.tx.662: Med. 

Phrase: "Med."
Processing 00000000.tx.663: 30, 447450[CrossRef][Medline] [OrderarticleviaInfotrieve] Tabner, B. 

Phrase: "30,"

Phrase: "447450"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tabner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.664: J., Turnbull, S., El Agnaf, O. 

Phrase: "J.,"

Phrase: "Turnbull,"

Phrase: "S."

Phrase: ","

Phrase: "El Agnaf,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.665: M., and Allsop, D. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Allsop,"

Phrase: "D."
Processing 00000000.tx.666: (2002) Free Radic. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.667: Biol. 

Phrase: "Biol."
Processing 00000000.tx.668: Med. 

Phrase: "Med."
Processing 00000000.tx.669: 32, 10761083[CrossRef][Medline] [OrderarticleviaInfotrieve] Ivins, K. 

Phrase: "32,"

Phrase: "10761083"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ivins,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.670: J., Thornton, P. 

Phrase: "J.,"

Phrase: "Thornton,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.671: L., Rohn, T. 

Phrase: "L., Rohn,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.672: T., and Cotman, C. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Cotman,"

Phrase: "C."
Processing 00000000.tx.673: W. 

Phrase: "W."
Processing 00000000.tx.674: (1999) Neurobiol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.675: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.676: 6, 440449[CrossRef][Medline] [OrderarticleviaInfotrieve] Bratton, S. 

Phrase: "6,"

Phrase: "440449"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bratton,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.677: B., Walker, G., Srinivasula, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Srinivasula,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.678: M., Sun, X. 

Phrase: "M."

Phrase: ","

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "X."
Processing 00000000.tx.679: M., Butterworth, M., Alnemri, E. 

Phrase: "M."

Phrase: ","

Phrase: "Butterworth,"

Phrase: "M."

Phrase: ","

Phrase: "Alnemri,"

Phrase: "E."
Processing 00000000.tx.680: S., and Cohen, G. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Cohen,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.681: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.682: (2001) EMBO J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.683: 20, 9981009[Abstract/Free FullText] Sanchez, I., Hughes, R. 

Phrase: "20,"

Phrase: "9981009"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sanchez,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Hughes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551730:Hughes [Population Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.684: T., Mayer, B. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mayer,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.685: J., Yee, K., Woodgett, J. 

Phrase: "J.,"

Phrase: "Yee,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Woodgett,"

Phrase: "J."
Processing 00000000.tx.686: R., Avruch, J., Kyriakis, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Avruch,"

Phrase: "J.,"

Phrase: "Kyriakis,"

Phrase: "J."
Processing 00000000.tx.687: M., and Zon, L. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Zon,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.688: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.689: (1994) Nature 372, 794798[Medline] [OrderarticleviaInfotrieve] Ghahremani, M. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Nature 372,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "794798"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ghahremani,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.690: H., Keramaris, E., Shree, T., Xia, Z., Davis, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Keramaris,"

Phrase: "E.,"

Phrase: "Shree,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Xia,"

Phrase: "Z.,"

Phrase: "Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.691: J., Flavell, R., Slack, R. 

Phrase: "J.,"

Phrase: "Flavell,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Slack,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425836:SLACK [Gene or Genome]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.692: S., and Park, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "D."
Processing 00000000.tx.693: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.694: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.695: Biol. 

Phrase: "Biol."
Processing 00000000.tx.696: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.697: 277, 3558635596[Abstract/Free FullText] Mesner, P. 

Phrase: "277,"

Phrase: "3558635596"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mesner,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.698: W., Epting, C. 

Phrase: "W., Epting,"

Phrase: "C."
Processing 00000000.tx.699: L., Hegarty, J. 

Phrase: "L., Hegarty,"

Phrase: "J."
Processing 00000000.tx.700: L., and Green, S. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.701: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.702: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.703: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.704: 15, 73577366[Abstract] Bennett, B. 

Phrase: "15,"

Phrase: "73577366"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bennett,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.705: L., Sasaki, D. 

Phrase: "L., Sasaki,"

Phrase: "D."
Processing 00000000.tx.706: T., Murray, B. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Murray,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.707: W., O'Leary, E. 

Phrase: "W., O'Leary,"

Phrase: "E."
Processing 00000000.tx.708: C., Sakata, S. 

Phrase: "C., Sakata,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.709: T., Xu, W., Leisten, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Xu,"

Phrase: "W.,"

Phrase: "Leisten,"

Phrase: "J."
Processing 00000000.tx.710: C., Motiwala, A., Pierce, S., Satoh, Y., Bhagwat, S. 

Phrase: "C., Motiwala,"

Phrase: "A.,"

Phrase: "Pierce,"

Phrase: "S."

Phrase: ","

Phrase: "Satoh,"

Phrase: "Y.,"

Phrase: "Bhagwat,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.711: S., Manning, A. 

Phrase: "S."

Phrase: ","

Phrase: "Manning,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0024554:MAN [Finding]
   966   C0025266:Man [Population Group]
   966   C0086418:Man [Human]

Phrase: "A."
Processing 00000000.tx.712: M., and Anderson, D. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Anderson,"

Phrase: "D."
Processing 00000000.tx.713: W. 

Phrase: "W."
Processing 00000000.tx.714: (2001) Proc. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.715: Natl. 

Phrase: "Natl."
Processing 00000000.tx.716: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.717: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.718: U. 

Phrase: "U."
Processing 00000000.tx.719: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.720: A. 

Phrase: "A."
Processing 00000000.tx.721: 98, 1368113686[Abstract/Free FullText] Selkoe, D. 

Phrase: "98,"

Phrase: "1368113686"

Phrase: "[Abstract/Free FullText"

Phrase: "] Selkoe,"

Phrase: "D."
Processing 00000000.tx.722: J. 

Phrase: "J."
Processing 00000000.tx.723: (2002) Science 298, 789791[Abstract/Free FullText] Hartmann, T. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Science 298,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "789791"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hartmann,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.724: (1999) Eur. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.725: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.726: Psychiatry Clin. 

Phrase: "Psychiatry"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033872:Psychiatry [Professional or Occupational Group]
  1000   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   928 E C0205487:Psychiatric [Functional Concept]

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.727: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.728: 249, 291298[CrossRef][Medline] [OrderarticleviaInfotrieve] Hartmann, T., Bieger, S. 

Phrase: "249,"

Phrase: "291298"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hartmann,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bieger,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.729: C., Bruhl, B., Tienari, P. 

Phrase: "C., Bruhl,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Tienari,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.730: J., Ida, N., Allsop, D., Roberts, G. 

Phrase: "J.,"

Phrase: "Ida,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020789:IDA [Organic Chemical,Pharmacologic Substance]
  1000   C0063555:IdA [Organic Chemical,Pharmacologic Substance]
  1000   C2275731:Ida [Plant]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Allsop,"

Phrase: "D."

Phrase: ","

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.731: W., Masters, C. 

Phrase: "W., Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.732: L., Dotti, C. 

Phrase: "L., Dotti,"

Phrase: "C."
Processing 00000000.tx.733: G., Unsicker, K., and Beyreuther, K. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Unsicker,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.734: (1997) Nat. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.735: Med. 

Phrase: "Med."
Processing 00000000.tx.736: 3, 10161020[Medline] [OrderarticleviaInfotrieve] Mancini, M., Machamer, C. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "10161020"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mancini,"

Phrase: "M."

Phrase: ","

Phrase: "Machamer,"

Phrase: "C."
Processing 00000000.tx.737: E., Roy, S., Nicholson, D. 

Phrase: "E.,"

Phrase: "Roy,"

Phrase: "S."

Phrase: ","

Phrase: "Nicholson,"

Phrase: "D."
Processing 00000000.tx.738: W., Thornberry, N. 

Phrase: "W., Thornberry,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.739: A., Casciola-Rosen, L. 

Phrase: "A.,"

Phrase: "Casciola-Rosen,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.740: A., and Rosen, A. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Rosen,"

Phrase: "A."
Processing 00000000.tx.741: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.742: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.743: 149, 603612[Abstract/Free FullText] Paroni, G., Henderson, C., Schneider, C., and Brancolini, C. 

Phrase: "149,"

Phrase: "603612"

Phrase: "[Abstract/Free FullText"

Phrase: "] Paroni,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Henderson,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Schneider,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Brancolini,"

Phrase: "C."
Processing 00000000.tx.744: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.745: Biol. 

Phrase: "Biol."
Processing 00000000.tx.746: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.747: 277, 1514715161[Abstract/Free FullText] Zhivotovsky, B., Samali, A., Gahm, A., and Orrenius, S. 

Phrase: "277,"

Phrase: "1514715161"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhivotovsky,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Samali,"

Phrase: "A.,"

Phrase: "Gahm,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Orrenius,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.748: (1999) Cell Death Differ. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Cell Death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "Differ."
Processing 00000000.tx.749: 6, 644651[CrossRef][Medline] [OrderarticleviaInfotrieve] Lassus, P., Opitz-Araya, X., and Lazebnik, Y. 

Phrase: "6,"

Phrase: "644651"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lassus,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Opitz-Araya,"

Phrase: "X.,"

Phrase: "and"

Phrase: "Lazebnik,"

Phrase: "Y."
Processing 00000000.tx.750: (2002) Science 297, 13521354[Abstract/Free FullText] Robertson, J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Science 297,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "13521354"

Phrase: "[Abstract/Free FullText"

Phrase: "] Robertson,"

Phrase: "J."
Processing 00000000.tx.751: D., Enoksson, M., Suomela, M., Zhivotovsky, B., and Orrenius, S. 

Phrase: "D."

Phrase: ","

Phrase: "Enoksson,"

Phrase: "M."

Phrase: ","

Phrase: "Suomela,"

Phrase: "M."

Phrase: ","

Phrase: "Zhivotovsky,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Orrenius,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.752: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.753: Biol. 

Phrase: "Biol."
Processing 00000000.tx.754: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.755: 277, 2980329809[Abstract/Free FullText] Guo, Y., Srinivasula, S. 

Phrase: "277,"

Phrase: "2980329809"

Phrase: "[Abstract/Free FullText"

Phrase: "] Guo,"

Phrase: "Y.,"

Phrase: "Srinivasula,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.756: M., Druilhe, A., Fernandes-Alnemri, T., and Alnemri, E. 

Phrase: "M."

Phrase: ","

Phrase: "Druilhe,"

Phrase: "A.,"

Phrase: "Fernandes-Alnemri,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Alnemri,"

Phrase: "E."
Processing 00000000.tx.757: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.758: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.759: Biol. 

Phrase: "Biol."
Processing 00000000.tx.760: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.761: 277, 1343013437[Abstract/Free FullText] Eckert, A., Keil, U, Marques, C. 

Phrase: "277,"

Phrase: "1343013437"

Phrase: "[Abstract/Free FullText"

Phrase: "] Eckert,"

Phrase: "A.,"

Phrase: "Keil,"

Phrase: "U,"

Phrase: "Marques,"

Phrase: "C."
Processing 00000000.tx.762: A., Bonert, A, Frey, C., Schssel, K, and Muller, W. 

Phrase: "A.,"

Phrase: "Bonert,"

Phrase: "A,"

Phrase: "Frey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Schssel,"

Phrase: "K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Muller,"

Phrase: "W."
Processing 00000000.tx.763: E. 

Phrase: "E."
Processing 00000000.tx.764: (2003) Biochem. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.765: Pharmacol., in press Yin, K. 

Phrase: "Pharmacol.,"

Phrase: "in press Yin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2945618:yin [Idea or Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.766: J., Lee, J. 

Phrase: "J.,"

Phrase: "Lee,"

Phrase: "J."
Processing 00000000.tx.767: M., Chen, S. 

Phrase: "M."

Phrase: ","

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.768: D., Xu, J., and Hsu, C. 

Phrase: "D."

Phrase: ","

Phrase: "Xu,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Hsu,"

Phrase: "C."
Processing 00000000.tx.769: Y. 

Phrase: "Y."
Processing 00000000.tx.770: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.771: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.772: 22, 97649770[Abstract/Free FullText] Inoshita, S., Takeda, K., Hatai, T., Terada, Y., Sano, M., Hata, J., Umezawa, A., and Ichijo, H. 

Phrase: "22,"

Phrase: "97649770"

Phrase: "[Abstract/Free FullText"

Phrase: "] Inoshita,"

Phrase: "S."

Phrase: ","

Phrase: "Takeda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hatai,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Terada,"

Phrase: "Y.,"

Phrase: "Sano,"

Phrase: "M."

Phrase: ","

Phrase: "Hata,"

Phrase: "J.,"

Phrase: "Umezawa,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Ichijo,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.773: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.774: Biol. 

Phrase: "Biol."
Processing 00000000.tx.775: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.776: 277, 4373043734[Abstract/Free FullText] Maundrell, K., Antonsson, B., Magnenat, E., Camps, M., Muda, M., Chabert, C., Gillieron, C., Boschert, U., Vial-Knecht, E., Martinou, J. 

Phrase: "277,"

Phrase: "4373043734"

Phrase: "[Abstract/Free FullText"

Phrase: "] Maundrell,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Antonsson,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Magnenat,"

Phrase: "E.,"

Phrase: "Camps,"

Phrase: "M."

Phrase: ","

Phrase: "Muda,"

Phrase: "M."

Phrase: ","

Phrase: "Chabert,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Gillieron,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Boschert,"

Phrase: "U.,"

Phrase: "Vial-Knecht,"

Phrase: "E.,"

Phrase: "Martinou,"

Phrase: "J."
Processing 00000000.tx.777: C., and Arkinstall, S. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Arkinstall,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.778: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.779: Biol. 

Phrase: "Biol."
Processing 00000000.tx.780: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.781: 272, 2523825242[Abstract/Free FullText] Scheinfeld, M. 

Phrase: "272,"

Phrase: "2523825242"

Phrase: "[Abstract/Free FullText"

Phrase: "] Scheinfeld,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.782: H., Roncarati, R., Vito, P., Lopez, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Roncarati,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vito,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lopez,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.783: A., Abdallah, M., and D'Adamio, L. 

Phrase: "A.,"

Phrase: "Abdallah,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "D'"

Phrase: "Adamio,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.784: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.785: Biol. 

Phrase: "Biol."
Processing 00000000.tx.786: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.787: 277, 37673775[Abstract/Free FullText] Matsuda, S., Yasukawa, T., Homma, Y., Ito, Y., Niikura, T., Hiraki, T., Hirai, S., Ohno, S., Kita, Y., Kawasumi, M., Kouyama, K., Yamamoto, T., Kyriakis, J. 

Phrase: "277,"

Phrase: "37673775"

Phrase: "[Abstract/Free FullText"

Phrase: "] Matsuda,"

Phrase: "S."

Phrase: ","

Phrase: "Yasukawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Homma,"

Phrase: "Y.,"

Phrase: "Ito,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415618:ITO [Gene or Genome]

Phrase: "Y.,"

Phrase: "Niikura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hiraki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hirai,"

Phrase: "S."

Phrase: ","

Phrase: "Ohno,"

Phrase: "S."

Phrase: ","

Phrase: "Kita,"

Phrase: "Y.,"

Phrase: "Kawasumi,"

Phrase: "M."

Phrase: ","

Phrase: "Kouyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kyriakis,"

Phrase: "J."
Processing 00000000.tx.788: M., and Nishimoto, I. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Nishimoto,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.789: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.790: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.791: 21, 65976607[Abstract/Free FullText] Taru, H., Kirino, Y., and Suzuki, T. 

Phrase: "21,"

Phrase: "65976607"

Phrase: "[Abstract/Free FullText"

Phrase: "] Taru,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kirino,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.792: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.793: Biol. 

Phrase: "Biol."
Processing 00000000.tx.794: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.795: 277, 2756727574[Abstract/Free FullText] Taru, H., Iijima, K. 

Phrase: "277,"

Phrase: "2756727574"

Phrase: "[Abstract/Free FullText"

Phrase: "] Taru,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Iijima,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.796: K., Hase, M., Kirino, Y., Yagi, Y., and Suzuki, T. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hase,"

Phrase: "M."

Phrase: ","

Phrase: "Kirino,"

Phrase: "Y.,"

Phrase: "Yagi,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.797: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.798: Biol. 

Phrase: "Biol."
Processing 00000000.tx.799: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.800: 277, 2007020078[Abstract/Free FullText] Verhey, K. 

Phrase: "277,"

Phrase: "2007020078"

Phrase: "[Abstract/Free FullText"

Phrase: "] Verhey,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.801: J., Meyer, D., Deehan, R., Blenis, J., Schnapp, B. 

Phrase: "J.,"

Phrase: "Meyer,"

Phrase: "D."

Phrase: ","

Phrase: "Deehan,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Blenis,"

Phrase: "J.,"

Phrase: "Schnapp,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.802: J., Rapoport, T. 

Phrase: "J.,"

Phrase: "Rapoport,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.803: A., and Margolis, B. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Margolis,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.804: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.805: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.806: 152, 959970[Abstract/Free FullText] Kamal, A., Almenar-Queralt, A., LeBlanc, J. 

Phrase: "152,"

Phrase: "959970"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kamal,"

Phrase: "A.,"

Phrase: "Almenar-Queralt,"

Phrase: "A.,"

Phrase: "LeBlanc,"

Phrase: "J."
Processing 00000000.tx.807: F., Roberts, E. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "E."
Processing 00000000.tx.808: A., and Goldstein, L. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Goldstein,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.809: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.810: (2001) Nature 414, 643648[CrossRef][Medline] [OrderarticleviaInfotrieve] Troy, C. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Nature 414,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "643648"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Troy,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1420811:TROY [Gene or Genome]
  1000   C1883402:Troy [Quantitative Concept]

Phrase: "C."
Processing 00000000.tx.811: M., Rabacchi, S. 

Phrase: "M."

Phrase: ","

Phrase: "Rabacchi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.812: A., Hohl, J. 

Phrase: "A.,"

Phrase: "Hohl,"

Phrase: "J."
Processing 00000000.tx.813: B., Angelastro, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Angelastro,"

Phrase: "J."
Processing 00000000.tx.814: M., Greene, L. 

Phrase: "M."

Phrase: ","

Phrase: "Greene,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.815: A., and Shelanski, M. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Shelanski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.816: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.817: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.818: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.819: 21, 50075016[Abstract/Free FullText]

Phrase: "21,"

Phrase: "50075016"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

